var title_f9_0_9216="Passy Muir speaking valves";
var content_f9_0_9216=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F61596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F61596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Passy-Muir tracheostomy speaking valves",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 441px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The mode of connection of Passy-Muir tracheostomy speaking valves in patients undergoing mechanical ventilation. The valve functions in a unidirectional manner such that inspiration is allowed to occur through the valve but expiration is not permitted. Consequently expiration occurs around the deflated or partially deflated tracheostomy tube cuff, permitting the patient to speak.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Manzano, JL, Lubillos, S, Henriquez, D, et al, Crit Care Med 1993; 21:512.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9216=[""].join("\n");
var outline_f9_0_9216=null;
var title_f9_0_9217="Erdosteine: International drug information";
var content_f9_0_9217=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Erdosteine: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4303779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Dostein (MX);",
"     </li>",
"     <li>",
"      Edirel (FR);",
"     </li>",
"     <li>",
"      Erdopect (FI);",
"     </li>",
"     <li>",
"      Erdotin (IT);",
"     </li>",
"     <li>",
"      Esteclin (MX);",
"     </li>",
"     <li>",
"      Mucofor (CH);",
"     </li>",
"     <li>",
"      Mucothera (BE);",
"     </li>",
"     <li>",
"      Vectrine (FR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1978705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Mucolytic Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1978708\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acute and chronic airway diseases such as bronchitis, rhinitis, sinusitis, laryngopharyngitis, and exacerbations of chronic bronchitis; preventive treatment of stable and chronic bronchitis in smokers; recurrent infectious episodes and related conditions; co-treatment with antibiotics in cases of bacterial exacerbations",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1978702\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Adults: Oral: 300 mg twice daily",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1978707\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule: 300 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10377 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-8D13A6BE0D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9217=[""].join("\n");
var outline_f9_0_9217=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4303779\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978705\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978708\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978702\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821075\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978707\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10377\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10377|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_0_9218="Infant ankyloglossia";
var content_f9_0_9218=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60685&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60685&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ankyloglossia in a newborn",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Abnormally short frenulum, inserting at the tip of the tongue in a neonate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9218=[""].join("\n");
var outline_f9_0_9218=null;
var title_f9_0_9219="Differential occlusion test";
var content_f9_0_9219=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Differential occlusion objection test",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Child is not bothered when amblyopic left eye is covered, but becomes fussy when normal right eye is covered.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission of American Academy of Ophthalmology from Coats, DK, Jenkins, RH. Refinements: Vision assessment of the patient 1:1. San Francisco: American Academy of Ophthalmology 1997.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9219=[""].join("\n");
var outline_f9_0_9219=null;
var title_f9_0_9220="Adrenal insufficiency (Addison's disease)";
var content_f9_0_9220=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Adrenal insufficiency (Addison's disease) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?9/0/9220/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/0/9220/contributors\" id=\"au4031\">",
"       Lynnette K Nieman, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?9/0/9220/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/0/9220/contributors\" id=\"se6385\">",
"       Andre Lacroix, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?9/0/9220/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/0/9220/contributors\" id=\"de5123\">",
"       Kathryn A Martin, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?9/0/9220?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ADRENAL INSUFFICIENCY OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     The adrenal glands are located on top of each kidney (",
"     <a class=\"graphic graphic_figure graphicRef67279 \" href=\"mobipreview.htm?26/50/27424\">",
"      figure 1",
"     </a>",
"     ) and normally produce three classes of hormones: glucocorticoids, mineralocorticoids, and androgens. Adrenal insufficiency occurs when the adrenal glands produce an insufficient amount of one or more of these classes of hormones.",
"    </p>",
"    <p>",
"     Early detection of adrenal insufficiency can be difficult, although treatment is usually successful once it is initiated. Treatment is tailored to the underlying cause and, in most cases, lifelong treatment is necessary. With appropriate treatment and a few added precautions, people with adrenal insufficiency can lead active lives and have a normal life expectancy.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      TYPES OF ADRENAL HORMONES",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Glucocorticoids",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cortisol is the main glucocorticoid produced by the adrenal gland. Adrenocorticotropin hormone (ACTH) is made in the pituitary and stimulates the adrenal gland to produce cortisol. Cortisol has many important functions including:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Helping to regulate glucose (blood sugar) levels",
"      </li>",
"      <li>",
"       Increase fat in the body",
"      </li>",
"      <li>",
"       Help to defend the body against infection",
"      </li>",
"      <li>",
"       Help the body respond to stress",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Mineralocorticoids",
"     </span>",
"     &nbsp;&mdash;&nbsp;Aldosterone is the main mineralocorticoid produced by the adrenal glands. It helps to regulate the body's sodium and potassium levels, blood volume, and blood pressure.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Androgens",
"     </span>",
"     &nbsp;&mdash;&nbsp;Androgen hormones, including testosterone, dehydroepiandrosterone (DHEA), and DHEA sulfate, are present in both men and women. In women, androgens are produced in the adrenal glands and the ovaries. In women, adrenal androgens promote the development of sex characteristics such as underarm and pubic hair.",
"    </p>",
"    <p>",
"     In men, most androgens (eg, testosterone) are produced in the testes. Androgens made by the adrenal glands are not as important for normal sexual function.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      ADRENAL GLAND PRODUCTION OF HORMONES",
"     </span>",
"    </p>",
"    <p>",
"     Cortisol levels are normally regulated by the hypothalamus and pituitary gland (",
"     <a class=\"graphic graphic_figure graphicRef52283 \" href=\"mobipreview.htm?13/54/14182\">",
"      figure 2",
"     </a>",
"     ). The hypothalamus sends corticotropin releasing hormone (CRH) to the pituitary gland. The pituitary gland responds by producing several hormones, one of which is ACTH (adrenocorticotropin hormone). ACTH stimulates the adrenal gland to produce cortisol. Cortisol levels help to control the pituitary's production of ACTH.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      PRIMARY ADRENAL INSUFFICIENCY",
"     </span>",
"    </p>",
"    <p>",
"     Primary adrenal insufficiency, also known as Addison's disease, occurs when the adrenal glands cannot produce an adequate amount of hormones despite a normal or increased ACTH level (",
"     <a class=\"graphic graphic_figure graphicRef52283 \" href=\"mobipreview.htm?13/54/14182\">",
"      figure 2",
"     </a>",
"     ). This is a rare disease, occurring in about 35 to 120 people in every one million people.",
"    </p>",
"    <p>",
"     Most patients with Addison's disease experience fatigue, generalized weakness, loss of appetite and weight loss. The type and severity of symptoms depends upon the speed with which the condition develops, the severity of the hormone deficiency, the underlying cause of the condition, and other stresses on the body. Other common symptoms include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Darkening of the skin, especially on the face, neck, and back of hands (",
"       <a class=\"graphic graphic_picture graphicRef74922 \" href=\"mobipreview.htm?39/63/40951\">",
"        picture 1",
"       </a>",
"       and",
"       <a class=\"graphic graphic_picture graphicRef56229 \" href=\"mobipreview.htm?20/61/21456\">",
"        picture 2",
"       </a>",
"       and",
"       <a class=\"graphic graphic_picture graphicRef66895 \" href=\"mobipreview.htm?2/54/2912\">",
"        picture 3",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Gastrointestinal symptoms such as nausea and vomiting (vomiting and abdominal pain may be a sign of an adrenal crisis) (see",
"       <a class=\"local\" href=\"#H22\">",
"        'Adrenal crisis'",
"       </a>",
"       below)",
"      </li>",
"      <li>",
"       Low blood pressure with lightheadedness after standing or sitting up",
"      </li>",
"      <li>",
"       Muscle and joint pain",
"      </li>",
"      <li>",
"       Salt cravings",
"      </li>",
"      <li>",
"       In women, decreased hair in the armpits and pubic area, and decreased sexual desire",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      SECONDARY AND TERTIARY ADRENAL INSUFFICIENCY",
"     </span>",
"    </p>",
"    <p>",
"     In secondary adrenal insufficiency, an insufficient amount of ACTH is produced by the pituitary gland. In tertiary adrenal insufficiency, an insufficient amount of CRH is produced by the hypothalamus.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;The symptoms of secondary and tertiary adrenal insufficiency are similar to those of primary insufficiency, with a few exceptions:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Darkening of the skin and dehydration do not occur",
"      </li>",
"      <li>",
"       Gastrointestinal symptoms are less common",
"      </li>",
"      <li>",
"       Symptoms of hypoglycemia (low blood sugar) are more common, including sweating, anxiety, shaking, nausea, or heart palpitations",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     A tumor or other growth in the pituitary or hypothalamus can cause other symptoms, including headaches and difficulty seeing objects in the periphery of vision (to the far left and right). Also, low levels of pituitary hormones can develop and may cause infertility, impotence, fatigue, hoarseness, constipation, or a delay in beginning puberty or short stature in children.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      ADRENAL INSUFFICIENCY DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     The diagnosis of adrenal insufficiency is a four part process:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       The blood cortisol level is measured",
"      </li>",
"      <li>",
"       Other tests are usually needed to confirm the diagnosis of adrenal insufficiency",
"      </li>",
"      <li>",
"       The level of the defect is determined (primary versus",
"       <span class=\"nowrap\">",
"        secondary/tertiary)",
"       </span>",
"       by measuring ACTH",
"      </li>",
"      <li>",
"       Once the level of the defect is known, further evaluation is done to determine the cause of the defect or to evaluate for other associated problems",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Cortisol and ACTH level testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;To determine a person's cortisol and ACTH level, a blood sample is taken early in the morning, usually at around 8 AM.",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       If the cortisol level is very low, the person is likely to have adrenal insufficiency.",
"      </li>",
"      <li>",
"       If the cortisol level is above a certain normal level, the person is very unlikely to have adrenal insufficiency.",
"      </li>",
"      <li>",
"       Many patients have cortisol results in an intermediate zone and need to have additional testing.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     A variety of other tests can be done to confirm the diagnosis of adrenal insufficiency.",
"    </p>",
"    <p>",
"     Most often, an ACTH stimulation test is done to establish the diagnosis. To perform this test, a blood sample is taken at any time of day to measure the \"baseline\" cortisol level. A high dose of ACTH is then given into a vein. A blood sample is then taken again 30 to 60 minutes later to measure the cortisol level. A low cortisol level after a dose of ACTH confirms that the person has adrenal insufficiency.",
"    </p>",
"    <p>",
"     Measurement of a blood ACTH level helps to determine if the problem lies within the adrenal gland (causing primary adrenal insufficiency) or in the pituitary or hypothalamus (causing secondary adrenal insufficiency):",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       If the ACTH level is high, the person probably has primary adrenal insufficiency.",
"      </li>",
"      <li>",
"       If the ACTH level is low, the person probably has secondary or tertiary adrenal insufficiency.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Determine the underlying cause",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      For primary adrenal insufficiency",
"     </span>",
"     &nbsp;&mdash;&nbsp;To determine the cause of primary adrenal insufficiency, the clinician must consider the patient's age, gender, and other medical problems. Most clinicians recommend an abdominal CT scan to evaluate the adrenal glands. In some cases, blood tests or a chest x-ray will also be recommended.",
"    </p>",
"    <p>",
"     In the past, tuberculosis was the most common cause of primary adrenal insufficiency. Currently, the most common cause of Addison's disease is autoimmune adrenalitis (a disease that causes the body to develop antibodies against the adrenal gland, eventually destroying it).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      For secondary/tertiary adrenal insufficiency",
"     </span>",
"     &nbsp;&mdash;&nbsp;Possible causes of secondary and tertiary adrenal insufficiency include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       An abnormal growth in the pituitary or hypothalamus",
"      </li>",
"      <li>",
"       Some people have deficiencies in ACTH and possibly other pituitary hormones (partial or panhypopituitarism) at birth; these are called congenital deficiencies",
"      </li>",
"      <li>",
"       Long-term treatment with glucocorticoid medications (eg, taking prednisone for asthma); this can interfere with normal pituitary function and is the most common cause of secondary adrenal insufficiency",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     The clinician will usually obtain a MRI scan of the pituitary gland as well as blood tests of pituitary hormones. The scan provides a detailed image, to determine if a mass or abnormal growth is present.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H15\">",
"     <span class=\"h1\">",
"      ADRENAL INSUFFICIENCY TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The treatment of adrenal insufficiency includes replacement of the deficient hormones. The goal of treatment is to relieve the symptoms of hormone deficiency without developing signs of hormone excess. Treatment usually requires lifelong hormone replacement. Correct use of these hormone medications is essential to minimize symptoms and the chance of adrenal crisis.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Primary insufficiency",
"     </span>",
"     &nbsp;&mdash;&nbsp;Treatment of adrenal insufficiency requires a daily dose of a glucocorticoid and mineralocorticoid pill, usually for life. Androgen replacement may be recommended for women. The goal of treatment is to stabilize hormone levels and relieve symptoms. Hormone levels must remain balanced to minimize symptoms and the chance of adrenal crisis (see",
"     <a class=\"local\" href=\"#H22\">",
"      'Adrenal crisis'",
"     </a>",
"     below). Fatigue and nausea usually begin to disappear within days of starting treatment.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h3\">",
"      Glucocorticoids",
"     </span>",
"     &nbsp;&mdash;&nbsp;Several options are available for replacing glucocorticoids; a clinician will work with the patient to determine the regimen that is most effective, convenient, and that causes minimal side effects.",
"    </p>",
"    <p>",
"     Many clinicians prescribe the short-acting preparation oral hydrocortisone (similar to cortisol produced normally), with two or three doses per day. The largest dose is taken in the early morning and a smaller dose is taken in mid morning and mid- afternoon; this mimics the normal variation in blood cortisol levels. Because hydrocortisone is available in a variety of doses, the amount of hydrocortisone can be adjusted easily, which may be an advantage over the longer acting glucocorticoids.",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       A longer acting glucocorticoid like prednisone is sometimes preferred because it can be taken once per day. Occasionally, a small additional dose is needed in the afternoon. It may be difficult to adjust the dose of these medications to avoid over-treatment.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Monitoring during treatment &mdash; The development of weight gain or a puffy face is a sign of possible overtreatment and the glucocorticoid dose is usually decreased as a result. Higher doses of glucocorticoids are of no benefit and may increase the risk of bone thinning (osteoporosis). A clinician will monitor closely for these complications.",
"      </li>",
"      <li>",
"       Dosing &mdash; The dose of any of glucocorticoids is tailored to the patient's body weight and age; obese people may need a higher dose, while children and small adults may need a lower dose. Adjustments in dose are often necessary when starting treatment.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h3\">",
"      Mineralocorticoids",
"     </span>",
"     &nbsp;&mdash;&nbsp;Mineralocorticoids are replaced with an oral, synthetic mineralocorticoid drug called fludrocortisone (Florinef&reg;). The dose of this medication is tailored to manage blood pressure and fluid balance.",
"    </p>",
"    <p>",
"     When the dose is adequate, there should be no problems with lightheadedness or dizziness when standing up. If the dose is too high, the person may notice swelling in the ankles, and the clinician may note hypertension (high blood pressure) or low blood potassium levels. In this case, the dose of fludrocortisone would be decreased.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h3\">",
"      Androgens",
"     </span>",
"     &nbsp;&mdash;&nbsp;Androgen replacement is sometimes recommended for women with primary adrenal insufficiency. A daily dose of dehydroepiandrosterone (DHEA) may improve libido and provide an improved overall sense of well-being. However, there are potential side effects associated with DHEA that are related to elevated androgen levels (eg, acne, facial hair, deepened voice). In addition, DHEA is only available as a dietary supplement in the United States. Because it is not regulated by the Food and Drug Administration, there are concerns about quality control and safety.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Secondary and tertiary insufficiency",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with secondary and tertiary adrenal insufficiency require only glucocorticoid replacement (not mineralocorticoid or androgen replacement). Doses may be adjusted frequently in the beginning. Treatment may also include replacement of other deficient pituitary hormones.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      ADRENAL CRISIS",
"     </span>",
"    </p>",
"    <p>",
"     Adrenal crisis refers to overwhelming and life-threatening adrenal insufficiency. The most common signs of adrenal crisis are shock (very low blood pressure with a loss of consciousness), dehydration, and an imbalance of sodium and potassium levels in the body. In some cases, shock is preceded by fever, nausea, vomiting, and abdominal pain, weakness or fatigue, and confusion. Adrenal crisis usually occurs after an infection, trauma, or another stressor.",
"    </p>",
"    <p>",
"     Adrenal crisis is a life-threatening condition that requires emergency medical treatment. The patient or a family member or friend should immediately give an emergency injection of a glucocorticoid at the first signs of adrenal crisis (see",
"     <a class=\"local\" href=\"#H25\">",
"      'Emergency precautions'",
"     </a>",
"     below). In the emergency department or ambulance, treatment usually includes giving several liters of a salt solution (saline) and an injection of a glucocorticoid (dexamethasone or another form of cortisol) into a vein. Mineralocorticoid treatment (if needed) is usually started at a later time, when the saline treatment is completed.",
"    </p>",
"    <p>",
"     Following treatment, it is important look for and treat any factors that may have triggered the crisis, such as infection.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H23\">",
"     <span class=\"h1\">",
"      ADRENAL INSUFFICIENCY PRECAUTIONS AND SPECIAL SITUATIONS",
"     </span>",
"    </p>",
"    <p>",
"     People with adrenal insufficiency should learn as much as possible about their condition and should be aware of early warning signs of hormone deficiency. It is also wise to share this information with family, friends, and any caregivers, so that they can also identify signs of trouble and be prepared to act in case of adrenal crisis.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      General precautions",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with adrenal insufficiency should wear a medical alert bracelet or necklace. They should also carry an emergency medical information card that lists the names and doses of their daily medications and the clinician and family member(s) to call in case of emergency. It is extremely important to identify early symptoms of adrenal deficiency and adrenal crisis; a clinician can describe subtle symptoms that should not be ignored.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h2\">",
"      Emergency precautions",
"     </span>",
"     &nbsp;&mdash;&nbsp;Even with careful use of medications and medical monitoring, some people with primary adrenal insufficiency will experience adrenal crisis. As a safety measure, the patient should always carry a syringe and a vial of dexamethasone (or another glucocorticoid). This system should be stored at home, at work or school, and in the patient's handbag or backpack.",
"    </p>",
"    <p>",
"     The patient or a family member or friend should give the injection into a muscle (usually the thigh) if any of the following occurs:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       After a major injury with substantial blood loss, fracture, or shock",
"      </li>",
"      <li>",
"       During an episode of nausea and vomiting if oral medications are thrown up",
"      </li>",
"      <li>",
"       If there are any signs or symptoms of adrenal crisis",
"      </li>",
"      <li>",
"       If a person is found unconscious",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Most people with adrenal insufficiency go years without needing an injection. However, the injection is recommended if there is any reason to believe it might be needed. There is little to no risk of being given an extra dose of a glucocorticoid while there are significant risks of having a low glucocorticoid level.",
"    </p>",
"    <p>",
"     After the injection is given, the patient should seek medical care immediately. After a major injury or if the person is found unconscious, it is best to call for emergency medical services. In the United States, most people can access emergency care by calling 911.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H26\">",
"     <span class=\"h2\">",
"      Illnesses, medical procedures, and surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;The adrenal glands normally increase cortisol output when the body is stressed by illness, major medical procedures, or surgery. People with adrenal insufficiency do not have this ability. The risk of adrenal crisis can be minimized by adjusting the dose of medications.",
"    </p>",
"    <p>",
"     During symptoms of a cold or flu, it is safe to double or triple the daily dose of glucocorticoid for three days without calling the doctor. However, if symptoms become worse during that time, or if it is not possible to return to the usual glucocorticoid dose on the fourth day, the healthcare provider should be called for advice.",
"    </p>",
"    <p>",
"     It is important to call the provider if there are any signs of a stomach illness with nausea, diarrhea, or vomiting. It is also important to call before any medical procedures or surgery. The provider will usually recommend temporarily increasing the glucocorticoid dose for these types of stresses.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27\">",
"     <span class=\"h2\">",
"      Pregnancy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most women who have primary adrenal insufficiency are able to have a healthy pregnancy, labor, and delivery. During this time, it is important to take medications on schedule and have careful monitoring of the growing fetus as well as the woman's adrenal insufficiency. Some women require changes in glucocorticoid doses, especially during the third trimester and during labor. Women who have severe morning sickness may need to switch from oral medication to injected medication until the morning sickness subsides.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H28\">",
"     <span class=\"h1\">",
"      ADRENAL INSUFFICIENCY PROGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     The long term outlook is good for most people with adrenal insufficiency who are treated and monitored. Most people can lead an active life, and have a normal life expectancy. Children with adrenal insufficiency who are treated and monitored carefully can grow normally and experience puberty without difficulty.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H29\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12675498\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12675506\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/26/20898?source=see_link\">",
"      Patient information: Addison&rsquo;s disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?5/61/6099?source=see_link\">",
"      Patient information: Cushing's syndrome (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/19/11570?source=see_link\">",
"      Patient information: Adrenal crisis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/10/38050?source=see_link\">",
"      Patient information: Panhypopituitarism (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12675532\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     This topic has no corresponding Beyond the Basics information.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H30\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/0/40969?source=see_link\">",
"      Causes of primary adrenal insufficiency (Addison's disease)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/50/3880?source=see_link\">",
"      Causes of secondary and tertiary adrenal insufficiency in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/0/33800?source=see_link\">",
"      Clinical manifestations of adrenal insufficiency in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/46/44777?source=see_link\">",
"      Diagnosis of adrenal insufficiency in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/20/24905?source=see_link\">",
"      Evaluation of the response to ACTH in adrenal insufficiency",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/17/25876?source=see_link\">",
"      Hyponatremia and hyperkalemia in adrenal insufficiency",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/42/9896?source=see_link\">",
"      Pathogenesis of autoimmune adrenal insufficiency",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/47/42745?source=see_link\">",
"      Treatment of adrenal insufficiency in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/22/31078?source=see_link\">",
"      Treatment of adrenal insufficiency in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/7/12408?source=see_link\">",
"      Unusual causes of adrenal insufficiency",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Diabetes and Digestive and Kidney Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.niddk.nih.gov/\">",
"      www.niddk.nih.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Hormone Health Network",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp; (",
"     <a class=\"external\" href=\"file://www.hormone.org/\">",
"      www.hormone.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Adrenal Diseases Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nadf.us/\">",
"      www.nadf.us",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?9/0/9220/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 30, 2013.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?9/0/9220?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9220/abstract/1\">",
"      Peacey SR, Guo CY, Robinson AM, et al. Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf) 1997; 46:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9220/abstract/2\">",
"      Barnhart KT, Freeman E, Grisso JA, et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 1999; 84:3896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9220/abstract/3\">",
"      Grant DB, Barnes ND, Moncrieff MW, Savage MO. Clinical presentation, growth, and pubertal development in Addison's disease. Arch Dis Child 1985; 60:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9220/abstract/4\">",
"      Jadoul M, Ferrant A, De Plaen JF, Crabb&eacute; J. Mineralocorticoids in the management of primary adrenocortical insufficiency. J Endocrinol Invest 1991; 14:87.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f9_0_9220=[""].join("\n");
var outline_f9_0_9220=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ADRENAL INSUFFICIENCY OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           TYPES OF ADRENAL HORMONES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           ADRENAL GLAND PRODUCTION OF HORMONES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           PRIMARY ADRENAL INSUFFICIENCY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           SECONDARY AND TERTIARY ADRENAL INSUFFICIENCY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           ADRENAL INSUFFICIENCY DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H15\">",
"           ADRENAL INSUFFICIENCY TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           ADRENAL CRISIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H23\">",
"           ADRENAL INSUFFICIENCY PRECAUTIONS AND SPECIAL SITUATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H28\">",
"           ADRENAL INSUFFICIENCY PROGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H29\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/50/27424\" title=\"figure 1\">",
"           Endocrine glands PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?13/54/14182\" title=\"figure 2\">",
"           Cortisol production PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/63/40951\" title=\"picture 1\">",
"           Hyperpigmentation in Addisons disease",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/61/21456\" title=\"picture 2\">",
"           Buccal hyperpigmentation PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/54/2912\" title=\"picture 3\">",
"           Pigmented nails Addisons PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f9_0_9221="Centerline measurements or abdominal aorta";
var content_f9_0_9221=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F81447&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F81447&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 604px\">",
"   <div class=\"ttl\">",
"    Centerline measurements of abdominal aorta",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 584px; height: 292px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Centerline measurement of AAA allows the accurate measurement of the treatment length and the landing zone diameters, accounting for tortuosity. It also allows an accurate estimation of the aortic neck angulation between the renal arteries and the aneurysm sac.",
"    <div class=\"footnotes\">",
"     AAA: abdominal aortic aneurysm; AP: antero-posterior.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9221=[""].join("\n");
var outline_f9_0_9221=null;
var title_f9_0_9222="LCDD in bone marrow";
var content_f9_0_9222=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F82433&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F82433&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 549px\">",
"   <div class=\"ttl\">",
"    Bone marrow in light chain deposition disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 529px; height: 251px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immunoperoxidase stain of a bone marrow biopsy from a patient with light chain deposition diesease shows the presence of cells with monoclonal kappa light chains (left panel) but not lambda light chains (right panel).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9222=[""].join("\n");
var outline_f9_0_9222=null;
var title_f9_0_9223="T cell targeted therapies for rheumatoid arthritis";
var content_f9_0_9223=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   T cell targeted therapies for rheumatoid arthritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?9/0/9223/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/0/9223/contributors\">",
"     Vibeke Strand, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/0/9223/contributors\">",
"     Edward Keystone, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?9/0/9223/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/0/9223/contributors\">",
"     RN Maini, BA, MB BChir, FRCP, FMedSci, FRS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?9/0/9223/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/0/9223/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?9/0/9223/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rationale for using T cell targeted therapies for the treatment of rheumatoid arthritis (RA) stems from data that highlight the role of T cells in disease pathogenesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/15/41210?source=see_link\">",
"     \"Pathogenesis of rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The data include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Animal models of inflammatory arthritis that demonstrate a crucial role for antigen-specific CD4+ T cells",
"     </li>",
"     <li>",
"      The presence of an intense CD4+ T cell infiltrate within rheumatoid synovium",
"     </li>",
"     <li>",
"      The association between the inheritance of certain major histocompatibility complex (MHC) class II alleles and the development of RA. MHC class II alleles are required for antigen presentation to T cells. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/63/23546?source=see_link\">",
"       \"HLA and other susceptibility genes in rheumatoid arthritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Clinical data from the 1980s and 1990s suggesting that RA symptoms improved following lymphocyte depletion mediated by apheresis or total lymphoid irradiation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review the use of T cell targeted therapies for the treatment of RA. Other biologic therapies and conventional approaches to the treatment of RA are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/11/39098?source=see_link\">",
"     \"General principles of management of rheumatoid arthritis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/10/10410?source=see_link\">",
"     \"Randomized clinical trials of tumor necrosis factor inhibitors in rheumatoid arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21130?source=see_link\">",
"     \"Rituximab and other B cell targeted therapies for rheumatoid arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/12/35016?source=see_link\">",
"     \"Randomized clinical trials in rheumatoid arthritis of biologic agents that inhibit IL-1, IL-6, and RANKL\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     T CELL TARGET SITES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several sites on the T cell are potential targets for biologic therapies. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cytotoxic T lymphocyte-associated antigen 4 (CTLA4) &mdash; CTLA4 is an inhibitory receptor on the T cell surface that binds with either CD80 or CD86 on antigen presenting cells. CD80 and CD86 are also known as B7-1 and B7-2, respectively, and are sometimes referred to simply as B7. The binding of CTLA4 eventually leads to the termination of an immune response.",
"     </li>",
"     <li>",
"      Surface antigens &mdash; CD4 is an antigen that was believed to be unique to T helper cells but is now known to be present on other functional subpopulations such as T regulatory cells. Attempts to interrupt the function of T cells through the administration of both depleting and non-depleting monoclonal antibodies (mAb) were among the first attempts at developing biologic agents for the rheumatic diseases.",
"     </li>",
"     <li>",
"      T cell receptors &mdash; T cell receptors (TcR) expressed on pathogenic synovial T cells offer another potential target for therapy. The rationale for this method is based upon the assumption that these T cells express a limited set of TcRs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/2,3\">",
"       2,3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Class II MHC antigens &mdash; Class II MHC antigens combine with the TcR and antigen to form the \"trimolecular complex,\" which is central to immune responses. Attempts to prevent immune responses by targeting specific class II MHC molecules that bind culprit antigen are limited because of the lack of information regarding the specific antigen(s) recognized by pathogenic T cells in RA.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All four of these sites have been targeted in laboratory models and in clinical trials in humans with RA. Future efforts may involve the upregulation of T regulatory cells (CD25hi, FoxP3+).",
"   </p>",
"   <p>",
"    An effective approach of interfering with T cell function through the binding of CTLA4, leading to inhibition of the \"second signal\" required for T cell activation, has been developed. This approach is discussed first.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     COSTIMULATORY MOLECULE INHIBITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Activation of T cells by antigen-presenting cells requires two distinct signals. First, the trimolecular complex must be formed, consisting of the T cell receptor (TcR), antigenic peptide, and MHC class II molecule from the antigen-presenting cell. Second, binding of cell surface costimulatory molecules that provide an essential \"second signal\" for activation must occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/4-6\">",
"     4-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two important costimulatory systems have been delineated:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CD28 (an activation receptor)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      CTLA4 (an inhibitory receptor) can bind to one of two other proteins, CD80 or CD86 (B7-1 or B7-2) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CD40 binds to CD40 ligand (also known as CD40L, CD154, or gp39) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These costimulatory molecules regulate T cell activation and T cell-dependent B cell function. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/27/10682?source=see_link&amp;anchor=H12#H12\">",
"     \"Transplantation immunobiology\", section on 'T-cell costimulation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     CD28/CTLA4 system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attempts to inhibit the second signal by manipulating the",
"    <span class=\"nowrap\">",
"     CD28/CTLA4",
"    </span>",
"    costimulatory system have been more successful than have attempts to disrupt the",
"    <span class=\"nowrap\">",
"     CD40/CD40",
"    </span>",
"    ligand system.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Abatacept",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"     Abatacept",
"    </a>",
"    (CTLA4-Ig) is a soluble fusion protein that is effective for the treatment of RA. It consists of the extracellular domain of CTLA4 and the Fc portion of IgG1. CTLA4-Ig binds CD80 (B7-1) and CD86 (B7-2) on antigen presenting cells, thereby acting as a competitive inhibitor of the CD28-B7 costimulatory interaction. Because soluble CTLA4-Ig binds to CD80 (B7-1) and CD86 (B7-2), it prevents the second activation signal received by T cells via CD28 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"     Abatacept",
"    </a>",
"    is available in a number of countries. It has been approved by the United States Food and Drug Administration for the treatment of patients with moderately to severely active RA who have had an inadequate response to one or more disease modifying antirheumatic drugs (DMARDs) or TNF inhibitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy and safety of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"     abatacept",
"    </a>",
"    in RA has been analyzed in a 2009 meta-analysis, which included seven randomized trials with 2908 patients and which compared abatacept alone or in combination with nonbiologic or biologic DMARDs with placebo alone or in combination with nonbiologic or biologic DMARDs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Patients on abatacept were significantly more likely to achieve an ACR50 response at one year (relative risk, RR, 2.2, 95% CI 1.7-2.8, and absolute risk difference of 21 percent, 95% CI 16-27 percent). Improvements in physical function and reduction in disease activity and pain were also significant.",
"   </p>",
"   <p>",
"    There was a significantly increased number of serious infections at 12 months in the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"     abatacept",
"    </a>",
"    -treated patients (Peto odds ratio, OR, 1.9, 95% CI 1.1-3.4), a finding consistent with trends observed in another meta-analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/13\">",
"     13",
"    </a>",
"    ]. Serious adverse events were also increased when abatacept was used in combination with other biologic DMARDs (RR 2.3, 95% CI 1.2-4.6). Serious infections most commonly associated with abatacept were those of the bronchopulmonary tree.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"     Abatacept",
"    </a>",
"    was initially available only for intravenous (IV) use but can also be administered subcutaneously (SC) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/9,14\">",
"     9,14",
"    </a>",
"    ]. The manufacturer recommends that weekly SC administration should be preceded by an IV loading dose, although, in patients unable to receive an infusion, the loading dose is not required [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy and safety of the SC and IV preparations of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"     abatacept",
"    </a>",
"    were comparable in a randomized trial involving 1457 patients with a previous inadequate response to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/14\">",
"     14",
"    </a>",
"    ]. The efficacy of abatacept SC (125 mg SC on days one and eight, then weekly, plus an IV loading dose on day one of approximately 10",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    was comparable to abatacept IV (approximately 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV on days 1, 15, 29, then every four weeks) in achieving an ACR20 response after six months of treatment (both 76 percent). The onset and magnitude of the responses, disease activity, improvements in physical function, and adverse effects were also comparable. Injection site reactions were mostly mild and were as frequent in patients receiving the active SC drug as in those receiving SC placebo (2.5 to 2.6 percent).",
"   </p>",
"   <p>",
"    A number of studies have also documented the efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"     abatacept",
"    </a>",
"    in certain important subsets of patients with RA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/16-22\">",
"     16-22",
"    </a>",
"    ]. These include patients with active RA resistant to either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    (MTX) or the combination of MTX and a tumor necrosis factor (TNF) inhibitor, as well as MTX-naive patients with early RA and poor prognostic factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/17,18,22\">",
"     17,18,22",
"    </a>",
"    ]. In studies evaluating radiographic outcomes, abatacept demonstrated significant inhibition of radiographic progression in addition to clinical improvement. Additionally, two-year follow-up data for one of the trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/22\">",
"     22",
"    </a>",
"    ], which compared abatacept plus MTX with MTX alone in early RA patients with erosive joint disease, showed sustained clinical benefit and no added safety concerns with the combination therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/23\">",
"     23",
"    </a>",
"    ]. The patients receiving abatacept plus MTX also experienced statistically significantly less radiographic progression (change in Genant-modified Sharp total score of 0.84 versus 1.75).",
"   </p>",
"   <p>",
"    Treatment of RA patients with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"     abatacept",
"    </a>",
"    has not been associated with an increased frequency of malignancy in the abatacept clinical trials participants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/24\">",
"     24",
"    </a>",
"    ]. Abatacept should not be used concurrently with TNF inhibitors or with the interleukin-1 receptor antagonist,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/294?source=see_link\">",
"     anakinra",
"    </a>",
"    . Live vaccines should not be given concurrently or within three months of stopping abatacept.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Belatacept",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/41/43669?source=see_link\">",
"     Belatacept",
"    </a>",
"    is a second-generation CTLA4-Ig that has superior binding to CD80 and CD86 compared with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"     abatacept",
"    </a>",
"    . This medication has been used primarily in organ transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/6/44135?source=see_link\">",
"     \"Investigational immunosuppressive drugs and approaches in clinical kidney transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     CD40/CD40 ligand system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical trials designed to inhibit the",
"    <span class=\"nowrap\">",
"     CD40/CD40",
"    </span>",
"    ligand system and thereby block costimulation have been attempted in systemic lupus erythematosus, without demonstration of efficacy and with significant thromboembolic complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/26\">",
"     26",
"    </a>",
"    ]. No trials using this approach have been attempted in RA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ANTI-CD4 MONOCLONAL ANTIBODIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, monoclonal antibodies (mAb) directed against CD4 were among the first approaches to the development of biologic therapies for rheumatic diseases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Both depleting and non-depleting mAbs against CD4 were determined to be ineffective in randomized clinical trials. The results of these trials are discussed briefly because of their impact on the subsequent design of clinical trials of biologic agents in RA.",
"   </p>",
"   <p>",
"    Between 1989 and 1995, there were eight open trials involving 129 patients treated with anti-CD4 monoclonal antibodies (mAb). All eight reported clinical benefit. However, three subsequent randomized, double-blind, placebo-controlled trials involving a total of 133 patients all reported negative results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. The discordance between the open-label studies and randomized trial results was attributed to both the strong placebo effect and expectation bias (ie, false assumptions on the part of the investigators that the therapies would be effective) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of observations may explain the lack of clinical efficacy following depleting mAb treatment:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Depletion of peripheral CD4+ T cells, although profound, may have been inadequate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/32\">",
"       32",
"      </a>",
"      ]. Peripheral CD4+ T cell counts were found to be profoundly depressed following administration of either of the two mAb used in these trials [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/33-35\">",
"       33-35",
"      </a>",
"      ]. This effect persisted for as long as 5 to 10 years. However, synovial tissue CD4+ T cell infiltrates were affected only modestly by the administration of the depleting mAb [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Naive T cells are more susceptible than activated T cells to the effects of depleting mAbs. As a result, the pathogenic T cells in RA may not have been affected. Subset analyses of peripheral T cell populations revealed a diminution in the naive T cell population (CD45RA+ cells) but not in the memory population (CD45RO+ cells).",
"     </li>",
"     <li>",
"      Since the CD4 antigen is found not only on T helper cells but also on effector and regulatory T cells, CD4-directed antibody targeted all three T cell subtypes, making the possible therapeutic effect unpredictable.",
"     </li>",
"     <li>",
"      Most of the studies noted above were performed in patients with refractory RA, who may be less likely to respond to any form of therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/33,37,38\">",
"       33,37,38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Non-depleting monoclonal antibody treatment trials were similarly unsuccessful in the treatment of RA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     THE TRIMOLECULAR COMPLEX",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, the trimolecular binding complex consists of the MHC class II molecule, its cognate antigen, and the TcR. Antigen-presenting cells present peptides derived from antigens that are bound to the MHC molecule, thereby activating the T cell via its receptor. Interference with MHC binding of antigen could prevent or diminish T cell mediated responses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     TcR inhibition",
"    </span>",
"    &nbsp;&mdash;&nbsp;A clonal expansion of antigen&ndash;specific arthritogenic T cells occurs in both collagen-induced arthritis (CIA) and adjuvant arthritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/40\">",
"     40",
"    </a>",
"    ]. In these animal models, immunization with synthetic peptides based upon the antigen-specific T cell receptors has been shown to prevent or ameliorate disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/41\">",
"     41",
"    </a>",
"    ]. These effects are specific to the peptide administered, and adoptive transfer of serum from these animals delays the onset of arthritis in recipient animals. These observations suggest that the benefits observed are due to antibodies reactive with the pathogenic forms of the TcR and that these antibodies contribute to the elimination or downregulation of pathogenic T cells.",
"   </p>",
"   <p>",
"    A similar preferential expansion of antigen-specific T cells has been sought in humans. Although most of the data are consistent with the conclusion that the synovial T cell infiltrate in RA patients is heterogeneous, overexpression of specific TcRs (V-beta 3, 14, and 17) has been demonstrated following interleukin-2 stimulated expansion in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/42\">",
"     42",
"    </a>",
"    ]. In one study, V beta 14+ T cells were overexpressed in synovial fluid but were virtually undetectable in peripheral blood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/42\">",
"     42",
"    </a>",
"    ]. Clinical trials utilizing the administration of V-beta peptides by either oral or nasal installation have failed repeatedly.",
"   </p>",
"   <p>",
"    These results suggest that therapy aimed at T cells in the peripheral blood rather than within the synovium are likely to be less effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/36\">",
"     36",
"    </a>",
"    ]. However, attempts to extend these results to the clinic have met with limited success [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     MHC ANTAGONISTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Administration of anti-MHC class II mAbs to block peptide-MHC binding ameliorates CIA, and immunization with DRB1-derived peptides can prevent CIA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/43\">",
"     43",
"    </a>",
"    ]. Based upon the finding that a shared DR epitope is present in more than 50 percent of patients with RA, the efficacy",
"    <span class=\"nowrap\">",
"     DR4/DR1",
"    </span>",
"    peptide immunization was evaluated in 52 patients with RA who were heterozygous for HLA-DR4 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9223/abstract/44\">",
"     44",
"    </a>",
"    ]. However, enzyme immunoassays failed to demonstrate",
"    <span class=\"nowrap\">",
"     anti-DR4/1",
"    </span>",
"    antibody production by any of the patients. No significant differences in clinical efficacy were noted between those patients who were immunized and those who were not.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Several sites on the T cell are potential targets for biologic therapies. These include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Blockade of",
"      <span class=\"nowrap\">",
"       B7/CD28",
"      </span>",
"      interactions",
"     </li>",
"     <li>",
"      Surface antigens such as CD4",
"     </li>",
"     <li>",
"      T cell receptors",
"     </li>",
"     <li>",
"      Class II MHC antigens",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the future, approaches designed to upregulate the function of T regulatory cells (CD25hi, FoxP3+) may play a role in the treatment of RA. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'T cell target sites'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      To date, only costimulatory molecule inhibition (as typified by soluble CTLA4-Ig) has been demonstrated to be effective in the treatment of RA. The binding of soluble CTLA4-Ig has an inhibitory effect on T cells, leading to termination of the immune response. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Costimulatory molecule inhibition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"       Abatacept",
"      </a>",
"      (CTLA4-Ig) is a soluble fusion protein that consists of CTLA4 and the Fc portion of IgG1. Through its high affinity binding for CD28, CTLA4-Ig interferes with the binding of CD80 (B7-1) or CD86 (B7-2) to CD28, thereby inhibiting transmission of the second signal required for T cell activation. Abatacept was initially available only for intravenous use but can also be administered subcutaneously. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Abatacept'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Biologic agents directed against CD4, the T cell receptor, and class II MHC antigens have been unsuccessful in the clinic. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Anti-CD4 monoclonal antibodies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'The trimolecular complex'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'MHC antagonists'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/1\">",
"      Lipsky PE, Davis LS. The central involvement of T cells in rheumatoid arthritis. The Immunologist 1998; 6:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/2\">",
"      Kotzin BL, Kappler J. Targeting the T cell receptor in rheumatoid arthritis. Arthritis Rheum 1998; 41:1906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/3\">",
"      Moreland LW, Morgan EE, Adamson TC 3rd, et al. T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides. Arthritis Rheum 1998; 41:1919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/4\">",
"      Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/5\">",
"      Foy TM, Aruffo A, Bajorath J, et al. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 1996; 14:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/6\">",
"      Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338:1813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/7\">",
"      Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/8\">",
"      Quattrocchi E, Dallman MJ, Feldmann M. Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis. Arthritis Rheum 2000; 43:1688.",
"     </a>",
"    </li>",
"    <li>",
"     Orencia (abatacept) full prescribing information. file://packageinserts.bms.com/pi/pi_orencia.pdf (Accessed on October 10, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/10\">",
"      Abatacept (Orencia) for rheumatoid arthritis. Med Lett Drugs Ther 2006; 48:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/11\">",
"      Maxwell L, Singh JA. Abatacept for rheumatoid arthritis. Cochrane Database Syst Rev 2009; :CD007277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/12\">",
"      Maxwell LJ, Singh JA. Abatacept for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol 2010; 37:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/13\">",
"      Salliot C, Dougados M, Gossec L. Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials. Ann Rheum Dis 2009; 68:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/14\">",
"      Genovese MC, Covarrubias A, Leon G, et al. Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate. Arthritis Rheum 2011; 63:2854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/15\">",
"      Nash P, Ludivico C, Delaet I, et al. Improvements in disease activity and physical function in patients with RA receiving subcutaneous abatacept in the presence or absence of an initial loading dose. Ann Rheum Dis 2011; 70(Suppl3):615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/16\">",
"      Kremer JM, Westhovens R, Leon M, et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003; 349:1907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/17\">",
"      Kremer JM, Genant HK, Moreland LW, et al. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. Ann Intern Med 2006; 144:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/18\">",
"      Genovese MC, Becker JC, Schiff M, et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N Engl J Med 2005; 353:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/19\">",
"      Kremer JM, Genant HK, Moreland LW, et al. Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis Rheum 2008; 58:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/20\">",
"      Kremer JM, Dougados M, Emery P, et al. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005; 52:2263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/21\">",
"      Weinblatt M, Combe B, Covucci A, et al. Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study. Arthritis Rheum 2006; 54:2807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/22\">",
"      Westhovens R, Robles M, Ximenes AC, et al. Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors. Ann Rheum Dis 2009; 68:1870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/23\">",
"      Bathon J, Robles M, Ximenes AC, et al. Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes. Ann Rheum Dis 2011; 70:1949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/24\">",
"      Simon TA, Smitten AL, Franklin J, et al. Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment. Ann Rheum Dis 2009; 68:1819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/25\">",
"      Vincenti F, Luggen M. T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation. Annu Rev Med 2007; 58:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/26\">",
"      Kalunian KC, Davis JC Jr, Merrill JT, et al. Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002; 46:3251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/27\">",
"      Ridgeway W, Fathman CG. Anti-CD4 in the treatment of rheumatoid arthritis: A reappraisal. The Immunologist 1996; 4:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/28\">",
"      Strand V, Kimberly R, Isaacs JD. Biologic therapies in rheumatology: lessons learned, future directions. Nat Rev Drug Discov 2007; 6:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/29\">",
"      Epstein WV. Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience. Arthritis Rheum 1996; 39:1773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/30\">",
"      Choy EH, Pitzalis C, Cauli A, et al. Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens. Arthritis Rheum 1996; 39:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/31\">",
"      Choy EH, Chikanza IC, Kingsley GH, et al. Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody. Scand J Immunol 1992; 36:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/32\">",
"      Marchal G, Seman M, Milon G, et al. Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J Immunol 1982; 129:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/33\">",
"      Moreland LW, Pratt PW, Bucy RP, et al. Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term followup of CD4+ T cell counts. Arthritis Rheum 1994; 37:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/34\">",
"      Moreland LW, Bucy RP, Jackson B, et al. Long term (5 years) follow up of RA patients treated with a depleting anti-CD4 mAb, cM-T412 (abstract). Arthritis Rheum 1996; 39:S244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/35\">",
"      Brett S, Baxter G, Cooper H, et al. Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H. Immunology 1996; 88:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/36\">",
"      Ruderman EM, Weinblatt ME, Thurmond LM, et al. Synovial tissue response to treatment with Campath-1H. Arthritis Rheum 1995; 38:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/37\">",
"      Matteson EL, Yocum DE, St Clair EW, et al. Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injection. Arthritis Rheum 1995; 38:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/38\">",
"      Weinblatt ME, Maddison PJ, Bulpitt KJ, et al. CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study. Arthritis Rheum 1995; 38:1589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/39\">",
"      Schulze-Koops H, Davis LS, Haverty TP, et al. Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4. J Rheumatol 1998; 25:2065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/40\">",
"      Osman GE, Toda M, Kanagawa O, Hood LE. Characterization of the T cell receptor repertoire causing collagen arthritis in mice. J Exp Med 1993; 177:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/41\">",
"      Haqqi TM, Qu XM, Anthony D, et al. Immunization with T cell receptor V beta chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice. J Clin Invest 1996; 97:2849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/42\">",
"      Paliard X, West SG, Lafferty JA, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991; 253:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/43\">",
"      Cooper SM, Sriram S, Ranges GE. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. J Immunol 1988; 141:1958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9223/abstract/44\">",
"      St Clair EW, Cohen SB, Lee ML, et al. Treatment of rheumatoid arthritis with a DR4/1 peptide. J Rheumatol 2000; 27:1855.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7479 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-2EE9D05621-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9223=[""].join("\n");
var outline_f9_0_9223=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      T CELL TARGET SITES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      COSTIMULATORY MOLECULE INHIBITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CD28/CTLA4 system",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Abatacept",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Belatacept",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CD40/CD40 ligand system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ANTI-CD4 MONOCLONAL ANTIBODIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      THE TRIMOLECULAR COMPLEX",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      TcR inhibition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MHC ANTAGONISTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/11/39098?source=related_link\">",
"      General principles of management of rheumatoid arthritis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/63/23546?source=related_link\">",
"      HLA and other susceptibility genes in rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/6/44135?source=related_link\">",
"      Investigational immunosuppressive drugs and approaches in clinical kidney transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/15/41210?source=related_link\">",
"      Pathogenesis of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/12/35016?source=related_link\">",
"      Randomized clinical trials in rheumatoid arthritis of biologic agents that inhibit IL-1, IL-6, and RANKL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/10/10410?source=related_link\">",
"      Randomized clinical trials of tumor necrosis factor inhibitors in rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21130?source=related_link\">",
"      Rituximab and other B cell targeted therapies for rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/27/10682?source=related_link\">",
"      Transplantation immunobiology",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_0_9224="Developmental milestones 24 through 42 mos A";
var content_f9_0_9224=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68086%7EPEDS%2F79265&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68086%7EPEDS%2F79265&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Developmental milestones: 24 months through 3 years six months",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 652px; background-image: url(data:image/gif;base64,R0lGODlhYgKMAsQAAP///+rq6gAAAIiIiERERLu7uyIiIt3d3ZmZmTMzMxEREcDAwGZmZu7u7szMzHd3d6qqqlVVVRAQEH19fU5OTi8vL9ra2pycnD4+Pm1tbR8fH8vLy4yMjF5eXqysrAAAACH5BAAAAAAALAAAAABiAowCAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbkMF8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkHsiAgGVlpeYmZqbnJ2en5WUoKOkpaaXoqeqq5+prK+lrrCzq7K0t7O2uLuqury/nAKTwMSmvsXImMfJuMvMsc/IztHA09S81tevwgDZ2rTe37Dh4q3lp+TnwerS7MXp7sHD8b/w9J729/na+/H995n+AUQ1cNu8grkQglNISuAzh+cgDpQIkKI6bhbpZfTHcNTGeh1BfWQ38mLIWAdP/xpT2YvlOpUlmcUsN1NczYcpNRUQQAHXBQETfAIN6HIlSw8CPChjeZMVBgwv1VngeUlC0G1FoWWV1y0TBwlwJuzseevnVU8SJHwyS3SryExg4VSYMPTX1AqkOuBdCrNTgQpwMlhQlTYA4MGFR20QcCGqKg4aBGgQ7GlspqlkA3wdjHVUBjkcaB0OkPiWMwpyOAOzzAojpp89N2BgTYtt2boE3ZrDJGFvsrukrLY9ecxC78GzX402NUFDp3yLYydXhdkShsytSX1urEHtrOXYPKFW3dH1JQwCNljaWSFyhgCo0VugK7kAaQnoocqG0yEAW9QCYDDYZwIUVoFaFwAmQP8GP8EhoG256fYcXL6ZRRd6jPkXmQChWZIWehSgVsFgAAoIoAAF0KeBfR/utdlwIR1DV4eVXLBhaBtEBtYEF8LR2IH0AXWgcc7RdYGNcNA42YSrIFVBBuoFsJ8A/U05Ik9TwbFidVJmOI52GWrgHHwOWmBlACoWsNOGGQQ5wYE/9UeBBBYgyaFWnIxnnQQbdMAYapFpsEGPR96IZhwT2EkBZp+FpgFeJZIXUE4HXrITVN2Rad9P74l5XwB+ejAkXYkCtd1YSPVkoFoSjHnJZ6WeZUlT19gS14IWArUYVBL0VKmHaqHnwYynYikAXpwG4GlpAVynCa3ZbfKZfZUYByn/iuilCBSpuxqm1miVolYABs716m0lSFG7yT4nQjUqUNlWS1WNxpLV3EKexSHooQWYFW8ASE1g3GxUAbYBuGqJaZyqvnrnkXhxqGVBd0OJGyeplZh74GK+dccZZqhuiyKEz+aEXpQBWHaYuIcGNV5h2xW2E4NAsdwbxqvSNi6iJIciIT4UWpKrwMfuJIe6hYlLqs1X4oXxyw7v1BiM5XEy43pUGVkYqaQCVynC/lG5oNFx2EeBb+vOkgF6X6k1c2mYWeAnHIvOu2RC+V6AXmMn8lRakAVaJi7Yn/l5AdlwqLtbngKQR5d34o6FMeIoAiiBtmFVd2AHdPaN3aRdXcIB/1Wyqdw4y8kuq9Z278ZaLAXJrkqab58NC1TPAUAbja0Vikw0Xr1pkjSKpL5OmnOpl+twBq7yRRwnGxzXbAHBD04n10B5HWx65yqb+OyXGCfrs6xcsGgA07aOAZ/ywg7UWNX9pHi0oGwXfZF3VrJ+lEj1V4llmTrZuRYjmYyhrSEQU030dqQp7F0leJigy3tSdqzqjC5r+cNHTtAUFw6YzgIsO1R9PmU/DPXnP2UiU3e+hSAFCQYwkYkV1X7mPA/1jkfZO5Z/FNQ4YDWwYimcG+ZW9KlKaGB8s2JKJxKUOTuFhnqS8Z32NBOWX9FlL0yEw3wc5hhTbCADYNEAjkwoJf8MXakngKoXfKCCr/pliC79mduCzjSBuFRgJ2CRQGMu+CbvoGeCWezhwzrRNwtszE8cQA1YoIKxHZYtDgKKy5bmBZapyXGC69ogO6LHxs7QkHwh+QnKali1WYSKFxXwH5PiYRwafSkatElGP0JIEk2WQ0F3xNsnZ5gV3bWkfHHAJD92CcpnxLIdr6DlRWz5SV/KhIbONIqEoolMYkaomcyEpjVJuZV8TKtZ86qEMjHBpbcQY5wgUcmvBkmKdZYSFO4siHm26TNO7IxKrnwGeKS5C4stqGXp1ARkJEMZTExrdPlEpyXKubhfKHQTx2woMbYD0FPEE2iluChCvKFRfWT/82fF6Y16JqDKaOwTT8BI1js2EZ0yzg99xPOSJR4aAIZiFBg0NQ0zKKocLkr0Ex2dSDt9OpGPUkdf9iFQYZxIDBllMGP4uVaAzIQhtbhppgE61uPskyY3TUlOWZVUEkvRv+OBc4EYeBKK4qJHkWGoMQ0Cy0tvigknQakSX4Up2WQVH8mMVEsFAFkU/5k2TzRoqqCKgyHjEJoL5BFFee3rXAJXnTr6iK6e6GpWrRLDMvKHbO5zWZnY4x7DMLZ77BzF1077oQDpr0A8+SAPGwsHuZIJsSj1RKUIRCUyoWdf6AELBT7I2yrpCIi4bYVRgUmBVH1KY0TVqbRQxBvvvM5w/3jVISZQY7sJ9C95ph1M63KajlZ5ACycLOK0kjW0brVKU/zcLiSb5ZzaTctIWapZUkbn3ezhR7C+4l4xPwGrRi60MO8VF7lg6gHukqp/mHGuOT8RsIE92LXvbR1FzfK6SynLYcZhYW6BCmIEqyVUpBrLB6uFYOcobWS4Sa1uuQiYAnCXvymObcEEadqdaQuH/Yrxc5ZrCrnFgQI4u9wc5qrLTMyIPqqCHHV7A0WqWE5dLxYLT57WuNHIbEHkPYWfOkAuPwUlMev959DuIjjqjtigbLuVqWI6NawGuU1yoJOO0ehmXmLinvpVl2UDZ+W1ymECWYbfloXcRavlOcdR/v/UzDYc6Nl9cNAiRmBGrcpWEv4JRSre8RZr22Yby+FzP+VEpTjAQ1PfOXJ7Di+ry7Y1/R7ZI0QuhVnGEjtWHTCglxGpZdDMGNpEhjMStDOkwSvA8fZ5wKMYnVU4xz1iF6Csa65g9Z494decb1r7s8R9ZSpOGGegrO0DYHTr2YnaYa9DA3vutcbFvnL/WNHN7W23O4Hulg2bhfMRGW0n0GFR4+dTQYU2ieNtYphe4HXdOvbB02KtH+ZT0/AUsbj8mQGIu/bY4UJR666GktDxIo18XqEjtVgNv2DoTqWJ1Ik8CEnVJBqDI+RjZLnNTVDIdXRjsrZp24rD34kwMkxuNF7/wSiZMcbh4XSW7505KBfB5rHOfg4fDIcix4CrXEWQfbn5YqrluvVk0FhXuNXsCOlP5TV6PEHhVC8tGdlhXLVWrTurVseYxUaGz+1pHF2+riXqXjK+nagUFJHOcb8XOvAWWDyow8j1YOLa5MxI70PoOdZ4JLyw54ho1pXI+dwlg7+bbjIvUJ+XpNQi18qRS9LDU3pqwrRAF0/1NUTf86LYvqnEyK+A3Ih71dNC+GLVxGGFaQzY+770pgcp6acJ/d+3nJjzpKf1ge2W7WO2m9UPP/ad7xLv78L86Ji+btAvXc6z//WY3+b7jd9L9Xdf/O63Zvblj//12x/8tdd/0ER+//+HfdrUF9IXgAq4S/unfwIIgM+TgPm3gNgUfw5IgfeHgNSHgRfIgJMQCSAYgiI4giRYgiZ4giiYgiq4giyICB/YgjAYgzI4gzRYgzZ4gziYg3owCW7Agz3IDWUAhFsghGNAhGtghGqAhGSAET3YDU2ohF8AhVUghV1AhUH4hEfog25ghUt4BlwYBV+YBWEYBmMIBmWoBUz4g1hoBmfIBG1IBW/IBXE4hFnohGp4h1dYhV64hltYh3OIhnzYhXrIhoHIBn8Ih1poBQVAADUQhwMwAIv4AgZwAEbwhoeoA5coiZQ4A5nYAgZQAD5wicLwiCZAiigQiT8whqM4AHLoh/8zUAAGIAAK4AAj8ACdCACoyIknkAAQUAK8WAKPmIssMImVeAICwAAiYIubSAK3aANE2AAEAAcJsIw6QIy6WIpxgIzVCIojQACseANEyABwoADc2AKrWIrfeALCyAPhGAcGYALnSIckgADviIvNOARpGAOkGAERIAIDAAc5QACguI4wgIQP8AAAMAAKAAANIAANAIyQyIguYI1EgISy+JAKIADUmIhOQIQEkAAN0AAJIJE7QJExYIQOIAC0OAAIoAKm6Inl6AJWGI6M+AALKZMJmY4j8JImQJCYWAIMoI3GmJOtOI/1uBNmyJEx8AD96AAKgABEaACxqADRqJIAII7/x5iQCQAHEACViWMAGYmQXnmTK4CEEJAAAJAAs3iW3QAHrBiMjDgAIImV/TgCWKmRIgkHCAABdSkCCeAAcsmVNGCREbCXEaCR/ygAxCgMsOgACJCRjDiWJJCYJokDQtiQtAgAKXkADLCVAtCStigArPiRsngAeSmaJHCXB+AAsWgAtIiVyPiII1kCKPmZqQkHsSmXVSkAZ+mWI3CaLWkAWzmL0QiavjmWWEkAkkmbQMmIO0GZlMibKFI2TkiKofmW6XgAArCVIBmJccCK5AgACECSMhCOQsmaikmL5wibaZmZAMCXTgkH7nkEREiPIoCUdAkA13mVcNCXHamUPQkH/w/QAAqwiazpAAegABCAlCRgAKOJjAzwABBQoAkKmHHJiAKJi5OYkgBgAL2IkybQkAn6AANwkCOAlHA5AIyonQ9JAgVQoB16AA+AlhNKoAAQAQxgoyqakORZkMYIAQQQARCgkd3IiigyiQQKit7ooSngjexIAtq5jCjCAP34mLBomsTJihHAkmhZAi9KiZOYAAjJlBN6ABUqlxtph8DYmntJobOIpkSJAF1KAjP6ngvpoFfZjwyAAFdKoE75oXbIpEOZmjVZjwDgpKi5k4y4in36ptlplQ6aiyiKjL84mED5nWKqn/24imVaoST6pSQaoU1Qn0epkQ55n0g6i6cqBf/52KR8GovayJqg6JVx0KCguKcJuacSqZykGIkZiorCIKcCgJAsoIQJMABCmgC82ACHCZDBKJ/+qAB4KgLjKQKTyADfqJG8yADK2Y+92qMvYJEAoAALqZH06Ju+qZ3fKazESq2xmKg/+ZtWqZkaia0AoJ20iiIZ+ogNII4JUI7VGqOfqKEBy6s6OQJSqJAFiwCmSIr9up3laK/dcAADW617mq9QyYzUupXtirCXmp7niprc4ACeuag5ma8F8JLaKQLYuojMWqvaCQGGeo12KZQDC4vVyZK7aph7OqMO4ADRGAFpWpElYJ/vOYrSypJHo5DT+gSt+gL0OJ/2WAIDi6v/A8AAneqouIihvQiszDi0zHkCNokABOqQ9smhwciLFImzIiCzDZCgMkqjC2mTEKCQ2Lm1lgqP+omQGmkALbml3eCUBYCZ8LiMfnujBwuOJfCRITmb9iqXbtuNoPiSVzsCbgu3mUqmbgqYiaumI4AAEfCQCpm1nOuPHVu5ySi3HQqKEYCQexq5DKmgCNuik7CRNDkChwu43BCUPJqzsEuUIrCyDeChi3i23EAACtC54QqUQpm5m5qTpEugaAmWJKCcSkCEKdmLETCnsPi7qAqGAMoCdwmEDIq7t9qSlcue35qQiSORwlCy5ogCQ/qQ23uvrcmocfmX31m9ilmgwGmn/wxpletLsxqLsAdAmUaqmeT4mHoJvzsJB02bA89YldPIn7IIiqGpkfs6AEN6wfwLlqvZmq+Jm8AbtiRAshB8qyRsiikpnR4sAv/7rhWMqxl8AGP5sqQpAOB6u/4IwQlsj4ppstYZBwf8qHDgnARAsYrJDfPrjMw7Aujpmjlrwdp4rJqqn9IItkJghJTpAA3pmxncwvD6n55riIUoBlYosWS8BNaruEewsiyAuo14xnl4j6xKx0m5Amo8qksAlQZAu3P8xlw4sE6Mh2jwtHXYh4Q4iHmoyI58yOELyUKQoSjAk5UZyDfAkyZAyaEIBD55AnCsAnaMBKP8BnhcBBT7pP9lnMgycLgrwMno2KCcKZSYjAJG65LKKwICecs7EIa8vAKfbAKhnAKlXIyGbMZMkMq9HMl7+MoxGQOwDJGyHK+ZnMuH+szL/APBXALDjALFXATfzMeTac0tsM3GfKLgCgTKHK/h7IYnMJa0SjZKqiYEYIvLqcvDSYnqy4qqSYrbuZ0M6ZkzS8wh6pkReaj5fJrvOMRjfM2+ms9Y3NAgar5XOQCnedCk6b8C7aL525DcGdB6qZ3cCcgF3MhtIITqyptkqZ8DEMXzedHvypKQKZ5gmZX4SLVuudIk6tIkwJck8Jc8LZ29qZiq3M5LgISCes2TiaFqMrBJXaSIS7rBCKP/k+jPoEiOcmm/8Vu03IuhWiqbWh2MqSrGDu3ViNuoUrvVFI2tcorOh/rVWb3OW7uj3XDVBVCnZQqpymvUQcDXSUCEpviXWf2Xzms0ytnVsaukLPnH2pnWPUCEqCjYaEnYYxoBhm2jOGqjztsNb4mWcm2ZzLzIXD2sSo3COlzWG0vaknuyO/uIAVvVPyyQ9vrZ3hyi/krPSv2Is73QSkudkuurk9vbiVOeVHurFn3bwJ2Tu+2i0GqHsp2tcLzHJS2Ijwy8JOqNj7m6GkoCD/uvkZjSovna2PzYXiqR1y3T2s22I7Ct3Zre77i7rEjbhezXpCzKB0AAvci7OyqQ60ik/7oc3FLNwYxdoP7830z5ngNd25XMAMn9iAcus9D7xyfA30wd4STtoz9Ntlbsjwxe4Q7ejxB+omobnQYut8L71NONA9FMtGSgySleom2rAA/glP242aXI4GhJuNTKiCl54eTtol06oTOuADVe2SVAt3ablkbODQ+e4PNNx/CbmEZjAEwd2UdcvcFNxUQZjSBc4NesxFKp1pY7jri9wWDO2xHt3//d4KxYw8Q9j9LIwWTO5mfO0VoJxwIJnCmdzgBq08roAit+07dJwnpMy0ng4h57wolDuFbM02N+wcMb3hn5mbRKzhJcApFu0VbZ6CJcAhMawLQY1MEbiwng5IFM3//0GQZtXaw2sOrijAOunorGqAAYqeaJvrjjvcXNaY9aLAOIbgO/vspBELDg7IrHnAXqGp6sLgPJnuupbgPNruvwWJh8iZgQzJlHjJ76mtBVqcIC4J+gTagI3gAoTIz9bKQfHZ/zmtIFwJ6f+67I++3sq5imadCkSACGLuxAQOwsngaInISn7AWonre0CaRCquaIqsvt6qRbuqNfuqqqbJdxkMROiqxfGqNWPa7t3rH+yIqk++4H8KIICvHYPaeP6KR6e+x1HPAELcxciOh52ZLhXr0K6dgv8ACdKfMnII75fpICP5TkOrEh+8OEnNtXKwcJmbQRz7K7GgHvqsOvXcT/zl0AQPvty0iKC/u5K1qP5hrT3Z2yiunjA5+aOr/0zTz2/d4CvIuE3VzJnUvXl160OGrpNL2LL+rjCoz3GF6UzGmiffu3RvqQ9bzaH96Tpk7wTO+X25uOl0vgsV2ObZyQCPnxO67VE5u76Xi1JfoA6Yz2LFv22ezvoW3Sy+vyotzxJxDsq73sVOsAzysDIgkBPX+ffO7zjDzd1q6YWqrD2r6IwQ2NEPzFEl3IEp/Fpo2M0UiuUn+8d53FUJw47l75ypz7DtrBWK2lO/wEuNrJNKD61zv61D3OI1mVcfnD3PzPIOnSyRmYvDkCKV3ulHidtMr6O3/Ei2iL5I+3GQ22/14JAkljCEIBoKm6sqjQwrE80+tb47lO3/shNHbCoaqHcpBMiJIIkSQoBBEAIxkpDQCEEgFQMEQfgGUJQZwZAY6owOFICAyHb/hXKjywWrjiQOU2bJk0wAlknaXcpCEyNrIsAgwk+KE0KBQMZEH+OAAYSIo9TN0MdJWqZGplDUR8HVg6EJzwoKF8zQJYFhR0EWRFHK40CEAAJAzwOkI6Mhc1P+ssxyQFQzenEYjlEhsPOM0pOPw0MJg2JaToujoAKRQzmFmnMWirRrbKsUdmucL6AgAr0AfFKYEI0F1zYW3hEEipIpUwkWrTDQYDDJz4AoAUvy4pUiURQIDMHVk1pP8p9OJxQMRdvU48XPGDIINkjVAyJIIzZ0KePmWkwYhiZiR4XQ4YcHHA4hgGXpKyvGNTAFF4C9PEkoI0oiyPL1KRNGEyEwKPfyKSE5AAFyJFP9+2cJjlh59LE7d1GvpiBIQEoUYFSWWTYJZjKSAYCIKCQDFaQIMkowvgUrKx1dJxOza47ZnNPncyhStkJ9wlSZlh0zas2LGyAJAqZYrAqSuqk126GNYpQTxoy0YatuU1khjEirXARDYQgCgWA5zeTClatNzFAhTY1QQAgtnXXNWQMNDpiq+OqLK8KeE0T4kDUR3HIG9zC3bclmGQEeFZ5wqBJU7HsF9OoFVzynRAPcP/AHRCXPIMVkkUkF8DrsG20VJZzPaUFtdRNlxUvF21AnuTpCdATcOxYwJ7VN3HACCCGABBCQ1Gt9GB1J3xQG83wsejMisogOFlLAjIEIE7mARDTDUyQlotDvr4k5NRRiMdlSFeaWSWTQK5IBUYdkGGO+akJQWWK7hoIhWFIMDSenogUUZEa5SQlx0mpOnlDljBIYcTXEQxRZzipVneWU5JUsI7JUyBQpreMNEAL3mMtuWZlnJmI6ZQ/pQkjjoIhWkaBRSShWwEWNIYL6eMMyALEPRxQDgMTIGAAk31E042KZhEj3NZwHqArHlVqsI/rHwjkDhA+MXcKIQFO+wppbRq/8M2rCET6p6bcqqCrGwdqO0alDw5Jbc95uQpXOZ6Au6Vy7DjwKlEeVEnQQp8cikKrmkx21wvzBbWLbyekFUE5ILl0Uj8qRDSSEedRpVQGnHE70iCmYJvNS8Q9VyR6J57xiKh+ajtPSdZGbLIb6nbwscN7WBylkYckEAnBbTxgFPlpGpLAoiRq5E8r8Y66yrozGYcr/UwZmxvAxRXNLHbqhDcGBAr1WxzQOwTbTgYpyC0Qqt18zKCKnMJ5HGMZBgzW8OsDYNbaGe6wqCdqKWWCoHcsaFI4JXEB7lnRUBNen6CoWYOkBRK4QsG8NEJe6Yy+mklV8AZRQJhzshdJDZHNP/kjyzkeVaDGa54QJwSlTAiuSkWUDrDKZRo1GsRqx7eeCKlUjrGw+iRyL6Rmh0Du3Rbq8IbtiQuxt1EYUSHAPW0DdBcCjQweb9BQn5dXj87djzywrOg9Sgn0BhJFwKlc8mui/0STLXzrRKBEw1wsjiRyznuian4vCIcXJuO+Hh0vOeIanyzU2CVVACBRq3jBeaD3i7y8QJBRERDUMtVLBqVL1o5akdySxkDUcaCiSXlBp5KUwkgcgdt3ecjGrOJw/gls7OpgF9X8067riawAWjMcsgzlx2m9q4SUg2JOEjDA4WjEBRScCopqF67xCOwJAmFX1YplxL1V76/aMpTzdH/S10mRbB9EAkjCLGaa9gRNxyGbTmIGcPjThCBByhNBWKTEgyKV4OWLbCLmkJNAokgB4Ycsm5HQIgUzTcM1XVIOlSURBfyiBwUCOWOKAAfFwUJMsCJJ4y44FscNlSf1fEiOZjBwggMUTuSiM54LSgUIfLmCSb4YUUpMoQQ9didMwASZjNQENoKaAARDlIGTuCjCoipPhkk0hrRDORkIIMi3f0BDLhJpkwEEI/UYRGX23jjI0joyXLSTYcNPCc2MvJLIgSzWDvw41sKOEJZEmE+7ooLmqBjIBhMUwZLokFA5ZkCkm2JFSa05xCRp04vsjOHLWnePjZ3t/6tzikEEJwi//UCBxH0jgvUEApTiEEMQZwgTY3qyRRndCjAiWUXLUkmKWPHhWSQBAEY7dNWDJFB7aHzoP7sBUdZqDqeTqoNbNglzvSw0ev4wah0aoNBh5K+K41roed80lbvGVFjZcSCn/OD+fq3qwz9Axgd9U4nPpEJgVCChinVxCrW14cB+mYFMUKB12LBNFycwggFudUNeNEzeJi1fvp8SgCNyE1nniKtyvGDHI6Fj5TWY0k4s0dABiIHX1Hzqwyl22iL2dV2qkQhD0Fh/7KoUVWurJuOyoQ3zCLXL2mKhV8JYrf2BQcdKcwJuJBFibpgBN1qihdV0elRHseVxQosqI6CzgNesv8PG/ZUJDYxmHuy0ADMXTA52OVuVbc6t67yE73p/SqviiHFh5hvjkvoBnNei8bYemsvMXrrcki1SQQQQjvOSmNe4wJEYenqr8QMrArGmBuV6MYYCJCvBIPhXy0Uw5LSjUQfRiAGyxhHVjWz8C8vJoZl6gPEiRExr5D5SU+eV73OkHHy2EuQkqj2EHerJRzqFQf7DjSJKbiTKSgnklZCSi0CJmViQlfgFBSiC6VDpSyaagDj7g1GANGuKf4D4I++oHZIfk/qNuw3EVwyFVsAw1HVYxPXpehPJEhzFtbcB9eVV7Q0rvGeudnF0sIAtISULQMBzYgt9nbPht5SjBXdZ/L/2dgR+Rkck4a8aGZSCdEs7fOlj+hnGXe6kJE2rXkfbU71hjpKjaaxPXFCL34GeXSjVlmqCWjqT+/AEueaEj1p0Gsv1npmLUBgN5bJ5xa8upyxrrQtgjdLPam60Ke9dWkRUA9ReyciinOiIzbjzEwF29MrQKAmvQqDZFtr2Wkb9zvXe2yeoCTcQhakvKPNiHhSCRIL60+7h/DrJZ4avQ6hB3RwOqNhPEVelfOoWiQ106/Ect2oCNMTArWPQkXls1w4HCTtNeiDMgrjlBREF2x2mJUOrdSmnocV9GCrv+0NQGrA3pck1D94t2BhL19fF7SX0Y3IqKkm8ETkpCeGkMKc/2r19pFDohBXVLkjEa6olqXbGgwGq3utz0xWOMZxF2MJ2LKC3jTVSTGJ9uFhsg+IOLP/TG00kekgurDHR67dL7hlprY8xDkLRjJ3X6RSDv44sVN4+ZEufBCA+uAvpRu4dAMO+xiJUcmrgwfEfOlltsW1UdbxO/EdVogqX/8TL2/gMPJ+/F754siN7/BAeDzA5FpS+aPngSHayEHb1SCAEQ/ynI7ZDt1PdtqdDMELgblWU5vPYldy/FClv905TokAz3vmgjXgQmwz4cuCsdz50J6CQribSBCOab2NBMFqLd502FIYmH+V0RLoAAPfubrr6B/09k+JsEwQsrf6kM0xUP/YZ+QcgFGVcFiSYehMbiEK4tnRA7zXZMXW493IwG3SidDRdSDcGsiIsxGZj10Z57Gd5zWbIYifUqQCeWTcL4hE7eBZ6gEPL6ngIdBHgyggyqXcuEVE4ZFa7aGJ/mnEy3nTR4hO7A1Pw/GYvOmbGQghAiRD6lgZD4Ig4uFSBJ5Fv3WSD67ctCnQIsRLJJgBBeYZqiHC2bGA/YjbodmdXu0Tp4ihrW0h7TWU3QxhInxULrCJrqXA2olJM4EJ4dTUvLGaNcgKOcHhGUwaNLVhT7xhLw2iHJLWsIVHGKIPHqADrBiDA0hCJu7VD15NtQyWIIIa/glcwHGhMLENtMmav2H/4bpIWwwAkSiFBlWsnS/Yyhj8lh/u0OU9h7aJIhnGITR8X8o1oivWgGRAGiJQEfuxgLG5TCvW0yvmUAQEBmEthiVux63AygOsAcrZBgosYDm0n4P9YikG4zMMY4EVYzTqQJLwWr8tY+oJwb/l4BwqTyEIhQoVQC0NYYQZRpQpj+agSugwWTmeIqctRDq6ISlCGbE0kTdlUN6gw/OY3hc4289pTxUwistFiv2BHJdtTy+C5M5VoDTCGEM+Iu0sFQOwCXO4XBR0AT9mQiE0BjuuI6Y1mNpphztW4gRVpGecVU0I3qzEnQjknUd6QX/1whTAlXD83QjWYyRCYkoiZDPV/wMI2QoHNUh5+N+0QONCnuPJwZ7JhVdKyAIU/eQvuZbAyAbuAR9S6lBlnEBcEkDxQeXwSeWsAaMW0s4WHAxT/EBYhMVzXJ15GONNEiALyJ8n3IqNNI0oORJVYN+FQVkW6IwlteX+HSUc2YJSXlJTQtgBliQO4FsN0AmdNB5ntkAt9YaLqCIs3uUYmiNfrsBIMIUk5BH/fQ4RptZhouQmWWajfEUL6ePdZNMlIFnYMMGbtEdmBmFHquYVyqWj3FSYsIGL1d9ZRMTglCYNqJVaGSRBdMcaGCIL0EUmIKM8UqXpuIv5QQMGIdPaDUXkoIvrpEmDpE4TyiTY+GZYrqfb9f+HzJ0RMJ1Ad7qbklQDPSrkOlXlQfVcY9KAupnNvp2Q4RmhESKlLr4iYmano02lRghdgRYAUiAAx00VsfCjTmlb0gEc6ajHnaQAhDiZAZCAAggC3qDRcMbBHGSD+HCoqzTT+jBLGSCH0d1JXzib4WATr3DBLB2CYWxWhuZfCa3aKPqnEi3CHkWWcNkDK4wdOF7irZiEgZpZX2lWd2xWvhDAzogBxCUT4N1Qi9ImFfScARghJlaZWIGF/4WNR5gPC3BgVBxCaOQLzqTmjAHjj87enAKoHiXF5vklJnEF6uGWhYzpIuJTDgXXmeYCePWQVSCQmwIMNdBjMnroRxLKIbD/yDa5aVqsRZ9iUljl3JCEBpTuhKIOGq5G5X9iKYF1H4b945BQ6J2KqYiWl5kmKMWpQR1RgRmEao56ghkExFdmaoM6ilkQa5F6yLURmxesERjNZwNgH+kcwoXyqblxoa7iJa8iUZYmhZW9xAgMgAuKUyW05KXmme8k6+3EAbOCKg/exQqWqilCojjaK5FWGYooyoyMEgnM65LmgiBAWxIkRc1cB6YSbLtm7EleqcZ24UGeqrWm62/uJceOj7qiosiyK71tLMt2LJWapMsyqpUmKsm+28mC7M3ypjHKAEJxC8oyI836iKaBG0qGBUQ2qnIa3rNZSrwJVGyuYqAVCLXy/6zK6hV22mMibKfFhsNCEO0UCWgWWq1StOymOAS1LgMFOi06LajESS2SYGzQlixpxq2w2QC5mOsUvaYQfC3DAK16JgIlSKRK5MHdNFFD9uEhfh7pQYGZZALG/cdSbBxPnSj7ickG6g7G0eQYwGQGQqjbUqeasGQZuIlL8tLqkETl6st6ju4QyoJMbmdFziTvUe5SOaKT2aresoB8VsKt6Ovm5JRMwupTLcc9/W3UFoHgVuLAONKtRAAD6FonHsjZjoEcKIvXCRivhF39fOkqWp+N/CkpmALUFehF1CTy9hVW3spscND7XFL3rqvQUkGtFOsmXuPeYYQk+IHYrSFOSv+UvNbLAWBQC53cCExYBJjpJByWTp1raknW2Rxv2wWuWW4TChkDBJQDAtRKLiru4YHe+AkY6QnY6fnloaZs5fUQxRAG5eneQUyPelqMv/BQwGjbwNwvpcbv3AJmeJGMSVDQak1qCTui1OXuvkCbJbRJNuhdv6TCcrlq9llX1lXp3CYvBdvEnz6AOwDRxpjw6m4d1lgI+UXr+XGN+i0G1hrU90oQGHHN74jmBLdd+h5NU1iS+z7mGS+qyN4mOsiC/WLYNkASJjypsKIxXmaIrWQPOmBoU7RAAmBPBIQDsuKFhH3EgkynFJdtr8qN4F7jdmETJvpjk3awj+ld6HXXlvn/wn+wIO2qxwtG7eWGGTbNYGo1IUAi70vd51wyp2RCSFS4cg7PZuhu5T6Wynu4iDY9BL2qRRfjZYmYAdfGbXNg4ks9xIdMGMMOL2wZr83mrCbj7A50q93Oqc+arDlGMOjKb9Lm5TF6HKMxJDnLrDlz81R6c9bGc8jis8qds9bBU92iSSGH1huS6YHWwMDyM8y+bDcPATxzG9/tMwkiwkA3E0CnrKme2zfemz+bWTPKnEFDdD3nczoTAUP3pkPPcztq9EFRdJ7VWjBJtM7mnDvlQNuiqzqvrELzbcR5dIs+dGjdjYFgBEnOLvH6gZMlCjfklBcPboqGpHM1p3p8jqKQ/0SIXlLK6iE4IsNITFQYgJIDOM6dpDRBg/RNQ6JaFeKUyagetC4CRFEvNGlSnQ7VpldPV/Qm/YUlzIEIbOVM7m/8KOczlcICK3UlZisBCOdBIbDUeGVViydjz5vNbKLNTGcEGcNf9A9Ni7XHzuzcagTU9JX7Ntv8cm5bo93AIBAnCRNd55kFW4RF2OVDWMZ3ZRDGLJdSX+MsCvAsiO8OMbF5mASkhrWp1qI33MpkDwdrNdd9obNmj20wx6oVBVeoyHYL7TBpR4UJ2MQPzNEE/uaffkFi6CZsi9ejuqlhURWI7KooFbZuP1M2Ipgm+vY7NKBjM2g2cqMCMGUvuNdwxP9XUswX1Nwyc4c0FVOSew/L+6DYC+zxI01mXdpGJC1GkBTtlRqnJ0BHE4r3PmzFnIGNNds2cjC1O25ES+hrakUFvNI3RFXCeZvHiV9THDhAEi7r0B10zJL1qAVm6DoF6oaHgmPzMUdSDW7TduBVap90Od9zDyL5jS+5j4SzkSc0PQu4kie5SFNxyQR38qh2eM6aagdFlvuvTVu5c+vzkVe5gu8ttvXQ/Uk5mY85gG55ffOql7MhbN7vEE/5m7c5nJu5mIvqHXKcOzdM5EBPTqHFvQqO6n50nl95o7tsnKt4SItqJVqWoMfo//wwDZ5AYccP/Nb1WOu5Xj56n4O6qF7/o8NYeqx+ouxqeqWu6j7g8Kczups7Op9HeZdDK3KYcRr20B0xuF1oQ9Ost3JTaGjNOk4juyZDupxarakjR+2k+i0t83EWAOxERYgnxy/LOkJvNplrm7DQp1Quuwl1u43TWrKLes5idN7mxE5PMa3Du7mHzLhbdKgvOe7ygxF0T9dqz0gEyeWi1B5AFTVw9603+bGbLbofPK0vAQAb6qXPb/tOgfWFomS5eyYjfLp/7MZrfMcvvAkUsaqXxRWdAL0gl2VcPK7F+55zvD2Lea1D4iFjD7ur+h3V8QlYHzmifANDn8FXecY3rcL/vHM782vwAVskwdmB0ywA/H/QWXL6/y2pA/06U/3Lr7zHt0Cc5hvGc3tzyzubY73VC/0JgTmQ0ruUXr3LnzvLhz2oc+zZRyfMfzMOfF0NuKZrLnrXD3jaB4h1KWLflT06wX217n3MJn3j1f0MkCd51njLF37Mh23fI4czgu2ae0duU37Blzvb23O+JAAO5rqv8dxy6z2TD/3NTuff1+ZwBf67j73b632+SMJla0fiHqEIUGzfGHvp2/s9V4bgFArHyaXBlUEy7DuOJixJmDXN8bTU876Ae37wmbr0rji2JEPKt/3Uq3Nl+LUKKdZLGFbUwYPx/49j2oesPkD/4tPg13TvU3nST0hy34UL1wPwXb9ct7/2w/8+yF4yCAyAAACGgBIFAajrQQIMspoFgLCky6qlgVAcSsSisRSLHZfMpvMJjSKl1Kr1qrxqt8+sSVSCGHCkgSgrGAIaAgggMajVuCO6/T7F6/d1vp/uVeNjNtLwBgYgWLDC5vBGw2JwE/FQx9PiBjCgwFKV9Aeq5RVK6jRaCuplgNiQIOCqefaWUoSAktAg18l1iurX6+sLHFwa2HNDGCFA4OAqwKBYM4ACVHPyOrSzyDJNwpZJ9Uk8nkdOPGy+hZ7etM7u+S4cj+q+ZQBu5TBmJT4fWu9PVEA7AP0VHHjkIMIoChd2+cOA1hYGiMKVc4inIUYmGhd2NPdxYMiNREb/kuxzkt/FlAJZ8nIJxWQwmfFoYrTpEOe8fjBV9sTys91PnSCD+jQqheg7nkgfNmX4tMhHpUuonosaE6tTrSVXcpX6lSNXVa4UOEIhQASBsgciLrMlQAEpqzPDVrWbEC9TvXiN0JVXZJWMCEQK7BARQZYJfKnG9gX72CvWvXb/LnUc+EaOBspQtECmGIGrSv8wR7bMDnVdlI9VF9WqatIDBGMcaItVSKqaP64bR2bd96CtfcEIDTclOWzvcct/GbmW4MCBEyc+41a2VqLvyb+B862FdlcRBTfGESLvtPnq06Z/lL/ZPnh3L7QBHFDA2HsUH1oIraOs3HzxSUKSensY/0iPgLXUJoADDRCAQgFuDRDEMokQ8IAAcMlVAlwkuMUAeHHhoICFZkyInH4B/oZgRkPF9x17IqalCQsFyOUNegTEQeA9R/gAgRD3OfJDJg3oaIZiKbY4l4Lc9cQkQU62ZkR9CVTilmckwIBWHJ2IJgBpJfiQw5gIEAHmA1yikKSKkEW5HZWwvTgni1PiMMZ9EDxAWFeNFCbeCLsR4EaQ0pmVkG1E4vZfcl/ByRuMJ0Gqzp0xdrhPkA5AKMAYMVSo4RzOiNeNDCiESMSoJKKAgH9ZuSnpik/CRGlLMt76qKOx5lonrbv+2iuvtR5oKVLDihWsfHZWpmuylz517F3OMv+7LJqBBgUgr7hCS+escm5bJrewTitrVNHmRa6233Z4LZ3nSlmtud3KG6+yaBpQIgMOKGAIRYXhG6Ym1EjX6SuuGNDAgxH69i4gxRrVcFfpAustng3AsCkCbBhSQgEGHGBbETvCUMCRZ94zgI0cOjduxc82FXGzvtb7bLiSiDYAqh13QgJtbMLwwxAEIJAlUdlSTK/LkyItLrgs2JawAugBOgUQACQGtAlCI8BnMTInvW7TLsWc4rY1d1nCAwkYMUcZ1AyQ9cctaMwpcXwcPXHeM+8Ntr1hLxHBmTOTDRTNxs4rtt+KH3Efx2N/nfjLh0PJNMwPi0v4UX9Pznfk1Jr//WTm8BgOMeKWk64uZqJbhLrpS+vdt+T0rp7U5a4XWDnnm89uO+wskU07ZKCXq3rvSpdOue+nD4+58bHr/nvuyDN/evCvUp9858vvnrphIWatx5oVEdvy88RvH73y0D97o5BEQSCA4+RbvxX3t29Ef/meE+9xzkB38zGfLaNEhGlGpw7QCjYdYQB2m5/z9oet+0lQfdPr2McEYBiRUehjN3IADB4kggEEbm1LOEF+XKQ/9MkugtkzX+rYNwYGQAhPbCrTdJAwnfA0ICIJeA8RoBapFK7vcy6EDwVZuC2P2cczVkuMDfeRBjgsUGdcAwD8FuXA1h3RiNob4vmImIh9/0REYJ2iEAtuKCgDPgN+cXmPGsenB7wd74VexJ/0kGi/yeVPKFrsIu622MLFhe6BKqwjF4sISD82r4+IVOQhIXjHCVoteXtEFvYcmZNIBnKFTSCEHYVYQUGGMiX5q6S0wAWwEKkggWlBiy3cs4IMGfBjrITj3SBXyC+O8nVz1GTnaHOxBqlgACTETdwWQaAdaWKEqzElui75uE0aMpHRtJZ7VOCvEhDimHO4xjJ2+AofBtGZfiEkL6vZyHQmrkxQG2YxB1AJNoCMPKKCY868Bko8ilKfpPQlOhXnIbWUzBkDsA0GI4KvbZRAjQxg49RKk88J9lKaf5yoRfsWruqZc/+XHP3kRSGZrIzqcaP8nKZH/Jk+aLqLpBL9Zz+pmdI8Io+cwpOpS88J0o/mcpEq3WlLRYLSl/Z0cCylaEkrqk6fwjSTETVqUA3yU6HaNKcspKnEhorUmFJ1q0qdaVExCVaElPKrN+UdI7mKU6mitaNPFSsSFgDXuMp1rnStq13vite86hWuAtirX/8K2MDOta+CLaxh90rYwyo2sIldrGMP29jHSvaxkZ2sZQ1b2ctqFq9yTKpJy+pRz7J1qSdtaljXGlqtdlW0R+XpVFer2rR+FrVRJepZYavW3M4Wt7u1LVZbW9udtDW1nBzpbXubVd2OVqfITZ9VcdncRyoXuKT/Te4gj7tc0Eo3uk6tLlBNq13vXqa7p+VtdleKXTokUHAJek0creDJoF3BOJ2Cyh74wxwtoHG6UJAbKPz7Emo1xGNxwSJT2bawPaQsvwtEi86MwIAHj+69gQEDASSMGyIAmArnEScf/YKqDO3mCfi9ShGyZMsS7Le/7GUxCu/VsWFsmA8zLhyawmNc+CKmT8QtiYfpEF/AFEFRmjiTTY78HAtjOMg1hoKrapcQfgGgRCOWTInXU4IIWzF+TFjxEuYwXhgnQsZV7mSKmdDkCWPKPvgB8pkZRoeuEQE9m+HUDdBmhgRcGAU8fnFCJCSCMhngBJxAgQdf8YoG7MvQKkZL/ywbRJ1DnyABB5OfmheqISK4ZUfE5PQIXLE2fZzKVALos9sOOAL4QcAZtTlYmYEjmBaECES4ydIBNiQiuVSIGzlT4PWkEjgIKOMAAGxLCkSNwewIQWEYJHWf7+AFLW8CALNEIKtlEGgWbPoaKRsoq1rAFpEVgJgoOKF9xZxBZQ/B1tVOdVpK1CBH49kZbmA3vA187jUritkFgAGoE2bnEfwMLav2NUTXYZgwHUkN+sDiPRMAgQXfqDBliM4Hg1gVQOMgEmqZtZoa9AUGiIkIhPDYDa4EAD6RzGSLqdQCqWNkbUaHUTcgD4ZwwICLl5MIyqQRMe0zBmWK8JQ/QMsahf9kFjPcaAgf89FzjISkJ+e7JBAgQATgNyjF3HxMiDGDynR+yxNT4wZCT8zabuivHCx9Z2MqgNqsKBdlJkbcC16wrdY85hZ0fe0fK/sIRCByklckg3VXgRC0FniX31iBEhcCyFfReIrjRjTNhMLQCIwqfYgTBmIgNQo4g5YMbyLWFM542iNxgxloIucxoMimSr2bkneCQB6L29YUv4Rpx8CTT1YBgYimCQWQvg4CVIy/bujNdqlCyeEamhlsduvR1GI0a0qL1H/dFakJqvh9IFDbY1G04A8f2hDOeZuTf/wYZjujc8AmGNIwiIoMUwRg1hyewnCb588+h7SIwesjQGz/IgB6niF70Pd/r1Y/94dyRZM1FFE0A1gGAshDP5ZFVkAb+NYCCiACcnZ/IRNkSsSBDrMEivIAs4Z6MnAm/uMNTjc3gnchJYByKhcDcjM0uNchEWAIupeDYNB7BSBFJfgvYNFEitE1nSdFH/YDSmYoQ2IGYnAxh4dDiQJy2qQk2DcFD1AJaTCEubF11mEGIWhBYadpIWIoR5hyhNF5QChDa5cIJKQCbxckXih/40Z/7TJ1tuEGEbA28eeE93EAZggczlcJ9eGBddiHUNiC9lcfesKBQNMA98CBhFgGI3dPTRJR4VcE8GMIzNZ0BYMbbKBAPeRnMfYM1FYiemYDKLh6/2vCAhmCDS44B6JmAIcmXzV4dwvFapOwDLyndYtADQwAijTSFQCkGDk0aNTmDBgGa0pGaiFCCBCCL3+oHbNgIaDSKlWYgBeRBsR4NcuAbCsAGpwYjG9mY1kWYgnAUDmUALVxitqWAo+YFqvkDGcSf3RXhzZIRrMohy3QKULAUH3gitFhUD5THbLHj9EYkAhYNninKXXDimvgkNRBAgblUBRIYThRiVrwiKVHB+DjVhAxclpAeVYoW+dlXtRlBB5pRDjhfVB1ByoZEDYBFzOnXyjwUAsZWybJXeW1RC/1XOCVkyj5kcylk0XpXO8QZBh3YuSoPTAJBaqXDg0BfGuwMv/4ZGZB2R5HMm3BwAYMpJRRMJWfVA8ZwgdJyTIQxpQu5ZRPAJXuVQVTWUVCxgRmeWCoAAMK+ZUUoY/KRArC9gBpaX/SmGlHAHyTFBgt9hruUCrkl2EQhZZXaR10UH/kUwRr6QRtSQ5SiSpX5phzCZhhFgp0KZfUlhiAyZlU8ACrhpc2WACEsZVVooxFMJkmtg778kqBQWic4gi0pm6bRm5t4GwcqWnzSAavYFAaghasdDK5yWglUEvctmt4ki+3uET/Vm0J12weojEEZWI8RwseUyKVgGwhspHNGAuoKJxrQFC/6QacwgK0MZ3RuWhTGCfFKReuCHjEiWed5p5rkkH/sngWoHaWP6Ihx7QhHiJ2pcieq2KHlGkEcfhD16BK3lZfvscmbvFsB/cEepJBFSZrMpCaSLcpXdcHhQd2o5hlhBEE33AInuQDcCgXgnFhIIomxVQDR0J2GxRMGJiNGPMFfqdNBHAk9YYAI8lgRoCjtRcyNwd88AR3h+IAxLSa9ocD78QNu4CjwIQxSJJ4VlkkFoRAZsEAKroyhEeTVEmHUxCDhNFsN8mYTDADx8SCJbaESXelOKp3XkoErdBiTDqhP3dDl3Ci7YUOHuIZGpZ6KTgDnTA09bh79zh6n5mN2LZEWZMzLpp67zcdibp6ezqBNVB9ZuQe5dhoWcZA4aFG/wTQgBozgd2pTY7WNqkIfMywcWYimgFWBODUQwbZDRhkM4ZaUBACgJZYo2FiqBr3QZ0Rga8aIZ5EArTnKd/noEcQpzNYAGkSmexiq3UYqnqqnuPzexOafp8xB5FaeVHQoYiqijlTp5sCGrlhkGGIopRKTCwKB06KCSm3NnFIIKqXkSQHDWvzJ9oKNRAKZZW5gquGCNImpCCXAOz1r156l1OmUHXwgzlHQu16q/gIsLI3seTBTvFDnzyHmGLoFwzkOP5CTJJoTGlAsfhKAmvaB6eJq0swA/K0L+8Bf/igsXU4sO0VoSV7sZ9RhEG3CMUURucKBek6qv46a6NWj9ghe//jmJ6kRme3oGjN+nnE2a+KSgQVCY8UAm9FijZ/eWlLRAsMlXAGwA23gAAV6ar8KDUVSwIJlwAUsbCjtrHUWZEGCSFzG1CroiEJSawwSAuumAZuQR7GuKxySx4G9Z+RNrMWSZ0ndiYIRR6qsphZprf3aI16eqwU9woTaoxGG7ZoAxg/GS0idaZTd5KpMqXTaoENGreXKakuyQS2+LqEibTjpbonIVKkurtRSQfBS7xSkE0UNRyWJpRNwCVumhrQZZTB1WPWNb3kxVo+SVZGsGixO5qpkpazaYETiqQPi5NSYLxUM6C0hb3s+0e/qwdzN5S1QLuyWb9QMKseNnFISAX/6ct2hvmm2Yt31ktHZvVbTUCz4oZlRHB1UiC+b0m+RwBx/Iu+DfrAIkiUS3u/C1xcXmU4APpprwCRCVacQ4O1yomgQDseHNMlR1IEfykNENdn6OieFyJLEvoZc9c4KReSNbUv/VJQruZu8KmgA6MIWYIA1TafPFpTiVNs4BkwNQhPNRCd3CZlyXukr+VbmyOzbTpuKiNu9gpP+xp3lCu7LiybMRula4OOK7BgLhwBwLgySZpMgzihIEgaYflMZnIkILRMf2cxPsp1ioApfixCXUqSHLUjSuoNQmojQook7acxXOaW+6RRhgOtk4uJbWepEaapCWyyzskhEJhyKSO2/2M2hRAnQwjgmrA6e5pBvkAAhXq8c9bCyiaAY5/yysVHyLWHy8cmrFM6VgvCJrFKIo7wAkbnJR0CB7GpwpacY1xcCV0TA2+YoZ8hxjCar987ZYbAskHyAPtCGD4oBkPwAPixCXDjsvTUCUM7CJxABFjIv0ciioCoy9QWP0MYDf4FiGaSyFsAyvWpzzyzBsD4yD/rg6IMvRwMRnUCv9wrudVcMnWjwDOZMMS5uYXLwG7AuGvgsJAaHXH4J3/LzqR4t9bBojBobt7BAPvwj5+CZ2+jCJySFgxFuJNaiinnsvthxl9JjLHqAyJHxWMbtvoKmgCFFrjwBPXxkQ+9Of4bDP/6UBhVucexFReGQGVVLa1Z/AeBc9RnQ5UlywUXfJHbq1z9PA7ZxKfnK1ul9rbDVmyb9o3qxm/BKbt7sMPRWy+vNCQ6TSPaKQhsUUsaxiYgXKo2sMTthixODc08KVwJUXVXt9N5Ws1iIndelwiOx7wB3NgYldTIFKb7QqSC0HVGqr4ye9iS0KVAKi2MTYVS4GXzi1Zk3ZENVMtgoX1pwH3WynOgEX7mete6lDq3uQmGepszQMhmoKvv0U03oESpXQAHmHx85NqNuaFjAMAxyTTVsMH6ZdtNfIVZOB1nMndc1oXxB4ZJG9wFPNwxcM5O6JwOCwn7qE06k9BvMM08hrP/DzU0aI0u1b23RBDb31UxCTybtB0FA35VNbWNb9ONzHAN4BgL4oi6VSvc8eEh6IG4xEYN882HNvkeYWvYnJtQCfmPi10shICf/GghrGS0UCyeOJyZ7eEhykmu71kikWBw6ubXIlBtLm7XC+6+4ZXBX8pUAM4joS3K43Z2L/4xS2rHlYw+L0rGN46nixwol117RzKiywSoF7TZw3zA7atp09jUKU4hRjdujjaul1AH4Srl0BPUn7wNoTqZ8Xes6CcCNwTcQj68RC7A74vm8F2pFFu0N66mG+jMnZk4hGLUccgDCN27fIgw4BvPaEgcz+3nk/rYY+7YR2k4Ko4WB0DS//02aS9O0Gu76PVZ6CPQ02XZ3SvRDTZ+CdZY1N8n6igAMsmojghT4dJbK9V94dHc2XeAyBw8sa6OlXXpurirxdcr6On1lrfgvbKb7Bi0oBhaS3nGDK5mtqIc5NMQIvuJnuAtW3Id0dQW0fCzCc3JzcNeMUSsSkGQ5om2oBZtQxVXbkGOQsL+Qtf+xTWicz8nc0ITQleHg0AgbIOKc5InpUSnWmzYxfh9hoB87O/O3hiOMBhjdR7tBvd6p8AJB/leIwJPyWHn7zAysWyQptIgfJfqgr/8TQrQKhgSQi9fC8CorNZt7smVUZn8rM4drdQWzLXb0GBkMxLeyR67e4vak/+8ivMV+OwlpQCVMA0NEK9hRPAZBogJwC8RgCjy2iEzwCA8v+nJJfH5bbFq7wW6+8wdjFFPEz8+IMZTK/ID0HmvlPWa3u9mLVs38m12zybbDgb/WIRyQbVoknMSafbSWxM2e2zpDsLuTe1GD++erUD8YdEGadEJBAuCL4xlLe1kTgwRy+nV27x/rlVQHU0pL152wCVMDPH8RfrQ/k+sD+qeDujLXlpFXvupv8XFnnvL3GOjoODO7mTYyNC2z/uxcx+vXgprzTrVPcFFUP2Ch+B6XU6GefydXnSvaATXZ/nAz/y5pbIkbA77C2XVLc/TtjHhT/x3ENBn6x3d//gemgD/GSr+NXv6IACII1maJ5qqp7C6LxzHrVzbd0qTSiMSAy5YSkBmIp0wqUQhR5AEIKFwPAGCK3AwKBAAg0SDcY2QxAKGN3EtihDXlhmNUAi6DrrAoWoeAYRCg5qAwVIhSZNBVgJC10GLlhWAm4ACiYHaVMFbgR/mgRnBZCWTYakMn2mqkSrraYkDlA+QiaOBQIKaQUMDwRWniQInY+AVAoABJ8Psw8Mqaiu0CWqDwIHCwwDziKbX1k+jQA8JhMKBtcNAVzrJHwC5+VSw3wBDswtqy98XwAFh9A0iIAkYMOL3CEgLA2wsAWFARsS6HwAiIBShcMWzf4YyaoTGsSOrJhAe/8474QiQAmMK1xUYVYJeFAgPoJA7lmwWAjQwaHwEmepZggERnhBpEOFNN015ICpINKKgHwSQuLAT1iXqGwEDHPSKcGAPCz8FlPHz5/MFoitgCjrqFgmBGnsWrcK60qUdJBpwBciVdvbn3449Ay8RSVIiLRoGvoYyc8WkAAiEyFrpd7ONTrR9CEd79iBlAzoNEBBycLAAkcXbzL47N/WqjyKtpywtEQqs3z8PyEjmjHuEUxG93bhFUg04pwgPGKCJyCmvuCNfw/pWMrg6juvYbTSBNUIiNT0i2h5jjGD3OJc+FACZ6a7SokDL+mLcvN3UMwjhJkLpN+i0OgmYhkUZV/80BwRVIwzwWByS4HGeWtORklsB/iVg1n32WTQLAMSoUVwUdlkSoVIG3PUcEEcRIAhsfmUI0IulaBfjPcD0sKAABUDQInmqhcLLFYRgU4J+PRAjgDGTBCUCEc7QWMiMT+Yg5SqGIKNKlDRmSWUJW3I5Ah+UjfCAMTYkICFEma3QkiuRfJndm3DGOWUpVwI254R4VqmnZiVY80sqdq4QSJk7achnfS64gWEMqv3lZYaQutAOlIh2aWmfmP6mKZiHcnqpC/Lc4OhZkm5nqiWFirXRp6hK6eqTsJ7q6aed1uimDKT6JCthvLq1aqWc+hpprXnWylOx1L0U5CdZ1QFkjlb/6AeoYwfUtVgtt+SyiyCqyqkpIjc5ogYYY3IYGla+rEgJmt9iOux98M6aLLLJgoqCRPWyVIlWJLT01WISCXVSaCrJRJN67loaLgDKOKJHcO5E0IABCIwkFiQlUWRdq/be6zGux9JaLCqkEVivYy00AdVittjVo3mUHSeEvCAx7DANYhaczpD6zIIXh0HULBjIthY9dKkji2xCxRNVZEUP6BktnC7WHLDkeIqZ515NSSD9TxPxBdUWxQtFwUMEU2BsD9AcC1u00h3TG/fbJuDoFA0qQksIH70YUE5dZ8Ac1ZHewliCy0F+ubJaAzgiIgnodf3HgFyg6Da4cIfscROa/6BBXilD8oOJeCRY890bhtv6da+aPwPTmxyBXh3rHrl+u78KlDP7ErYsA4V7JEzyneqg1v4o7najQVZBobB3yy0A3HFF6aTRgUYvdUjy9xkOas/FAx/JfnyimcNN/q4lFJAIA23dfYDJddBBxrUHHBl0w7MsyY2fOmTfoovQZ7PkvWR5QGjeQ6IVjHqYgDQNeJgIQlMABz5MHj9YH6DoFDu5HY2AAFjfSZDwA9IcoCUOcAQvshABuKCAMk7RxONowLs7mM14HrTX6wwoiRNthnJdkRDLCoCjHLFsElhIUPkWx0GQCZBo/ppML7aHBbb4oxqJI0AYbpHB/DEJQXzgXf9JJtREjYwRbCiAyXIaxkM3USoqT7FDHo4TjIKYJjzbAKCxYuCIdnVmiZzz4PoMkhBjUISK0sEaCWA3Asq4J3imkyEY7rDFQ9DNfB08AUyml4A10kA3EXrKG4DQC91NMJTeQxISN5WENt7JkkwEpD/E4IUgDcCQlQkcA/RDiQy6jBBX22UJjIgAaKkpgDecWyugcgJlCs02IppeHkTxliukZBOb6AS7GmaX+iVxYcckGQ4r+a5vFoKZwcQjd04gQQZaZCEJWQgrI5KiLZRDFl4gSR4RVcY+ni+cm/PnJV05S19wRQBe2UszWoDQVQWOh1pQ5hW7qU9y+rFu+7QdDrT/kEpi/eNPJpgeH/e0RwCIyo3SMc4BCFAE5njBofScDiIlyqeLtoKmIfGnTbF0giaRgKcK8kasNCImEmyMZs4kZfhu8UvttYBFAy2RS7VZB1zKVE85beUrVdC0ONUroJFrxgAqQY3oQASoWtIID07QtsNtsG5e/WMNMhajrmaVSFCQAhWgYEqNBiiLBqVdYsjVgPdJtRr1u98IvNOhbk0iezlKqig9kc9XVRSZb7Ve9/5wv9QppgDgy0Mu7CcI/OFHnN40ATWsgQ1tiIAbfF0HCuf1SIhx6IL1DJgKWUikh3CtEm0DYWi4Ms/JBtWtdT3u9h6YB33Ewi098uyVBLbC/+Zi9Kql3alQiAIBoyBFo9RjSsRa1z8RKCN+tbxKy96ARTEkAFAX42Jl2mbEHK3VRW0VKECRG8Q/iAkSz03QFbPY3up+8zPDFA1ppHea1EgokL75YgvK1jSKSOaB5YhpmhIbi96uKhvu0MV3LqcsJRoXrpeFIy+E2FwPp1aSCcKwF4p5XevKCAVF4k9Z/pOUAA2oXw9OjIjuJkpKAE4QuaRmBtNaOIb6IqnVqO/HuETjdPazyqAkkGZHWzkx/M2zV8GlLkuq039aFrkGcUFsXzDUGnO1suC0chvQ2WYyv/mtZ06By0ibAo9iVcpuXtqJx0lnQJt5pnOacg0QXRiKGv960JVdcwpYOaqQeu0fG2XzfQVt5zLLTdGYK4Oe1TrJGugqWNC4NKvmjF9O57fTx4Q0vkadK0obNRqobq2cDaVqTRe6zkvzdKVNwIBu+eGZLrNcP+BSupEoJVrOo8cbaN3MEtyvfuuwyRy0p4VN/u+DLep2nhVGJWBnqteEdjWcF0mGOYxAggSQSyiuhI1/ia6lfiDDv8rTZ0k0V7qhKSEYLLhtCUnw0gXPdbn9XOJWM9x85J52Ccjivk0IqivCiQBBZuKAhq6KZdIWt4DXp9784SyUGRuilxO5iVvrOtOn3bSv0b1psnxhpMF493eeAITQQOFvDWsODytstX0raNj/QVufLuxYVoN8JRhItLlnqUtll0803Q0X9MPFLVULErkADji2Zp2yJPRAFVh+q+d1x4Fkqh5DJ9lGUsZG6fRvd51iPp46iVcd86ufNutsNfehA79wVhMe64zWO5787ncNAn7whrd64RMveMT/ufKNXnyiDx8DQiVt1y9vPOUvT84Bf5AO5fJ8EtiUPtQ3GubntugxH/eLBDSD9ihgeWB85VMyTp7XJga95B3teJt0KFrXJu8Y8pztLmB2eWPgZ8QNhM16ggJav2CtE6neeuB/XubmvtJJvGCWNFNFgvOgYBzJWlMTzEa4Tsu3vVWfk9Vr36qa7z7sIT+X4j+nRWFN/wRVxJBWBNH/hVqqCc9VhALQKFPKYAb95Z3v8Z3l2Z/wIZ6d2J7tqQ8yQIHS7ZCCiYODrR+R7M4UAA38Sc2Y0Af0QSD+Rd4EBh/mtUn/SF9LKFW7hZLd1dKDGNEAUAOBYFT0ZdblVF/2+MPumRHrUaDrvaDgxeCeqII5Zd8SqN4AJWHwLeHwVZ0TthwrRCHvFQLnPaDChR4ZRqDD3V/VlaFsmeHeuaDo6d/rbd8YsmEctuHjYaEajlvvtaAd1mHfoaEcpiELCuLvFWL+4SEd7qEeZiEj5mFbbWHCSaAVzhUTEqIkUiAk3goiziEnWqIbOiKJZWJV+aEiUlYjJuIpNv8hICohKnIUKF4h982ZACwALdaiLd4iLuaiLu4iL/aiL9LiLP6iMA4jMRajLQajMSajMvoiMi6jMxJjMz6jNCpjNE6jNUpjNV6jNiZjNm6jN+4iXRniJw6iKb5iKfahFq4iLPLhWaWiJ6LjG27iO67jIprjJLrjI6rjOdJjObaiP7JjOsJhJfZjJwbiOAJkPMaiQbJiQTLkJf6jLOrjPdZfO9ojRQ5kKErkRaoSZ5gK7h3gonXei8yf+iCcfWmGXNXjC0haIpFWSgpBqdmQDYic2hSX3byBV1THVj3hEehE+PBRTiHBWJHAUN6eSZraCMTQmchgFaJORoxUMsnYR0b/2Xy1y0G4nADiD0v+lN3UEqNMGm5sCSREAD69SMnIQ0rJWips5d+BSVrRAVDGyxAUAQHwhtSV5Bc+0ldkIBdK4RGoJVeaAFvGAEn6yxp1U4KRwkvaZNZQ2mAu5mLiQExSUgWqAAqSlFVYnxUQyLYRgBmUZbANAf583SDoAWRJFT5dSXlxj5pA0xBtZr/8wWdJ02QZlMUcxQEQVgusjwMsnyRQk8oNQglxjwpm3leFRiUwQ7MlwxisDx00w2GNVmgmZTVQTHv84CIR2yMwi1QRQHRiJ9795THYggJkjx5UgzVNEVKc5mceAoGQZveopjcYkSa2gVks2VU2iIA4QQRA/1PpNGVjtttorQv1SV9ecCZQdZt7xqZkVUtYuoBSPMC/icDX/SdMEMG+bMMjnEmaYVqqSBVqNMNuABdtqB/xraZylQ47AUtr5QN0ccJFcKS01KV+SEi+kCgn/ECMqtUWLIZpTKc7EEEECIhPpQP5+Wg+5NZdilsM4dtiBBdSOISDhIxtTYd06VatHQKMitLyJNSvtOiqkGgd3V4+NMP8ySdVDCZlXlkdcNhBtN+8lQM2rCjyPJLJ9ds8tZ9cuZZZdYiYgalEUES+TebqTAoCiJxOfN0WOUJvpAx3PcbJNYUBtmUXIceVrM98CZGkWsJNBFFi/VA7PKqLJshC1SZJ8f8L/IQbgWRlqdrnEV2FqTRBaKyWGDQAxxVggiSEeoUckDKde2QqqJ2ZQikfbAQYewGmREWLahoDTFylqHZcVmhqxDzrlZzpTaQpsh5KYsIXenYDVITCSGScgBRUTopkgJJXbaHIt0pFDx4FpAIVyrWbu7qot6KXtIUjDJDGf34HewAACibYj6ZkIF0mxCVSSvhpiPrrUIDYE/XUMAUFHe2HbTBCEQDsqALQzJxkp2iDFRESQkhSB4KJhEyYWcWqCUhBCUUPSx0fBsFqFLikjBmnXkbBA1TYCdCcXh2Dx8IfjClSeFoBjCYDs6LBI5hpaeSDbDDsajzF0b6sv6KB2CT/aA3l0ba6aTe0H88dg3rchrkynYL0G4roqVcq2I5BHdOSLdAIHdqJ0Q00oNoZSRH6hy24hQ/2C+n1KkS8QfuQpgGY5hv0WNAoSS2Z0phECI7I7cUyCeSM2NRUg5BFgiS93V5oj4LQUq72avBcwwcFCRaF0uWCGZL16khZg0xEW4EA03YOQkNsk5GFWbYyXrElhNDGGOQWgy3MLY74698Sbo7NrVIMxG/eArw+BmLep3a6RYM4LXok1VJ2bVbeT9s0iBYg7o4VGykl5e3SKySc3b2aVgz4bA1QDFJCgxeKoEV2bQ3Amhg+JEJioikIyo9pRPneFD7GLw6oL4CKIzy6/69A1m9FkqNDHuQ8BuRfRCZIyqwMqOkBBwH85q8CnwChLrAMGHD+EoZkfBwC6+8fuoC7vi4MUHBIolnGVubZPnAIn+7puUAD+6UJIw4G420ZxOzStZAMeygMQOXZ5vALrDCQLlXxWImq7OSnQcRR3vAIE9gKPEDfBgsID/Gk/MKWtHCvmkaFHOwOZ2sTh6cUA8cLZ+kNZPEKrkAWb7H0LCmQFgAZhJVGgPHPnuEKWDHikKd5ShX2eAIofMEaoOb4MsmykQGSIAX0UNdnvQ+25mW7XcOERtBoMU8XXAIlOIBmZo0v6Gcfa2ZkRMua+oBk7ZUgrFS0+SfR3TFCTIso6//u3RUHuYxZ5QrnZvlCC8gDI3CBEVGFb4IyRNgDNzkoU6ZHGRDbs52mI6tNg0hTKGwC5dzueaYyKIdXJs8S0SLoJgkTHadBHm9oHktzsHxEDImZU3hmw9QsCbrfxtDAOhipxO6xv77UkNAr0GLmamTQBR0mEJZB2mDR1y7SATVyQ1BEF1ChW8CpOmtBP/OLnjVBoHKIa6nDH9zWJxTnHsNfXiAI2mnUk9ZkcXDCn54wO2xbYD4C9kBAIXOB+f0AnYqA6EjXoHbx1Aioqkgpu9XlB1X01+1z++2oz/hAwqKHAo1FXzDzSktCZrjWmYTGSllMOJdzFzyCQhN1w/wwlX3/hB050okO7bq2DTkjiDpsqkZfnLieJ7B0EqCQap4VMhLysh/IhZgwMvExgtsu3bqG63kISAM+g0GjyLO+hseRq0rzpDLlRZz9FLAuHVj3mXn11yy0wDlUQkgTQFbqtblYhHp5XAYvFv5IHL1marUqoA8gwELdtFhcKt/gtGNzZE7cNRCQB0Gs62tEwmugtlMbZ0+MHXUta4y1n1XfCFYv7Vb7ac+NAtL2UFij187yEIzZsDvkAcXIxT6Y9PI0cnIwA2h6QTNgrQL0tsI280ovYNO+htra6GtTKkQ/TXjb7Es8DRknHMkut3T30P7cRRGIdG2wQ6F4mNNSjYXZT3x3/9PXGQ7Orgp5E59ytJ/I6gPb5LQf4zTxHEOo8UFOWCzdLsUiiK23sTZW29EipFpP8O1/0jZMNEjbqMhr1O2k7vIIjF0CDRQbBXfeqi62hoaJGvdE2EV0VJvpNXKE7A0JbJn0KS8Z4Dhd2waKUO9qcy/z7nVfIl8d+DWS/8B1XoGEKPl51+dAJUK1uXIbHAdV4AgtP0iRaxiFGpn1lsOOPGFgb12OXl+0ucxS6qeIUI66eB0yp3iX+7Sn5ISQz8LdGIP05vZVZnmQfLeT9C8rQEANo3MAM2b7agQPZ00DkAlPttCI7x928AH4osCOSubUTpsoyuj+AvD/Jvo/XDDTgP/nkUP6Fa/h4+xrEBZxCy1uSG467LKvSjYkP3Y6qEekoJOwWWJkRy7TINjAor9AYT66r4WGGtsAM6npVBas92kwdgvBtpovRAIWMHgw4lh7AxU6cS1BtHetMvQtDwr7twEmqgmx1t0h8F1lEET5udf6p3vvtQfBsJd6zDkARQzucav6yoy7Cix7uxNwoelmDBXAaT4bgaasL8zyXTSo6cKwu1NiEEJb93QmA7iMuwJBMEOyLwfZF3iny2g744rCe/HxYWUPjJJOmjK8k0t7MPGEZNwEKDDt9YjFkol8X4WYc/IFpVaLhltBKkdy/ML6tpdEn8s0TGsMhzjHhB90Sjv/8UK+eyTo6Zr3FQs5hUNwWAQFQ82dNVCHZ4yiC8ahi3RlqNVHQJrOU9PTr68ft2Vw0cpUzXIRPMIwtbcdH06D0I+GZ0rbnk5jtBAN9KTDewCbF4UH75sjuBZwXDsU8kPZq9MfOtQrVAKyK7p2fSBltszk5iZkTLWCvMYuFBEwQCiQwRU1YGYz/nlZhJGTOJuqxGXs+1zw12GDjlLsq2y6bHh6HGineFv3uq4bJMmy9nQrLaUAzcq699KHbdWsLbMTe52aAhs/egtIOBfN3+U/d29BXcaMnedHmch+BgSElUBwyGVeiXKgfneHrKH/psPKB9Qg4AfqxtwrABughqjj/zzuZ3B38/2BgwBAFE8EnGiqrmzrrsIZv3Rt33g6q4MgGANAzOEj+QSH0Uk5GBR8BgKgJyhImUGCQKE45Fo7HeP0QMK+aFwYYPAlvOlp8HQwx2WsGcM3bp4YQQhjBQZsbgcNCT4IIlsKBX4ATwIJY19rigJSEAoADQIOAA6ZDA1aP4aUB1YiBXKNXAcQUncuaykIYbmUQRGaKLsCWQWJiwC7CrNTbygjrEJpt1qxDm0GoTMjplC13Sgzt97i4uHjcXUN3uFb6Qp2Oubda0AACSY8cyzPkebl8f9nzBlwZQPdA0YA/QFc+KIcOoYMwUGcaEMhxRVthJHLEwEBBF8HqP8Y8BKDkAME7qQguwgtBb0BCRBIqVPHB4RM+TI2yQQBGkybx44gcOAOVB6WEy1+GVhDZ1KkUL9h9JEvai2JVpEqzTpu3awIEN4RCFJlZINHIgYY6KlVBb1KMgHUeYUgwYp9UgZIiaF3CoGzPRkIetCQa7ythuUlpoh4sRo8jiOyKIYwcrSjXIQcQOCUqtwjwuoKIHxxnpsGcef6abAnAUFJtPyw4hvEylwAgh1oiQBHhVKi7+7w63rDGS3LNBp/uW0DgoEHljYiVwd5ej8Wfa2jWQfgAWEkBhhFIEuUmFHfvSHOy+c86BTSJwZEL2D31Wz7f43GbFYZHo3xXzAQXQr/w0lXg3Eu9WedcjkwV8MDML1GnXZ3YEXhhPjUUOCCR30TEhRkifIISotkctxTLuVTjCKi2OQDWic00EYTte2F3xRQIFCGKh2+gMUlGR4WpAoIXhgQQA7S8EYh1xm5XXVOxnFLTQJsU0V3VFEp4XQMUtglQGvVsA5Vu5xSxY5B7HRcE3v8Eh9PjfwC3HkVpaDlEcOwApMpkMAZTH9t9gFnQmgUIwAjBCjSBQp1KJJAA9X84AAhnoy00JdGWhjlZSv40VcBj5ilgAMbcrmpmIm1eaItLjzRin2iksoMCn6s0Vd2njzCAHyPEViVq8ZlN8KtfyWDW2WcHHDAqMReisYD/3ZxkhYAANJhFBAJEFbCFAg4IdmpN2gKbq8ZtrkIaJBUpR2mpoJ7SwO++PCqH8FUUWCtGep5RAG6CcAbufEFAe8RrUwSSiuyEXCbYMDQQkC3NTob4BxI/GjtH2q5Qmk990g8bnJQflxnp0Fse4Jz6cTH67orjDUqQJ+o5QJw6RXm7gqctTgvYSjTqm6tKQcMG00AwCiCgjbTSljORBScgHNeDFvjJ6Hsd3IXy5IaMaG+uTKWXylAC4C0Fn9W6U3amuDEAGxxLTKrLb09coZWFrIjEkRc6SXOEQBSS3grfAShC9WGO+6U1sSgRN5G+BDSz724eeM0j+w469wn5M3ZD/+KF6DnG1LDhuMPgPJxo9vfeJ3miYYi6go/VEoR6TWsLFszcb4xydThIcsNt+8gY+RAx3etesMDN93ezJbBn8oucs/TEKZh0Tt5C+lsMG9978Af2T0YyXmGgk4PK0CFRs4Y4M7KKLReJsBxSjF4jJ3gSVQ6fqv3fdzmqLpY9ZmCQc4GMokrGaANCjhFKNCEGx8QjzHc218EJbgVV6HgGQQgHrA8N5KmsUBsZNPe71JwlgJ8REYe6RiwEPCJoHmMUQAcB8NG2KO3xXBv6AnP7sBGDwKMYVeEQMSoqmQVcUlQKkf03goGJq8LOswVTOzcM8qRv4qJEHwE2tdZukUACEX/8RgJkA8EVZCkxcwQizT82A1Zhh7ODGQUPpACUxgmn3pBQgH0aAv/kjjB/SmEaWGgzxJcAciC0aIcIOyEEgBGNLQkQAHwGlUhz2K0b9mpejE8Yw03qUY++gYGXmhDAQTEQ1fQkQE9S8HGWGLEJK6RQy44QOJIOCMlyJJzhoxg614FP8q5YlvSumUbyFAfFF3SUZBShKUYmKgt9EZVqVEcSvSiKC8w8E9J+0MmGEEJSnhimyKoppWuCJVXtksHXsiF56AgR1MyQox3y5tG9GhO6HnSP92rXkdKs4I6hAIIXxtABIJ4Ft30oioziKYI7vG18RB0VMbSpBIZYAKUCMEV/5WLliIP+qlOOKaelgEpV1p5RJF+1I/dWJYLLQlDjGVEE3YsW0sUukgs1CsXf0AaPjFmtmyMkmJJeJ18QBMZk/6PjySloJFKBb+mkPMOEjXczcgYAxndhD0GCJpMidgenNZUqKmkWj10ikQU+A0mLRlBIuc1AJNdLTFGhSsN8idDdTUprtTTRxHiQcobMFWqONghX8navE1N6QiyIwWWHCdTX/zFUZ0b5Cvu9iFKEHaPbUKLT3eJhbp1x67lVEEw7Aq4qbqArmCDKmilg9eR2uKpE/kr5mwg2P5dNo0B/N4aUFuLy2VlDTgNy8FoINvWfvIFvD3QFZOLO+MW8bV+i//LAbegwEZRAlJFGW6tHIUL9QmgD2TxDDIawEAl/iGOCjWAohbomTYR7xR58ZNQOOU8lKaAuXIDLjggEKiCefcBVLqJ+BqoidkNV38q6C8DttmDMZBIdhkJxpyGu+BF3A83+VDoSsqLROdGxR9ViK4cs/BDAF9LPuyrFUZfw5kG+JMfTwDMCR564N6BCg7pDQJFaUzEyTyCWDKO6my3p9t7lvUEwRUG1kaVvgM0jV7F9E+2uvPAF45tyQ6g6DE6IYgSpqWLy8MN+7Rs0Ye1sGFmmx6N/ePh0ILhp8do57GmwICFDaBf/xKaT9GcvSZEkTl2NG9ckDyTGDBFJnYcAB7/q3K+dA1ND7dFo2EvYilGabawkoaILJ+LC6EM+mFFoo0nWiOhGTBllQjm88P8NhdBUEkYO1zcbp4ZhFaHcUAaVsRB0MVmI0eQCA6ADm7kfMq5WJU/Pksri2VXpSYAUsZjy2oab3yyQuCUKRFAnrRVyaTPeOHHU9NPpDmZhmekGiKV5ik0SmvediOpEH3lZ6dRkKyshfo9BBoQEafs1nNfWVmjOqtdukwnMC+hbUcza5rsQkkJdTUMsF4pZNqsR1WaDjgJIPY764zYxV4OX7wMimeaIMwYjJey7VbVigx9iMWCAk8p8GXCRmc1ILlkvjcwN0sZku6ipWwHGCSIUjC1/8iCdBsHRX/SvM1qunvnLSxbkJBjDSzv+5ous4R0cFGGkhFI+MByz3wRQcRGQsjWI44uT09S7ZvS6A0ad/l0S5qOTgOdW1kGninfAHbxKJpWk8DvGIVURqATgg1BmbfbLTgFEJZZFCEY4xQCdw1ViO16M1LfBQbB+gvYezJIjPHY54QozkpxlPELbzcQ8NZDZTlkfI4DMJQT/rtziy/UE4yvx94LPS2HLirdHxm8556Ih4BWebcVrd/qJKHI10kBVBctWp/kUnmyrBjMgoi5K+r9siG7Egc1qXFKIclaX+8RqWw/wUsFFUpT7r2YQfQg6mIUr8jepo68tyktgN8xKf8Sf90dd1wK11PnRTBKYC4x4FOsVn3KdmgDogSfNm7n930USHpV53nlZjwuoTxWRg9nQSPq536sQQnD10dXgTOF0DRK8Ak9EUYPx1YoYzsoIHjF5zn1QQBsEQNhREMC1xL9hoOth0RqZQLtAXIjsIPC1gw9wX3il2kYAVs5UFu1F3cTWFLmd1gcOGMaOD5Z+A+stywgOFaJkA/yMUW1V3K8xHcNsHJs1Qjqkx7kBw3aMCNUAA1wlHkCWICX5gmnUHk+4Fk+dUsJwIA+NQkGMCB1yHne5xIS8jV3IIV3R4UWOEZG9iV25xZdKCQ3h3aRwHdsI3ZmGIkUgV/0pW5ZsSv/TeICkJhNT1h6FXiFsHgGP5F7yKAMsAd4ToZ4sndB+yIlvGMVywKFs0WKDMF3mZgDa7BL6rUF/cJCp0BILwJNL+IS65UdOwR7shd5OOVuvrN2ReZr3AFkxiI6sEdtI2F8deECuGJz9fWNlagCa0UPWiYYHQVtLTE9KYIbEXAWshBlsJeO8fF8XMYdrwiOsfhJCcMcrPCP+3dLcTSCrjGDJuKLpnVUFJlsIaUCiSCBuwVUhyYFgoGADpJQusaIcSZmD2OSgACRo0RUuLV6JkiF/yBkSCeMuCVqVgBtrBATYxiDXbCDPBAdpLSOyNgNSZcDspWHF0E0SlmUvoJuEnh+/9A3W/HoCtl2LG5ljz0mA72BbYQBKnF4AjwJlHTWb9vYlDRAGUjBCjQDN5NoTHaSCcFxAzTZAuwWchcJDzNXiyrhBlnwA11wh6gkdrz4A1uIKrVwlKrYH0m5U/9wiU4IP42JkZH4NLOljC0nGJ41Xo41kePTcvWwMp4IdY+wmQQJQ6BJIIe5EKxQOFj0lv52AhFgAlnWAJB5WlGJkYrJjjCpfRoyB7vZKrGxWuTWX2pCK3CiiKmgF9PEF1BAEhXCAzxxGwT0X1rSDJwIJyOwOZrgDmrznNCwEt3BPuTmI7lpA4vihVTlBVM2JDgwmfpwBU/ljTKZAhHwKJ8pDPC1DP9A8Se7SAYqokjBYAV/V4rd2Gl/+Ixbpgla0kzpOTbEkwC6QQhUMYsI54RMCBPpQSxM6ERLcA9h8DXsYit5oTCmxkFOJmpL9GMl2gqcsQqj8hBLECL4eAwD8pIskAvbNg6pl4rWggj0gCZUAkeWwnhK5gMHoyVqOIPZRaSr8DBo55YHaSfxso86V0LiGBgIAJApcELhEXyh03vEiWn5RSTOx3xeNhaR0FABSi2l0Hx4kVqseJJHcy81EoEeyksm1xnR+ZS2caJmeC/7MnPbORNMggTcGSKiQRrZh5jveEkOJAmx4gfGJwQ6lmICk3tkiYozOgUDJZ/BA5tT2D5AsA//g1ojC8NCpNY+CsBFgxOmMuWURmmT6umbIgkaYShTT8MAD2MCRTJzZJqhkAMbHTpjNyh0bCAeIZKX+PEJTvYIgcorjeRorFCo1MeVgAMgEGdN5Ok9H+hRqniMGglrFfejYpNoQfBSNiIKs5Zs9xcdeOaQmlCt8xmTvUkkjCBLTmAX05owYlVzoCeWkBQBLzMspBGrTZUGwXmBItATWUknbSVZw/EAyaBoeVIfwDqnBAZe+QKSpkOq+omsIrGsBjpze6A+JWiHe7UEjkCt8pkah1pZ9KCDUWqZjupSB5YzXLiYgZNtY6qJMMSe2hY0fkCWe5SSKoN7LWhXD0OW9Bqq/1NKK0dgAjKiny07c1QQE6QpIcDkUSPAOAjbefGpXHmVRVXShwt6KGArVF3aCWI1h8KQsTj6i+MylTcrCuMxpj1nA8jjW3DpbXKRDJTlB4Lpg6nJOEtKBocgmE9rM6IqikqlkThBPmiHeVZQALJ0nhgyae54KhsptqrURVXgsY4TectDCOvjWgX5qKwLDPDHOo9gcEezin9LZPXpSf5ACBozAr8XEgKpffFHcY9bfgZZvCREaqZaBLHmL6rbjmmwt1B1owlrhS3wDFYwaCOBgMB7SM0bucNbqwn2s5KFM6ggVy1QhvxqBrELHzhotOUaJewCvXFQUAaKftVLC1bgk/8H0G+ny71vNi1E2adfsLDm+71Ae1/ii5coUEndezJiV7V60bKWO4cJfMDgN5eUiAbyGwfeUb8UOLaiowVv6Fn9O0FXElCrKasvcJcEXLYG7KMDeL7AqT1bYVIvzJuzGptCkHd/Zy69EXl6Z6QCdihHYz5jE2XTG7mtW3f/p8NQa7z3BU58J08E6kxMFxopIQqI5z+ZYw3YwF1Kd7v7OWErYXIvMqC96KBeoCpOSqa8KKbm2BsddXuW2h0aRcfXGsYYCMUQmgISSnhUocYICknGCRMEoHcMhHkZkcLHdcOqZ1bJx4K6t6YHBQ9pqhdpYgKYkDbRx8CL2EkrOkrwgY//htY2SdcXbEptAFxlTflF+qd+YWeAyIphXFl0m6bHuBu1Z+Gmu1wkbMqqbJGhzJBBkipEugEfXUKf94rA3jYD8rGmbCsVr6YWHTcPGlMIe4bDZWq2VRCvixqeJbk4E/nK6heAaVRIWKC/KPCDs7xWRXcTHky99KNoE9GWNhBGGDynu9qrudSGF0NoSwAxkmVHO5TM9nqgKyBwkhxGEevPeCBWYolQLsRvmjy+KozQPyp9yMaV2wqEQwmqTaDK7ptGaPgjIvygnrVIM8BZr9HBuGy/CncNEOGaaZkMjNyUFAsBFus0EhugwYxl0BxtWoXMEvfES6yH0Hhda/sKSEQi/2qrWI41g16sbC9tQ0TSsmA3kTT7C1RgiCCtY3FUuBqbFfRb1fKcOXl7tzWJmBDgHed5C9LytsRQS9GMZC8ygpkX1GlnuVHdK468ubncufBrGfGmzR+Mgu7wQ4HgQ1H6TcYgyHYNU1k8Tlwczwj914rBx9vsvMsc2DmaVf4kYnvkzpW8PJc8x9GD2Tan2gK8x7dru50N0zizf3AWFx1Zy3XdCtOsvaltv6zNrKZIMuJAu4C92Zz72octWsxGXj+0Fy7kzrmtDXTSb1tp2dv82x5MivApPbRq2CKD3dg9t4KNoBqBcVLQ145NxDIFgVvnWeht1pcdtcHtno/Y3Rdt3P+DPd7JjQs3nVvUG96GXWHqzYnhpREWSmB/oaDjs16L9Ze/wJ0E4J1u/N10G9v7zWcYbS3IpCZU1012YWDUyUGp+y0Aft/6uGWs6mgzxhclqspzPD46NlCxQj8F8KKg4gAyGpkUXpEZ7tmubS3/tBNC23pX8ggUHeLBi2AlnrCs5pxF4Gf1hx9vp73jQ0hQOqj7ArNcOdagzNk9Lts4gM/iCne4JzOZZmeRcGrYPEhqjuT+KzFLDrq0rKHqmy6FlDCqzL8hSC1Dm9EjYqhbnkagMeg3DN79ZM5mJb0WedQ1ABgpzJTLERxhIDjEuQbGthaRQNHKRtHOWh6hCOfyTWD/aCFzA4CGJvuQaJufzEBZvqTlmjGn5VDoFW4tmGvENXCbFg2+P34DbX0QflXBws0/fZuFlt5xkdDhg0R1Jwutb841cf7J6RdBss7jn+E1u3ZdlmcXOuFemveH4PTIYP4F85MrRdwDWsJh9TBcwYcE++LhYnt6U/Xsar3fsX4hhk5Vtd4DS6ti0lc71S1ZawXuF44DXppCdIyTMw6gNzY4KlrkUFjsvSnvE67ER+aY9kTtVMJx8QEIy/qri2arQCXwZ10oraoXryqygcBrJ9M3OiKhPkExuS7eOy7xXB7tVTjtXl7tMaKpIFiIUYZqQBjwxU3vqiOnK/BIkRQKKo1v/6lEQgqg7R7FF6SRzRN/3aE+8jdv77Ou85H9KEY418IAc1JbJd8+9Fh/wsvXAl07vkNQBCiHAkgIoi1SBVRf81ZdhRTv49Ku9dR+94yO9ZJ49Xmf9TiU836/6+Ee+JpN74Te+I7/+IRuwbB9B42LiQP88IJv84r/94Nf7+Xp+WSe391Q+Rt4AznTwgeN34kf8ZlPXE7Q364v+aCPloQf+pMfB6S/s6HrI5i/+IDP+otvs3B/oSEN+/eFiMA+ZLNv8XsPw7cvewyQEfHi4M8HqleMN4inEyLxpK0wYTo++MlNJX67nu1C87jVwfR8Zr6C67c+nLKv48tf8Zmd81zKq//LgBrFVEKVH8fGBwIFAZAkMYgAUTBP+b4CPNO1feN5Luu9/wNjsIPgAEi4coNBMLcC8njNKTUofUESR4UjCxCAmcvUINFggCMliLqUcCwN4TIYUi1dSXl8ba/v38H4BRLO7J0JJLAwITAAFBgADIAJFKQ8kSCMABgcyIGtbCJ8ooysOBAIRBjRDBa+NrnCzvbkER00GDA9hAE4fBYUURbwCjCCKbwYJAhwffUSIChMgjkoVONE0W7H0jQUKTwMPCQ9yoydjBA1wDQkRzC4S5aSDIzYE+4N7gO2wspym+JqAAMGjBxBugVAgSVTBdYYaHBAwYEETEgU0MIJAYAI9DD/qeDoLyDJHSVP2rBFSU1Cd6jKnWPSkosBOzB0AWDQxpyKNk9a1PqDcqgQGhYjZEkAoUEESvOCCXBQTwFONxAYRFODrp7MTXf09TMUVtA/ol9nQEC2CECjR5FSKWB46WGJVAYoOmAmIJ6cJWB0zS2WgJVYs0QBGi774tYDLQgoVTJA98s8tpALIGBWjtNDTUydYnqCShXhfogTFxr0QAECdwIajPIVMyOETiUgvVgNYcC0pxqXPPJaBezIwsbJvjqN+vjys81JKn8ucEiRIw9qszMBU5IL7IYIS+74ILYDGaFtmhCZUqj0bYPSsougxZMAOU/vvaF0kQSEZN+kLpGL/zHApRCIPpAhmKCCCyaoWHsmPUhFdBH6MCGFOqhkxEQQFFPEL2AEI1slHVYEijJgDEaffZhQI1hpI1l4YTYyJkcjFDYWhyOEOkrI43CGheceez5aQeR0Rq5nZIwyLqkkkkWaFSQt2jz5Q5M0WFNde1dGyKVZeyikQ2zNealjmTgC1AAz6inBRB7ABURllUEV4hGFZz6H50l6FoUSnxf+eScO+PwA3Jv7CUnZnHQSApINjsa5KHJE+nGOXuhxwgwXKTzWDBoCEGAQW6ZIM04vnSZzo6Q7rpqkDXD6YCgMsCYaaJdYymGAVIkkAkADqVRSQqfRoNiAmmAg0OkVnzpCh/8AmELZqq2JkoUPoSTgpJMI7qDHg6ia9OQWLjRBW2GrM57ragnMEgFGCeKUII80oFZ2qAoMQHKNCx/qysYLbzhbrqLTbmmUCw+oESxD+BSQqgkFfGOHRY0B0J8Kk1VM0URw3CNctKsSPEullRWIbWehEFHUtw5ZNkxmAmzGaLrMzcwHFhpzQSsbuSCwM0MqLOGmCiAucYK45VkHAMLywCOPtR4LFXKeNISHGw8rfOpuXQWkLElBFxXhKLghEQi1lelKXaNYZSvzUAQPbKtAt+w84AhWF1cc0Xeq1jxp3zYLu0k0tLqDgD3itDuH0C9MoneBMlQdiVJYIaBVVzD+7bf/Gwcn/DDCNKwQ8RHjaGExAZj2d8DGbPd4btqp+cM6tigewCkynxGQZQIsK01JifTynbmiwg/PH85wILoFU1z8V4KsjJMzwuNJf64bb2JcXtjrqPnB764P//rXC090asaxAnBEzQvMkmy2ua4jGaOUBRNffOZ7sE+r0mpYzNY16D/PeUyIQCj+4L2M+Soq7cNc/baXGAdyA4I/AsL8pCPBw9TPfvDTYN8uOBQPOshHIFQb8UZYEhOKbEj3yyAKDRQ/tLEwhh1U4d/8IKoa6G8KFQyhpFoosx7KsIQBkUcJssQK82Bsgj6k1vqSxzgnNmGHJATZCzcoxAYGBAGbsVNB/ygDKWFF4n1LnBINbkiDHEYxiTxc1BjRJa0gCk8WJQuCoxyFRNhxsGY21AtHgHUPN/UiYDkBRfiCVYJlNEMqxWCCH9nyCQJcYydjAaKTrBhHOPpKLwMgRfkaIAJe/GxsJMjFC4Ylq1P8TyoYMYWmXoScNq4xJ2qQRrwWtp8QPa1hrGCYwzjBBG11wiWjZMgoaseFddwAlh/jkTKDt0IsllIjwUmgxFAQHoIcAVPjgMETTsmCmE3TaHZKUjPzUUYmpIwalQhQU9xVNlFm7Qrh0YSy1ukydYRRS5NkYxXfCM0rxgsNikhB1whSICLUhpuq3Fq9LjaaVdyGZWi0WTldOP8DUZVBIbYkT0yCo0sSfG4G4XmbdwCgUczgUw+u7BMVK+lPgF7yjPjSgugsUjJIIqoiM+im0EASjYjibaJRwyQJPvUzuNhSRR1NwacIUMgwzi4RRiARUlFq0nyuFHAtpRQM/xnTNahFQAPoZMng88SdPsSbLgIqT5NJwxl6lZJcteQzYToFbP4rq9B5qx6JOqeKao6fca1hIKT4QL7ODLATfKkIu2pXwsJVsa177F/7udWvYpYKnqCfZI9E2Sp1No9PCu0yIXuHzVoQsY7NrGDnyti6srYJqJ2aaFcLW7k2lq6mzay/3OAAshKAF+eLxKckicHa6haurzWTbXd7W6b/xUMBNbVmWufTideQSbXJ7et2aUTafSqXtZPLSkHxtQlRbZY3VTGMnGLL3eWiqbnhva3S5Ha96RbocwnFCFS/pF34vveyzJRvgOlrseYBlwT0SUBE9MO9/wrYua3NLYAT69eWfvdsg62sSyM8Xwn7M8Pv++xoLYtb+n44xBe2cHeZRGAWk1iwIv4hiEFr4gmjuMAbnDGGVnzj+LY4yBWWsY+FTOEjn7jGMGYxj1mV4xJ3OMkp1rGKN0xlG0cZx0p+sYwX4OUvgznMYh4zmcts5jOj2csCSDOb2+zmN4d5zXCeM53TLOc64/nNd84zn+u85z4Dus9/DjSh6TzoQiPa/8ztfTKXswzkIRtZyhguMqRdi2QtT3nJXW2yG90LZUtLWtNb5jCn3WrlT1+awzGOdCVLrS5GO9pGpXY1eK9MSVrnCNagZi6rVe1pIp+6TXMUVDceZKFhf9BHwEGDIwIrI2T3WId6vYNtFkuLY7Fpr8itASQS+eh/QUsps6KHd1vRbF640kKdnMFE6oKsaBcVQaUxAAKgvSd2UwJqXSTKEqyRHc1lrdk32HdA7N3pnDT7WlSbdhWqPdnbfEIRYwICPiau7SUBJwLGJTYMyCEJ/2D3iQanrSCkuxB9ajUHNY1Zp4x3ALMe3C02QPbIzUkdrvUmByP/Yg+2kuu7BYPhhf+CIlBnUPNJ7lvhIhU6V37gcM8q2BhFJboOhFp0i3IppCQIpVOB9RAHL2F3xY2lFxLABS+AnR5lQIQqUmuICPSsKQeghm1kAInfXmMEqCoBQiUBta49YBOGNPULcDPIvVyMU3nnRC8iiO+HBLeThmKGFkgx9kxQ4nxsGvsi5wEM5twNO3mpjxGyNnc3Ud4XqYw6iNh3yDA0kgxm6Dzhi5pwVjaj9L4bfSc+GZVUDsPBBGjl4T20emcGHgYi8HdOBsD7A2RJgSYdBqmmoUlSYF3nYHiAO1jxi4V6LZu8vI2lVBfyWH5jIuLwOEZmk47p/5vkMYAAAZCiT6NFZlyQ32T/ubK2AhNNX1EJXrblmsylzsasQNzs39E5x2JUwkRMQjUZykPIhTqcH0NRTP/AH3+NC/LYWx743wEYzQBEwEd1wgQuxDfNAHAcoDOs0gu4Q0MwTDC5INLdHtB0BApQBCeIoBiUYHgARdORHw56hAkeQBAW27o4Qqd8RGtI1wjCAzixTf2xhTQxYLQhRjR0W7P9QhIhFHFBxme400WoF9UlIQwcRVIsRTvNBjZ83Hotx8jExRccwCj0Qi8kjjG8DDh1xMYBnuCpEc3gxthEQwISQB6SW6RQBxgwQHk9jyFOBRz+BNgQRhnWUwH4HOgJTgR8AqiMzQkuzimkAkQ1HSGq/0eBqJMlYMMl1h7CgZREjdUmdEInFpAvjOLp+QobBlUsYgv03eIyJd/UcUpWMB4oPFQlXs4TIMJAuQ+ULMkogF9d9IbWcVRlQNz+2NwMrIYTvkY1joFSOJzhZZdYeFwR0FsOfoE1QIz0xcCLPIYadU3qwFwrGuDxGGLzYIQ0Od7NjdKzjM4jWoI+iqMK2EEG9hJ/ldR9IN0mJIB87Ad2TAQuXs1k/FQ9dMfx3MZ8VIdcgOPL6Y2T8QYuGIAL8BREUoRFXF16bFM1lmRERGRdEKCTlUcSnEAKuIMijM5OqccUYoxB6aMSNUE8wYBZPZVSVcY39AJOWhRaYJd8XFV9uP+fJORH442j3xQB3QmNOs4L+uiFcExCzpUSJfQRVdKj4bEPJG5la/SFIjrgZEheKEJMXziY84CB5sWLg5FIJgIcJQzG6CEeUkmk59BOEbUeI8JgX1SV7B0AidAjsJjBLg7NXUCfXpgXSNFOeaBPrtwRcNgFRayVMzkSKDREUYWRX7bAYDbdXFRMWK2lc/wJXjUBKWXjr8VaufUa312gba4alv2JYbEXpaWarDWaSJGlcAYbqS2H1S0lbYpUIFblNrTFbDbBFe4jifHcj+XAbFkjbSHGuhWCcjbgDxCcDZxjHFKQc5rnD4RJDkTnckYd003Tcz7ZddbmDWgneN4bcq3/nEXh58Pp2k2gpwAl2/gEKBC0Z3hOZzNuG4L2J5LBCX3umg7cpxnizcXhQN8pnAHIgQIAi1ScZSs1lSBdnntiXjMQEUgFzRek3nAl3l3AjC98gsAx0bqAwspkirfR3vQVJuK9wRpEQCFBXqnIjLL4Ht0ZgaXUQe9I3YcgnnT+gSAdkqY4QL68qPc0lfecD4WySuI8hskU6aUc3sbJX+KIQCv5HpAqqZb6V+ENg4r2CosKqIOhirJAnL5Iwl+YnxwkADNEBJq+Ug74nzIwkt1chz0O0OI8DTJN0SGhB8BoAcC4CQVionW1KPSZhwscKBkp3w4236j4kizNxEKx4PGI/4MuicP4UeGIPYxbYAz++Z3fhWpwsYWMWhsfPI2ggmonIA0SYCMP8CrCZAYeCWjXSAYkpFXHKCqgjJsJHKqxvmrDhCrHzcoIKMykXtVZtR8noIejJATS1MUAEAHEsIa2jt+f9oDGtU1OpA8DmGJb8QDblKGwRtOLisMJ0BJAotdbjCZlzBOtphAMwBMjjMA8EUublqLgxB27NoYDCCWEMscTFIgdSt1SFSyI9Ku82mr2mMyoTE/kKErkLGOBgiQ68UCxbgK8UoWaHpeA7mKBxBMr3soL+CW1Pky+PpEYysAeVugLUobEgmvJGkE0CKW5sufgcYa6ek0LokJauQk7yP/OQNaqILxcOFiD5SjKCuiXvk4PStaNthUep3bt3YzUdXwk9GSM6jCPAlReMmjdzsKbCdhBgZyjnVBsQnKtv0Jdxsbnxr7N1nLOF7DDr+4EbObtNqWfOqKixkKt2zkPTTJtfu1EQkqrK+LDRGbtE1UjHoggpnQsR3gEsQatFonpUA1KMyQPEK7r4TlCWzXFCXQFUkqdkx6BiTQPSgKkimit4JlDfeDtosYbqOjOwA4mY5IAZrKAYebk5zyV24IkiJzsXwgN25AIVCRA75YWZchOMQ7G9BxQ63pPWjSDyB6c8aLBXexr2cCuyg4oYVYCTxXI8hKvsSnfX9DsxSxYfy3/gVF25Z1KwfRgJeiGxPISLXMGQbDiABLOKKYZp9OJ7/oScKgB2276QLv8TA2UD3zmrQLrpg/45mEdZ6VBGa7RTKZh5wZD8G2i2qYB5wlH6AJ7mK0NZwiv8HOUp4aBsPyicAm/Qg1vRH5ylwg7m41Q54IOWH0a8Q0HwhCTaJVRlpF+QVpILCS13d4JS7GMwjXYDR+pbsskwwpw0uK9mga7WA5HGQNocTRMQ+eZ8buxz955MexBjBbzihZEXzSqqgoHG/4xQu8d02vURDv4o0WMgkREhU74j9L+8cPY5FFR3azp8BELmCHTEhWGqiTLzfEkcuIJDjGUTjJUKwKfIR5T/5bPKgq4oFYR6GzU1QO7yuJaEIEp6iwkImIY+1oRI3Eto9cdXWIuw7JmaHLNUuJEHmMGM3Fsze3imDJWaW4/VhO4lMcZiIFSYKRKJSBNsSMtY1kLp/BJGJwSvxpGacETJCQ4K63mVrPndPLVUmRMvq0oxxZWlnJK0eH+VnEiwIaDGdVDsM/+hk5fpGUYJ46CvkpxVmdUDYayLiLwrI/1Plg9i+V7EkI3C/Qd53OFkkhF77OJ9LMxhI4cC6ZUZbDEMjR0qoUzzvAdiFKnsiVu4pwTyQIUryy2MEFDrqD6/mtbQqAO7FwDXy/KDd0NSDTGmtHA2bQHkx86/aTOKajDgv9UUkMIELMUSaT0UGtqW6rAAwAhQYACFZMAPKzpIUWzKQtDHWhSvJwx8SHo9EHeeBTL5PWK5aWBQ9ul7FbHs1SCDDxfHbNeJXinW9jp86UAItWgM1F1DRQ2Qr+Lx7CPjQ5f7nESMsi1Fs+AV6sKVKechIXrRIyCPi9OJr8eQc8oTlSvWFeGAedGOotTURdgZk9DIKdotRJUbuKNQWKsSn0B2OAgCYLyUbo2xFlqbpfgwP7S6DqZc42n0jJ2s8piuTwBbTsgp2qYZUPYY0AVUzMubhpmVpeyL7sBE8zjSmsvbFjgUQrUZNxQ2DAtiSZOI76rQcAlKqYsgaq0TxNzXfP/AS0Oc9OVV9FBTr4F9skQc4EFYyYgLGM/rihw96qetyuVgUl/cArKty2ztBu0BkpeoD4l33cX9KfyRyR06TY5j8DRdluldbgy8z++t0D21+koTTrT9ZHyAUpy0066wHTxd06+4NgGuKYFA1IrbdjCYkZIbV0UpIuDFEeshoNLcB5Yt/xFnVuiyACBCj2PkmSf0E3sx7Ewg4iAbwVn0ruReNSaeImaAUCK1VzWQ11aeVrT4fDgNWV+pohgRrHcuGkGNmper45tpd0YZvDuolhROf/OdSZcg5eLkV9ZKVWGjte1DProtVG/sAmLcXN0cDuPGm/6leDazwrwEreo625//3Wkj/EtE0WlFzcJI+eGeSyTH6/veAsC5PdvkjGks7Coz7ptSjcHaTqra13tqkdFyjqpy2cA5sDTpecPQJs3nxHVzRG7FiAHYzAFRfuzT9qGHRCrLy/daRGeh3qt47AD6oCxN/QNWFyyT3TVMbtwODvo3SB5Tju0s3m1SzAFCUyw2zo9ei1uhvu7j7ANO8FDmDshCFWzxyQItnsNiDsO2XTC+7s7/2cPNNW3m3UYMKkjaLfwlcq8CMcVI57Gf3l9hGkrogrbNQueRryf4BvlNcABmR7X4abKQ0Ww2PUjcfUP9Sh/BDeRuuhmUCmmWvF4753HC1KCKUvBw0DS4d4Omv8eYAfX71VD8EED8S398TX8jp10NguLNMlqW2h3tlJhDOJgJrjk7+1fg3tCsqqLp5/txnwrEdc2EUiFLgiuEWKTuEVd3O9H5eK2toZyqXrmRwC8rl5Bt76Ga5N2IoO963YMfjmV3CAtu9eDKTTrDnYCFDorEtJKiKS2EYI6jRVzjtUGv0NYvo9SeV9sVuMs3swygWNLPREEOkVCvKpL13hqSJAyBIGJt2xS4H+i+e2XKjffzLp5JiT4D7GBwr6Bak4Pf5cXae8hIpZNeYlA16w7wJ0bLPY+LRbIMQJH6vNU78f6HVu9lZk6vnc745jxLjhCAlT4WEUC0ijjNbP+M7P/4+XyV+2pPSJ7btPGNAgAwCEAjQElD/BEkNEcygEQyiCKpIkyDDAgAEoiQSM3pCGXTGKuoUgADApAQUiAWIVD5LXYEGgTgxcA4Rw6BI7cAHcNjwdxNiCBYHaRg9lpRVAAVAYjc0CW84VEgDCwgmAAsFYj+PYSM5PDqMeZk9YJGio6SlpkWoqaqjr6KeIgteoZO9vEBCEgoFBQgGvwgyZAdmAgQEwpgqCAm4eMK4CTvDxcDOOM0/kJrNDAgPsz0IsTIcBFS9pKgivkQGzQRlCceXuUk05u1SvkNE6QoJ7aClGLLUBwKUpz8AyuBA0a+PN35180AY3gCAHG8Au4YMyW/7SCF+xIoEE14h145U3Rg4Unl7UrMfJNSSoHVgZTgiqbM4ahIJn7iYRIK6BEzQ111CyXg20AGLzxJ0ZhrjAPt6xkV6xNsGAmoOYxIMjpUlxtQg3Vg+CHOQTlOiGAxaqoXD1nUQ1QW6/uXL1z+5r1CxjgEjQmFHT8qSiw0MCM4zJ5cA2FJgRhGgQBQgCKliKCdBUAe2fFQAGdCzyQAqEKaKcMVpwjlfYn207pdJXi2zjnT9BIduTe8zu4LOHEdY5Q0MYmNGcIvvTLdcAhrmtTpmN1l1cE2LFsUBrAWQs48d9DISPz94jMN4u+TwVSBPrznkBOiwwLO8ABvAjgOeEer//KfwDSNaBcAhZIy4EIxqLTQrt8B8VSWjDQHBbiDPAWE4qowEIE2U1RQGua4DCAh/6dsiBgR7nmSXQK2CZTHApsNt8uXHA4mgiBnAZAandQhoiOh50Y2GyzfPdXisjgRWBgSDKm4HBKgnJWbFMyOBgRfQCzDBEUOlfJANwEI4gI8Akinw5EbLffNP8QGeWVji3xighQccEjSV9oE4aONrrSjlZ+SkeRVGTYlEB/TfYmgKKrGBnLk9j45UMqVhIJ2HeVqrhKnABW+YMBQ8qZZA6EsTAjDCKE0QYeYJIkwl2JwIKjiSY0ulSZNbxF3aTikfrTWbwtEcGowKLoF6SrSIr/aWOJocVkeJk6CopMty1hLZXHSjtYtLH2OsuzfTWYiyA2NbqRqK9agottqxKTX6BIdEOFaSyhJIC3w3m6LbdIvNCfDPT0K2VQNfiTSQ4GIOxAAyAJwiUCkCjzw3UO8GLQrjd0gwu1BYPYFA5bSYExaYTmpwwbb5xMzDPRrNOyvh8XMZ1U23CcmVca3+XMATKN3FUveRnEsczI2lMyDhx7WMJnDixN6idY5UvJFec+w8WwIkBg6x0OvFzdM5wuS+OVixGcINpp10LAhUgYoHQElxWwzYxNSVwIG7W6gYWHdNPA7KLa4TdEaXxnKIKI3yJOEBSCtE3AI0b/6oURdluR/zCPPhLgdybf/VzaAFIMwwcOqR0gQ1mCw2pmo0Z48hnqrwP7SeRn/PAeaDJBcUAKTEABQAQMQOF4DXS0NW4qOB97ttqdyhYJ7QTG1CtobHHcsZcSZ/0Zmu7ceYyRgfu7msh+4ptZNwkUoJ8A/K2s/p/2PGP95K00ME72ppZTXxIjie8z81GiPqRzAzS4sIlmkQR/zgCCAuA2BLE5EIJy+kT9qsYFa7UmgUtIAAQYwAj+OOMZ4tqL865FuRPOqRSbGpH02BamtwkiAg8YyKrsgIfZrMEhohHeN7AgiEsYolR2ApIA6fNDN+CFEdm6SwGkwKocCMR+TPDJDi/3NxForv8KIxHiDH7mp4GYwQ0rOF3qfEXGM0RiEmaKBBvcZYXoma2DOHgA7v4EBNfQbRtRzMEDZtQHMdnBTHDxC7+21TwVovB5WyvklIYCkxgqjCUOE1q6JGYNSQQKYwYAoo5MQkRDHXEX+bhFuRAVQFPq4gQuS1lzFkLFJUzDGHzCGaHyMJKZfHGUs5SjJIjmDW0hYQ0UeUkYalYCCWWygkvAWALuqAhiCoJDEECej6I4EcrAa2yKFOYh1TaUqeHuH29YXmWipgqtcUIyuflmcVLEOEZ28zWzyMQDjLWgQ2YLWZ/i5zyFuQTbXcpxYFSYxwYUJ3XO603tVKE7Z1EbXcnzn6H/RIWyXmgqKlANJOtIGTFJkzh1VBKkQOOOA7xzUMc8tF9DueBGSFNQ7aR0PCvNp0MpajCcVlSnHhlM3sriOMWx7hRzqwJIdSHUtgGha4ysKfP0MEUS0EAXP6PHOZnJU6c2Ziho8CXBtIpOnqIRGdx7KfvatM89YK8ERAhE+/jTsnusDaxYbWYvxvmiAsiEHz1ypJLoStObMgGOlvLqVsU6VsTmdH+/XMNUdcVEFoGhQznN5a6CFCx/KjaFORAqKJQaVp0C1pCrG4Vl37nZnqZ2sUkRGzzyikpp5oAfI3VjGO8FlcmpdLWsNRVLROETjOJ0tMlbAsfAMbjPKGMFU+PS/54W0gDlCkCyQCFuiqxrUyRcVJGJXC12EfTdw54QkiNY04NaUgMWjaQOc4gdG4sSXoTy9mPbFWx8+zlfznJXsD31DVgSMqz1EsA3TuQCWO8b2PwiWLwLFk6Dg/NgA/HXYGE4iWcMnF5NaIG9dzieZtc23wg3dLPdTa2IxVs5Ceqhhded8HDodWFTTE2vBrkIdBMiYQXnV7//LDGJd3wU5CnQTEJWjIt7DOQk/5jHWVUyti7SMhu4bxA4S5eb8uOP75gUvkee54mh5GTE+lixXzYyEy4DiQPQzQEksIwAR6QIpZbIs0QpMz2ZQIa2IYcTaSUFheocZu+a+MNiDnSsLv8ihAKiS4CQmA58nEGAt850keBEy0WEBy4DruLP1TX0kslMaLHambRnRvQIorfoIRxBVMGjA60yzcHMjlcPLtCOA5iqaT5nOnH4DJCnQf2b+uZ41MUNsYamMxtFBzB45EiXmOCFr9b8FtCzHuzAVlUFPz4FF1rgKNJ8u4ymBBNLOi43uDP25EcVGRmG9TWTRfvr/VYbCcDDswNE57XLXAbbeu2VZu5mxj1PVNDmZney1s3ldw833l1G5O+yvQTItC0ZehKCWffpGwoZKda6KTjBM8oHqEAAHL+Arm3YcrKMUkwSWVYzFhBGA+zNdMyF9jiS540EpiwhNQ9YiodiNOD/RgGAqpKNIh4CrjrB2PzTrYWpxS8yvKiQQVYejCe7Y8AGOUfAORfK4vjCQ2wTLr2bYQcoEmq9BKOTyCIlyatsY7WQPBRtFmVPuLG160ug347ADCCBGca0PsaCKK6B8OQbACgKmoua4ThHG1cRLtyP8zYbeWd7WuTQ4RrcgA940aERMLsuQmBi5qFu8tKrLLpIB+pk2sCv886CWcczHt7aHWG/CRIbjBxhHj1ql664hINoh77tCfPm7BfezISJjga1Yhw7XV9p0999+qSQ1Zl1C9HZGX/sNdduOawVHxjE7y3Thb7sgdJn8hyfogdKR9IVJlGitGzXYF//zb2g/Gvs/y1WeBE6al9PFOk3YtQneZvWa5zwAEL2UIonfZO3YupgLRajSk/EUA7WcKoggCjmgNznZwfIBALjL01lf162eI2HGYOje8mWBqLDbWegDBbXCzQgBiBlFCNIdubAaaWHFCE4ZPtig/JGewCYdjOQAphHBirIB09XPKBlPENAf+5GgIPmBZGjN8UggzUTMZ0lUjozW5sBNUBzSxoDaU1Sd9QWhSRogk2RgAjAd0ioaVcwPxgyfwp3ZxtIgN3ThCWSCJYzIYdBBFuEBAnQBm0GO0NnGqjBRSZSFwwYhHaIfEKYfHwkdYSgEKWzBX00BXkgN3S4QgUohYmQNZDGQPpzN/851T/+5zWx8kCjdIoHkEuLWHqN6IloCIkd5Bq6Jx0Q8YYX4UrOxomJ94MutiHUYUVGgEN+eASA2IVeYFuUAIiveG05VYadxoFp6HB6UHznd4bABoqukFuzVAIbgQdnRw5hmEbHJDZtVQBhmEt8VX/VKIv3F32DAXmh5YizyBggWFzTKGvbCITz+Ij3+InCkYCkxo81CI8AqY2pcFqlQAZvNGk7xY0CSXsHCWIUeYPWyASspgnxxwkY4SLVtFT9iJHdR1al0JCdhX1iZ5F0F4z2uJCiEGceCQoG8AAQUEN5cFUumZDsR48oSZOF8X4M9pK16JMmyDWBqB+fMR3PkY3/ncCRgVg2AzeQBShsepCSfkRdRNmT8niURlkYwTM8XIRHSrWJoHAIRZaD5OaPJahyVIOLOhMIw4BJudBIqNWSbFmSFxh5dvJBIYRBfjJUelBCvIaQbdmAaoR1azAHzwgJgvB8p4aXRamQXvlVevBHI7d57wEL1JOHQsALouBBh7mXiSk+p3IXrbgf51F+kmmBv5iRiAmWLKUH12QHgcBKQRBDcgaaRBBcaad9eomPJnkG62CMjYmINZACvSJ0vvOaeUmVTPeVlSkcekiaw+mWrbUcIcGO6wg34MMCWwlmsPmP2KmRfRkcSxGRZmee8UgUETKZXUmLARmTlimdVVkUuiymfuTJl4lpn9fonhPZnvIGnVBYmrMJoPSJn/dZkZRZn/P5oLF5oAraoPIpodMZoeW5oAJqegWqdLJJnQmKoRtKnB3qoJfpn7SZohzKoMg3Qi8KozEqozNKozVqozeKozmqozvKoz3qoz8KpEEqpENKpEVqpEeKpEmqpEvKpD26Y08KpVEqpVNKpVVqpVeKpVmqpVvKpV3qpV8KpmEqpmNKpmVqpmeKpmmqpmvKpm3qpm8Kp3Eqp40RAgA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     &copy; 2007 Chris Johnson, MD, AAP Council on Children with Disabilities. Adapted with permission and contributions from: Frances Page Glascoe, PhD and Nicholas Robertshaw, authors of PEDS:Developmental Milestones; Franklin Trimm, MD, Vice Chair of Pediatrics, USA/APA Education Committee; the Center for Disease Control \"Act Early\" Initiative; the National Institute for Literacy/Reach Out and Read; and the Inventory of Early Development by Albert Brigance published by Curriculum Associates, Inc. Permission is granted to reproduce these pages on the condition that they are only used as guide to average development and not as a substitute for standardized validated screening for developmental-behavioral problems.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Developmental milestones: 24 months through 3 years 6 months (continued)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 297px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     &copy; 2007 Chris Johnson, MD, AAP Council on Children with Disabilities. Adapted with permission and contributions from: Frances Page Glascoe, PhD and Nicholas Robertshaw, authors of PEDS:Developmental Milestones; Franklin Trimm, MD, Vice Chair of Pediatrics, USA/APA Education Committee; the Center for Disease Control \"Act Early\" Initiative; the National Institute for Literacy/Reach Out and Read; and the Inventory of Early Development by Albert Brigance published by Curriculum Associates, Inc. Permission is granted to reproduce these pages on the condition that they are only used as guide to average development and not as a substitute for standardized validated screening for developmental-behavioral problems.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9224=[""].join("\n");
var outline_f9_0_9224=null;
var title_f9_0_9225="Lithium poisoning";
var content_f9_0_9225=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lithium poisoning",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?9/0/9225/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/0/9225/contributors\">",
"     Jeanmarie Perrone, MD, FACMT",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/0/9225/contributors\">",
"     Pia Chatterjee, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?9/0/9225/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/0/9225/contributors\">",
"     Stephen J Traub, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?9/0/9225/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/0/9225/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?9/0/9225/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;\"Lithia\" water was first used in the late 1800s to treat mania and gout. Over time, and likely due to low",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    content, \"Lithia\" water was ultimately replaced by lithium tablets. With the higher concentrations in the tablets, lithium's association with tremors and weakness became apparent and in 1898 the first descriptions of lithium toxicity appeared [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/1\">",
"     1",
"    </a>",
"    ]. About a half century later, the calming effects of lithium in 10 patients with mania were described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/2\">",
"     2",
"    </a>",
"    ]; the drug's more toxic effects were recognized when lithium chloride was used as a salt substitute in patients with heart failure in 1949 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    's toxic effects limited its clinical use until appropriate serum monitoring became more readily available. In the 1970s, Lithium carbonate was approved in the United States for the treatment of acute mania and bipolar disorder and it has been in use ever since. In 2010, there were 6307 cases of lithium intoxication reported to the American Association of Poison Control Centers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the diagnosis and management of acute and chronic",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    poisoning. The therapeutic use of lithium, major side effects of lithium therapy, and other aspects of the management of patients with acute poisoning are discussed separately. A summary table to facilitate emergent management of lithium poisoning is provided (",
"    <a class=\"graphic graphic_table graphicRef53656 \" href=\"mobipreview.htm?12/63/13309\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38026?source=see_link\">",
"     \"Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/9/27802?source=see_link\">",
"     \"Bipolar disorder in adults: Maintenance treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/14/32999?source=see_link\">",
"     \"Renal toxicity of lithium\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/29/42453?source=see_link\">",
"     \"Lithium and the thyroid\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    's exact mechanism of action is not clearly understood. It affects two intracellular signaling pathways, inositol monophosphate and glycogen synthase kinase-3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/6\">",
"     6",
"    </a>",
"    ]. Lithium decreases intracellular inositol, which may be a mechanism for mood stabilization. Lithium also inhibits glycogen synthase kinase-3, a component of diverse signaling pathways involved in energy metabolism, neuroprotection, and neuroplasticity.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    has a narrow therapeutic index; a large proportion of patients on chronic lithium therapy experience at least one episode of toxicity during treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/7\">",
"     7",
"    </a>",
"    ]. The highest intracellular lithium levels are found in the brain and the kidneys.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PHARMACOKINETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal absorption of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    is rapid and complete after oral administration. Peak blood levels are reached in one to two hours following therapeutic ingestion of immediate release products, and four to six hours after therapeutic ingestion of sustained release products. Up to 12 hours or longer may be required before peak levels are reached in acute overdose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    is a small molecule (74 Daltons) with no protein or tissue binding and is therefore amenable to hemodialysis. Lithium is freely distributed throughout total body water with a volume of distribution between 0.6 to 0.9",
"    <span class=\"nowrap\">",
"     L/kg,",
"    </span>",
"    although the volume may be smaller in the elderly, who have less lean body mass and less total body water. Steady state serum levels are typically reached within five days at the usual oral dose of 1200 to 1800",
"    <span class=\"nowrap\">",
"     mg/day.",
"    </span>",
"    The half life for lithium is approximately 18 hours in adults and 36 hours in the elderly.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    is excreted almost entirely by the kidneys and is handled in a manner similar to sodium. Lithium is freely filtered but over 60 percent is then reabsorbed by the proximal tubules.",
"   </p>",
"   <p>",
"    Volume depletion or renal impairment from any cause increases",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    reabsorption. Examples of such conditions include gastrointestinal losses, acute decompensated heart failure, cirrhosis, and the administration of diuretics, nonsteroidal antiinflammatory drugs, or angiotensin converting enzyme inhibitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/10-13\">",
"     10-13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Types of poisoning and risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    poisoning may be acute, as occurs when a patient who is not on lithium therapy ingests a bottle of lithium tablets in a suicide attempt; acute-on-chronic, as occurs when a patient who is on lithium therapy also ingests a large number of lithium tablets all at once; or chronic, as occurs when a patient on a stable lithium regimen suffers a reduction in renal function. The symptoms and signs of toxicity differ based upon the total body burden of lithium and the rate of onset of toxicity.",
"   </p>",
"   <p>",
"    Elderly patients are especially at risk for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity due to both a lower glomerular filtration rate and a reduced volume of distribution (secondary to reductions in lean body mass and total body water). Lithium toxicity can also occur with minor declines in renal function, as a result of nephrotoxic drug interactions, or from dehydration for any reason.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Acute and acute-on-chronic poisoning",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;With any acute ingestion, it is important to determine the formulation of the drug (eg, standard formulation or sustained release), the amount or dose ingested, the timing (eg, acute or chronic), and the intent (eg, intentional or not).",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    can be prescribed as lithium carbonate or more commonly as a sustained release formulation (eg, Lithobid&trade; and Eskalith&trade;).",
"   </p>",
"   <p>",
"    With",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    poisoning, it is important to ask about dehydration, medications, and coingestants. Any condition causing dehydration, such as vomiting or diarrhea, fever or heat-related illness, anorexia or infection, may contribute to lithium toxicity.",
"   </p>",
"   <p>",
"    Medications that cause dehydration or renal impairment can also precipitate",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity. Examples include diuretics, angiotensin converting enzyme (ACE) inhibitors, and nonsteroidal antiinflammatory drugs (NSAIDs) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/11\">",
"     11",
"    </a>",
"    ]. Therefore, it is important to inquire about any new medications or changes in the dose of long-standing medications.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    poisoning often occurs in vulnerable populations, such as patients with mental illness and poor living conditions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Clinical findings",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Gastrointestinal",
"      </strong>",
"      &ndash; Patients with acute",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      toxicity often develop and present with symptoms of nausea, vomiting, and diarrhea. If vomiting and diarrhea are severe, dehydration and compromised renal function can develop, impairing the ability to excrete lithium and exacerbating lithium toxicity.",
"     </li>",
"     <li>",
"      <strong>",
"       Cardiac",
"      </strong>",
"      &ndash; Although",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      toxicity can cause changes in the electrocardiogram (ECG), dangerous arrhythmias or other important clinical effects are rare [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]. Prolonged QTc intervals and bradycardia have been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/15-17\">",
"       15-17",
"      </a>",
"      ]. Lithium poisoning is not associated with elevations in cardiac biomarkers or left ventricular dysfunction.",
"     </li>",
"     <li>",
"      <strong>",
"       Neurologic",
"      </strong>",
"      &ndash; Neurologic findings develop late in acute",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      poisoning because time is required for the drug to be absorbed and to penetrate the central nervous system (CNS). Potential neurologic symptoms and signs include sluggishness, ataxia, confusion or agitation, and neuromuscular excitability, which can manifest as irregular coarse tremors, fasciculations, or myoclonic jerks. Severe lithium intoxication can lead to seizures, nonconvulsive status epilepticus, and encephalopathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Long-term neurologic sequelae",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some cases, neurologic complications persist despite",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    removal by hemodialysis. The syndrome of irreversible lithium effectuated neurotoxicity (SILENT) consists of prolonged neurologic and neuropsychiatric symptoms following lithium toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/18\">",
"     18",
"    </a>",
"    ]. In typical cases of SILENT, neurologic toxicity develops along with an elevated lithium concentration, but symptoms persist despite successful removal of the drug.",
"   </p>",
"   <p>",
"    Cerebellar dysfunction, extrapyramidal symptoms, brainstem dysfunction, and dementia can develop as part of SILENT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Other neurologic sequelae may include nystagmus, choreoathetoid movements, myopathy, and blindness. A review of 90 published cases identified cerebellar dysfunction as the most common sequelae, and proposed that demyelination at multiple sites in the CNS may be the cause [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/18\">",
"     18",
"    </a>",
"    ]. SILENT can continue for months and in rare cases effects persist for years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Chronic toxicity",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     History and common presentations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity presents in a different manner than either acute or acute-on-chronic toxicity.",
"   </p>",
"   <p>",
"    Long term",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    use may result in a concentrating deficit in the kidneys, such that a dilute urine is excreted. Normally, the resulting thirst and increased intake of free water compensate for these fluid losses. Thus, many patients on chronic lithium therapy have polyuria and polydipsia. However, when other toxic effects (eg, confusion), physical disability, or intercurrent illness prevent these patients from drinking free water, dehydration results and lithium toxicity ensues [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity can also develop solely from the effects of volume depletion, especially in warmer climates, or when concurrent medications, such as NSAIDs or ACE inhibitors, cause a decrease in renal excretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/11\">",
"     11",
"    </a>",
"    ]. In such cases, the clinical manifestations of toxicity (eg, agitation, confusion, slurred speech) are often superimposed on complications from chronic use (eg, neuromuscular irritability, tremor).",
"   </p>",
"   <p>",
"    As with acute poisoning, it is important to inquire about the dose and formulation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    and the duration of therapy, as well as any recent illness associated with fluid loss (eg, vomiting, diarrhea, fever).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Clinical findings",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Neurologic",
"      </strong>",
"      &ndash; In contradistinction to patients with acute",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      poisoning, in whom neurologic signs develop late, patients on chronic lithium therapy develop toxicity gradually and often present with neurologic findings.",
"      <br/>",
"      <br/>",
"      Potential neurologic symptoms and signs are identical to those seen with acute or acute-on-chronic poisoning and can include sluggishness, ataxia, confusion or agitation, and neuromuscular excitability, which can manifest as irregular coarse tremors, fasciculations, or myoclonic jerks. Severe toxicity can result in seizures, nonconvulsive status epilepticus, and encephalopathy.",
"      <br/>",
"      <br/>",
"      According to a retrospective review involving 28 patients with lithium poisoning complicated by severe neurotoxicity, risk factors for developing neurotoxicity include age over 50 years, chronic lithium therapy (rather than acute overdose), development of nephrogenic diabetes insipidus, hyperthyroidism, and impaired renal function [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/22\">",
"       22",
"      </a>",
"      ]. Patients with chronic toxicity are at risk for SILENT. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Long-term neurologic sequelae'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Cardiac",
"      </strong>",
"      &ndash; Patients with chronic",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      toxicity may also manifest the cardiac findings noted above, with comparably benign outcomes. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Acute and acute-on-chronic poisoning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Renal",
"      </strong>",
"      &ndash; Patients on chronic",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      therapy are at risk for developing nephrogenic diabetes insipidus (NDI). Volume depletion can occur due to excessive urinary water loss, concomitant effects of other drugs, or hospitalization with lack of recognition of the increased fluid requirements. Such patients can develop hypernatremia. Lithium-induced NDI is discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/14/32999?source=see_link&amp;anchor=H2#H2\">",
"       \"Renal toxicity of lithium\", section on 'Nephrogenic diabetes insipidus'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis for a patient with presumptive",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    poisoning includes serotonin syndrome (SS) and neuroleptic malignant syndrome (NMS), particularly if the patient has a history of mental illness and is taking psychiatric medications. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/4/20553?source=see_link\">",
"     \"Neuroleptic malignant syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Both syndromes cause altered mentation and profound neuromuscular findings. Although an elevated temperature may be seen in either SS or NMS, fever can also precipitate",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity in a patient on chronic therapy. NMS is characterized by \"lead pipe\" rigidity. Patients with either SS or lithium toxicity may manifest clonus, but in SS this is most prominent in the lower extremities. Ultimately, a serum lithium concentration helps to confirm the diagnosis of lithium poisoning. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Serum lithium concentration'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    toxicity may be confused with acute ethanol or benzodiazepine withdrawal. Signs and symptoms can include tachycardia, hypertension, hyperthermia, agitation, and possibly seizures and hallucinations. Neuromuscular findings are more prominent with lithium poisoning and less commonly seen with either ethanol or benzodiazepine withdrawal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/61/20441?source=see_link\">",
"     \"Management of moderate and severe alcohol withdrawal syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/52/11080?source=see_link\">",
"     \"Benzodiazepine poisoning and withdrawal\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other important diagnoses to consider in patients who present with alterations in mental status, neuromuscular excitability, or other neurologic findings include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypoglycemia",
"     </li>",
"     <li>",
"      Central nervous system infection (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=see_link\">",
"       \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Head trauma (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link\">",
"       \"Management of acute severe traumatic brain injury\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Stroke (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/17/40216?source=see_link\">",
"       \"Clinical diagnosis of stroke subtypes\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Seizures and status epilepticus (",
"      <a class=\"graphic graphic_table graphicRef54610 \" href=\"mobipreview.htm?28/21/29020\">",
"       table 2",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25753?source=see_link\">",
"       \"Evaluation of the first seizure in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/11/19642?source=see_link\">",
"       \"Status epilepticus in adults\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Drug intoxication (anticholinergic, phencyclidine, cocaine) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43319?source=see_link\">",
"       \"Anticholinergic poisoning\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6425?source=see_link\">",
"       \"Phencyclidine (PCP) intoxication in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/30/23018?source=see_link\">",
"       \"Cocaine: Acute intoxication\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Myxedema coma or thyrotoxicosis (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/29/42453?source=see_link\">",
"       \"Lithium and the thyroid\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     LABORATORY TESTING",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     General testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following laboratory studies should be performed in patients with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    poisoning: serum lithium concentration, complete blood count, basic electrolytes (particularly serum sodium concentration), and BUN and creatinine. Of note, lithium alone elevates the white blood cell count in the absence of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acid base disorders do",
"    <strong>",
"     not",
"    </strong>",
"    typically occur as a result of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity and if present should raise suspicion for other ingestions, such",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    or toxic alcohols.",
"   </p>",
"   <p>",
"    In the setting of intentional",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    ingestion, routine laboratory evaluation should be targeted at possible coingestants and should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fingerstick glucose, to rule out hypoglycemia as the cause of any alteration in mental status",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      and salicylate levels, to rule out these common coingestions",
"     </li>",
"     <li>",
"      Electrocardiogram, to rule out conduction system poisoning by drugs that affect the QRS or QTc intervals",
"     </li>",
"     <li>",
"      Pregnancy test in women of childbearing age",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Serum lithium concentration",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     When to obtain measurements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    concentrations can be useful for determining the severity of an overdose or the need for hemodialysis and should be obtained in any patient with suspected toxicity. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Extracorporeal removal'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The recommended therapeutic concentration for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    is between 0.8 and 1.2",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (0.8 and 1.2",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/3/43065?source=see_link&amp;anchor=H182696765#H182696765\">",
"     \"Bipolar disorder in adults and lithium: Pharmacology, administration, and side effects\", section on 'Lithium dose and serum concentrations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/9/27802?source=see_link&amp;anchor=H5#H5\">",
"     \"Bipolar disorder in adults: Maintenance treatment\", section on 'Lithium'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Of note,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    must be measured in a lithium free tube; some blood tubes are treated with lithiated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , which can cause falsely positive lithium levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A serum",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    concentration should be obtained when the patient presents to the emergency department. Early levels can be helpful to confirm ongoing toxicity but may not represent peak serum concentrations in a patient who has ingested sustained release tablets. Thus, lithium concentrations are repeated every two to four hours initially to determine the adequacy of therapy (IV hydration or hemodialysis) and to confirm a trend of improvement. Once they approach the therapeutic range or are consistently trending downward in a patient who is improving clinically, serum lithium concentrations may be obtained less frequently (ie, every 6 to 12 hours) until symptoms resolve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Correlation with clinical toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    concentrations often do not correlate with clinical signs of toxicity. Patients with acute ingestions may be relatively asymptomatic despite serum concentrations above 4",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (4",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    due to slow absorption into the central nervous system. In addition, reports exist of severe clinical toxicity despite therapeutic lithium concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/25\">",
"     25",
"    </a>",
"    ]. Therefore, treatment should be based upon clinical manifestations and not solely upon drug levels.",
"   </p>",
"   <p>",
"    Serum",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    concentrations correlate more closely with clinical signs in patients with chronic toxicity because drug distribution has reached a steady state [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/7\">",
"     7",
"    </a>",
"    ]. Nevertheless, clinical manifestations are the primary basis for treatment.",
"   </p>",
"   <p>",
"    In chronic poisoning, mild symptoms of toxicity, such as increased tremor, slurred speech, and mild lethargy, generally occur when the serum",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    concentration falls between 1.5 to 2.5",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (1.5 to 2.5",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p>",
"    Clinical findings of moderate severity, such as worsening lethargy, coarse tremors, and clonus, can be seen when",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    levels are between 2.5 to 3.5",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (2.5 to 3.5",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Severe toxicity generally occurs when lithium levels exceed 3.5",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (3.5",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Clinical presentation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Renal function",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    is associated with chronic but not acute renal toxicity. Serial creatinine and BUN concentrations should be obtained daily until the clinical manifestations of lithium toxicity have resolved. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/14/32999?source=see_link\">",
"     \"Renal toxicity of lithium\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Serum sodium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nephrogenic diabetes insipidus (NDI) is a known complication of chronic",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    poisoning. In patients on chronic lithium therapy who are suspected of concomitant NDI, the serum sodium concentration should be followed closely, particularly in patients receiving IV hydration and those with altered mentation who may not drink in response to thirst.",
"   </p>",
"   <p>",
"    In patients admitted with chronic",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity, measure the serum sodium concentration every 6 to 12 hours for the first 24 to 48 hours. Care must be taken to avoid hypernatremia from IV hydration in patients with inadequate free water intake. Lithium-induced NDI is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/14/32999?source=see_link&amp;anchor=H2#H2\">",
"     \"Renal toxicity of lithium\", section on 'Nephrogenic diabetes insipidus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Thyroid function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both hypothyroidism and hyperthyroidism, as well as calcium disturbances secondary to hyperparathyroidism, have been reported with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    poisoning. Therefore, it is reasonable to obtain a thyrotropin (TSH) concentration in patients with suspected lithium poisoning. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/29/42453?source=see_link\">",
"     \"Lithium and the thyroid\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/14/32999?source=see_link&amp;anchor=H8#H8\">",
"     \"Renal toxicity of lithium\", section on 'Hyperparathyroidism and hypercalcemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity can cause changes in the electrocardiogram (ECG), dangerous arrhythmias or other important clinical effects are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/14\">",
"     14",
"    </a>",
"    ]. Flattened T waves, prolonged QTc intervals, and bradycardia have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     ABCs and supportive care",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general approach to any poisoned patient begins with assessment and stabilization of the airway, breathing, and circulation. The treatment for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    poisoning includes intravenous fluids to maintain the glomerular filtration rate and replace losses, gastrointestinal decontamination in selected circumstances, and, hemodialysis in cases of severe toxicity. A summary table to facilitate emergent management of lithium poisoning is provided (",
"    <a class=\"graphic graphic_table graphicRef53656 \" href=\"mobipreview.htm?12/63/13309\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Potential complications from",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity, including altered mental status and seizures, are treated with supportive care. Benzodiazepines are first line therapy for seizures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13850?source=see_link\">",
"     \"Advanced cardiac life support (ACLS) in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Hydration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Restoration of sodium and water balance in hypovolemic patients with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity is essential to maximize lithium clearance. Gastrointestinal losses from vomiting and diarrhea are replaced with isotonic (0.9 percent) saline.",
"   </p>",
"   <p>",
"    In adults, IV hydration with isotonic saline is initiated at twice the maintenance rate for a total of approximately 2 to 3 liters, depending upon the patient's fluid status and cardiac function (if known). Quantifying urine output and measuring urine specific gravity can provide clues to the possibility of concomitant nephrogenic diabetes insipidus (NDI). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/7/34935?source=see_link\">",
"     \"Maintenance and replacement fluid therapy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    -induced NDI, the serum sodium concentration must be closely monitored. The combination of IV isotonic saline to restore euvolemia and hypotonic urinary losses can lead to hypernatremia in these patients, which can exacerbate the neurotoxicity of lithium poisoning. Early adjustments of saline therapy and the addition of free water can prevent hypernatremia in patients with NDI. Lithium-induced NDI is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/14/32999?source=see_link&amp;anchor=H2#H2\">",
"     \"Renal toxicity of lithium\", section on 'Nephrogenic diabetes insipidus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Gastrointestinal decontamination",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/52/39750?source=see_link\">",
"     Oral activated charcoal",
"    </a>",
"    (AC) does",
"    <strong>",
"     not",
"    </strong>",
"    prevent the absorption of charged particles such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    and has no role in the management of an isolated lithium ingestion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/26-28\">",
"     26-28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Whole bowel irrigation with polyethylene glycol (PEG) solution can be effective in patients with large acute ingestions or ingestions of sustained release preparations of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/29\">",
"     29",
"    </a>",
"    ]. There is no benefit from whole bowel irrigation in patients with chronic toxicity.",
"   </p>",
"   <p>",
"    We suggest that whole bowel irrigation with PEG solution be given to awake asymptomatic patients who present within two to three hours after a presumed significant ingestion of sustained-release",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    (greater than 10 to 15 tablets). The dose is 500 mL to 2 L of PEG per hour via nasogastric tube until the rectal effluent is clear. Whole bowel irrigation is contraindicated in patients with altered mentation or lethargy.",
"   </p>",
"   <p>",
"    Oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/16/43269?source=see_link\">",
"     sodium polystyrene sulfonate",
"    </a>",
"    (Kayexalate&trade;) has been shown to reduce",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    concentrations after a single dose or multiple doses in both humans and animals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/30-33\">",
"     30-33",
"    </a>",
"    ]. A retrospective study of 48 patients with chronic lithium toxicity describes significant reductions in the half-life of lithium among patients treated with polystyrene sulfonate as an adjunct to supportive care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/33\">",
"     33",
"    </a>",
"    ]. However, we do",
"    <strong>",
"     not",
"    </strong>",
"    recommend this treatment because of the impracticality of giving the large amounts of sodium polystyrene sulfonate required and the potential for hypokalemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Extracorporeal removal",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Hemodialysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    is readily dialyzable due to its low molecular weight, negligible protein binding, and small volume of distribution. Therefore, hemodialysis is the treatment of choice for severe lithium toxicity.",
"   </p>",
"   <p>",
"    The appropriate indications for the treatment of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    poisoning with hemodialysis remain controversial. We recommend treatment with hemodialysis for lithium poisoning in the following settings regardless of the nature of the ingestion (ie, acute, acute-on-chronic, or chronic) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/35-39\">",
"     35-39",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The serum",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      concentration is greater than 4",
"      <span class=\"nowrap\">",
"       mEq/L",
"      </span>",
"      (4",
"      <span class=\"nowrap\">",
"       mmol/L),",
"      </span>",
"      regardless of the clinical status of the patient. Lithium concentrations above 4",
"      <span class=\"nowrap\">",
"       mEq/L",
"      </span>",
"      represent a large total body lithium burden and suggest a window in which hemodialysis can remove substantial amounts of toxin.",
"     </li>",
"     <li>",
"      The serum",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      concentration is greater than 2.5",
"      <span class=\"nowrap\">",
"       mEq/L",
"      </span>",
"      (2.5",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      and the patient manifests signs of significant lithium toxicity (eg, seizures, depressed mental status), has renal insufficiency or other conditions that limit lithium excretion, or suffers from an illness that would be exacerbated by aggressive IV fluid hydration (eg, decompensated heart failure) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many patients do not fall neatly into these categories, such as those with moderate to severe clinical signs but a",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    concentration below 2.5",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (2.5",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    In such cases, we recommend consultation with a medical toxicologist. (See",
"    <a class=\"local\" href=\"#H31\">",
"     'Additional resources'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    clearance with hemodialysis ranges from 70 to 170",
"    <span class=\"nowrap\">",
"     mL/min,",
"    </span>",
"    compared to normal renal clearance of 10 to 40",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    (due to extensive reabsorption of lithium in the proximal tubules), and only 15",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    with peritoneal dialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    equilibrates slowly between the extracellular and intracellular fluids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/42\">",
"     42",
"    </a>",
"    ]. As a result, a rebound increase in serum lithium levels occurs after the cessation of hemodialysis, as intracellular lithium diffuses into the extracellular space. Continued gastrointestinal drug absorption may contribute to the rebound effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/43\">",
"     43",
"    </a>",
"    ]. Therefore, it is generally recommended that a serum lithium concentration be measured six hours after hemodialysis to confirm that levels are decreasing.",
"   </p>",
"   <p>",
"    Some experts recommend extending the duration of hemodialysis to minimize the rebound phenomenon and repeating dialysis as necessary until the serum",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    level remains below 1",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (1",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    for six to eight hours after treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/26,41,44-46\">",
"     26,41,44-46",
"    </a>",
"    ]. Nine hours of hemodialysis removes approximately 60 percent of the total lithium stores [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/34\">",
"     34",
"    </a>",
"    ]. Some authors suggest that at least two sessions of hemodialysis are required for adequate treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/12\">",
"     12",
"    </a>",
"    ]. However, in most cases, unless serum lithium concentrations are extremely high, one session of hemodialysis is usually sufficient. We suggest obtaining consultation with a medical toxicologist or poison control center if additional hemodialysis treatment may be needed. (See",
"    <a class=\"local\" href=\"#H31\">",
"     'Additional resources'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Alternative methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Experience with methods of extracorporeal removal other than conventional hemodialysis for the treatment of severe",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity is limited. Case reports suggest that lithium clearance is significantly lower with methods other than hemodialysis. However, alternative treatments minimize rebound elevations in lithium and may be useful in hemodynamically unstable patients who cannot tolerate hemodialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/47\">",
"     47",
"    </a>",
"    ], or when hemodialysis is not available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Continuous arteriovenous hemofiltration (AVHF) can augment",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. In one report of four patients treated with AVHF, elevated serum lithium levels (4.0, 4.6, 4.4 and 3.2",
"    <span class=\"nowrap\">",
"     mEq/L,",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    decreased to nontoxic levels (1.2, 0.8, 1.2, and 1.1",
"    <span class=\"nowrap\">",
"     mEq/L,",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    after treatment for 15, 19, 35, and 21 hours, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/48\">",
"     48",
"    </a>",
"    ]. There was no rebound increase in lithium concentrations 24 to 36 hours after hemofiltration was discontinued.",
"   </p>",
"   <p>",
"    According to other reports, the combination of hemodialysis, followed by continuous venovenous hemofiltration with hemodialysis, provided safe and effective treatment for two children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/49\">",
"     49",
"    </a>",
"    ] and one adult who developed hypotension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/0/9225/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Disposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with symptoms of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity are admitted to a monitored setting for observation, regardless of the serum lithium concentration. Patients with severe symptoms (eg, altered mental status, seizures) are admitted to an intensive care setting. Discharge is appropriate once patients are asymptomatic with a serum lithium concentration below 1.5",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (1.5",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Psychiatric evaluation is recommended for any patient with an intentional ingestion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       Lithium",
"      </a>",
"      poisoning may be acute, acute-on-chronic, or chronic. The symptoms and signs of toxicity differ based upon the total body burden of lithium and the rate of onset of toxicity. A summary table to facilitate emergent management of lithium poisoning is provided (",
"      <a class=\"graphic graphic_table graphicRef53656 \" href=\"mobipreview.htm?12/63/13309\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Types of poisoning and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Elderly patients are at higher risk for",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      toxicity due to both a lower glomerular filtration rate and a reduced volume of distribution (secondary to reductions in lean body mass and total body water). Lithium toxicity can also occur with minor declines in renal function (eg, from nephrotoxic medications) or from dehydration for any reason (eg, vomiting, diarrhea, fever).",
"     </li>",
"     <li>",
"      Patients with acute",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      toxicity often present with symptoms of nausea, vomiting, and diarrhea; neurologic findings develop late in acute poisoning. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Acute and acute-on-chronic poisoning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with chronic",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      toxicity often present with neurologic symptoms and signs. Neurologic findings can include sluggishness, ataxia, confusion or agitation, and neuromuscular excitability. Severe poisoning can lead to seizures, nonconvulsive status epilepticus, and encephalopathy. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Chronic toxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis for",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      poisoning includes serotonin syndrome and neuroleptic malignant syndrome. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serum",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      concentrations can be useful for determining the severity of an overdose or the need for hemodialysis and should be obtained in any patient with suspected toxicity. However, lithium concentrations often do",
"      <strong>",
"       not",
"      </strong>",
"      correlate with clinical signs of toxicity. The timing and frequency with which lithium concentrations should be measured, and other indicated laboratory tests (eg, serum sodium concentration, BUN and creatinine), are described in the text. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Serum lithium concentration'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Restoration of sodium and water balance in hypovolemic patients with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      toxicity is essential to maximize lithium clearance. Gastrointestinal losses are replaced with isotonic (0.9 percent) saline. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Hydration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       Lithium",
"      </a>",
"      is readily dialyzable due to its low molecular weight, negligible protein binding, and small volume of distribution. Therefore, hemodialysis is the treatment of choice for severe lithium toxicity. Indications for hemodialysis are described in the text. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Extracorporeal removal'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/1\">",
"      Strobusch AD, Jefferson JW. The checkered history of lithium in medicine. Pharm Hist 1980; 22:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/2\">",
"      CADE JF. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 2:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/3\">",
"      CORCORAN AC, TAYLOR RD, PAGE IH. Lithium poisoning from the use of salt substitutes. J Am Med Assoc 1949; 139:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/4\">",
"      Pauz&eacute; DK, Brooks DE. Lithium toxicity from an Internet dietary supplement. J Med Toxicol 2007; 3:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/5\">",
"      Bronstein AC, Spyker DA, Cantilena LR Jr, et al. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila) 2011; 49:910.",
"     </a>",
"    </li>",
"    <li>",
"     Meltzer, H. Antipsychotic Agents &amp; Lithium. In: Basic and Clinical Pharmacology, 11th ed, McGraw Hill, New York 2009. p.487.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/7\">",
"      Amdisen A. Clinical features and management of lithium poisoning. Med Toxicol Adverse Drug Exp 1988; 3:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/8\">",
"      Ward ME, Musa MN, Bailey L. Clinical pharmacokinetics of lithium. J Clin Pharmacol 1994; 34:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/9\">",
"      Dupuis RE, Cooper AA, Rosamond LJ, Campbell-Bright S. Multiple delayed peak lithium concentrations following acute intoxication with an extended-release product. Ann Pharmacother 1996; 30:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/10\">",
"      Jefferson JW, Kalin NH. Serum lithium levels and long-term diuretic use. JAMA 1979; 241:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/11\">",
"      Phelan KM, Mosholder AD, Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry 2003; 64:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/12\">",
"      Timmer RT, Sands JM. Lithium intoxication. J Am Soc Nephrol 1999; 10:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/13\">",
"      Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 1987; 10:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/14\">",
"      Demers RG, Heninger GR. Electrocardiographic T-wave changes during lithium carbonate treatment. JAMA 1971; 218:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/15\">",
"      Offerman SR, Alsop JA, Lee J, Holmes JF. Hospitalized lithium overdose cases reported to the California Poison Control System. Clin Toxicol (Phila) 2010; 48:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/16\">",
"      White B, Larry J, Kantharia BK. Protracted presyncope and profound bradycardia due to lithium toxicity. Int J Cardiol 2008; 125:e48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/17\">",
"      Farag S, Watson RD, Honeybourne D. Symptomatic junctional bradycardia due to lithium intoxication in patient with previously normal electrocardiogram. Lancet 1994; 343:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/18\">",
"      Munshi KR, Thampy A. The syndrome of irreversible lithium-effectuated neurotoxicity. Clin Neuropharmacol 2005; 28:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/19\">",
"      Schou M. Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 1984; 70:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/20\">",
"      Von Hartitzsch B, Hoenich NA, Leigh RJ, et al. Permanent neurological sequelae despite haemodialysis for lithium intoxication. Br Med J 1972; 4:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/21\">",
"      Singer I, Rotenberg D. Mechanisms of lithium action. N Engl J Med 1973; 289:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/22\">",
"      Oakley PW, Whyte IM, Carter GL. Lithium toxicity: an iatrogenic problem in susceptible individuals. Aust N Z J Psychiatry 2001; 35:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/23\">",
"      Carmen J, Okafor K, Ike E. The effects of lithium therapy on leukocytes: a 1-year follow-up study. J Natl Med Assoc 1993; 85:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/24\">",
"      Wills BK, Mycyk MB, Mazor S, et al. Factitious lithium toxicity secondary to lithium heparin-containing blood tubes. J Med Toxicol 2006; 2:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/25\">",
"      Speirs J, Hirsch SR. Severe lithium toxicity with \"normal\" serum concentrations. Br Med J 1978; 1:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/26\">",
"      Linakis JG, Lacouture PG, Eisenberg MS, et al. Administration of activated charcoal or sodium polystyrene sulfonate (Kayexalate) as gastric decontamination for lithium intoxication: an animal model. Pharmacol Toxicol 1989; 65:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/27\">",
"      Linakis JG, Eisenberg MS, Lacouture PG, et al. Multiple-dose sodium polystyrene sulfonate in lithium intoxication: an animal model. Pharmacol Toxicol 1992; 70:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/28\">",
"      Favin FD, Klein-Schwartz W, Oderda GM, Rose SR. In vitro study of lithium carbonate adsorption by activated charcoal. J Toxicol Clin Toxicol 1988; 26:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/29\">",
"      Smith SW, Ling LJ, Halstenson CE. Whole-bowel irrigation as a treatment for acute lithium overdose. Ann Emerg Med 1991; 20:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/30\">",
"      B&eacute;langer DR, Tierney MG, Dickinson G. Effect of sodium polystyrene sulfonate on lithium bioavailability. Ann Emerg Med 1992; 21:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/31\">",
"      Linakis JG, Hull KM, Lacouture PG, et al. Sodium polystyrene sulfonate treatment for lithium toxicity: effects on serum potassium concentrations. Acad Emerg Med 1996; 3:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/32\">",
"      Linakis JG, Hull KM, Lee CM, et al. Effect of delayed treatment with sodium polystyrene sulfonate on serum lithium concentrations in mice. Acad Emerg Med 1995; 2:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/33\">",
"      Ghannoum M, Lavergne V, Yue CS, et al. Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study. Clin Toxicol (Phila) 2010; 48:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/34\">",
"      Scharman EJ. Methods used to decrease lithium absorption or enhance elimination. J Toxicol Clin Toxicol 1997; 35:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/35\">",
"      Garella S. Extracorporeal techniques in the treatment of exogenous intoxications. Kidney Int 1988; 33:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/36\">",
"      Simard M, Gumbiner B, Lee A, et al. Lithium carbonate intoxication. A case report and review of the literature. Arch Intern Med 1989; 149:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/37\">",
"      DePaulo JR Jr. Lithium. Psychiatr Clin North Am 1984; 7:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/38\">",
"      Hauger RL, O'Connor KA, Yudofsky S, Meltzer HL. Lithium toxicity: when is hemodialysis necessary? Acta Psychiatr Scand 1990; 81:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/39\">",
"      Fenves AZ, Emmett M, White MG. Lithium intoxication associated with acute renal failure. South Med J 1984; 77:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/40\">",
"      Clendeninn NJ, Pond SM, Kaysen G, et al. Potential pitfalls in the evaluation of the usefulness of hemodialysis for the removal of lithium. J Toxicol Clin Toxicol 1982; 19:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/41\">",
"      Okusa MD, Crystal LJ. Clinical manifestations and management of acute lithium intoxication. Am J Med 1994; 97:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/42\">",
"      Friedberg RC, Spyker DA, Herold DA. Massive overdoses with sustained-release lithium carbonate preparations: pharmacokinetic model based on two case studies. Clin Chem 1991; 37:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/43\">",
"      Goodman JW, Goldfarb DS. The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial 2006; 19:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/44\">",
"      Hansen HE, Amdisen A. Lithium intoxication. (Report of 23 cases and review of 100 cases from the literature). Q J Med 1978; 47:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/45\">",
"      Jacobsen D, Aasen G, Frederichsen P, Eisenga B. Lithium intoxication: pharmacokinetics during and after terminated hemodialysis in acute intoxications. J Toxicol Clin Toxicol 1987; 25:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/46\">",
"      Beckmann U, Oakley PW, Dawson AH, Byth PL. Efficacy of continuous venovenous hemodialysis in the treatment of severe lithium toxicity. J Toxicol Clin Toxicol 2001; 39:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/47\">",
"      Bellomo R, Kearly Y, Parkin G, et al. Treatment of life-threatening lithium toxicity with continuous arterio-venous hemodiafiltration. Crit Care Med 1991; 19:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/48\">",
"      Leblanc M, Raymond M, Bonnardeaux A, et al. Lithium poisoning treated by high-performance continuous arteriovenous and venovenous hemodiafiltration. Am J Kidney Dis 1996; 27:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/0/9225/abstract/49\">",
"      Meyer RJ, Flynn JT, Brophy PD, et al. Hemodialysis followed by continuous hemofiltration for treatment of lithium intoxication in children. Am J Kidney Dis 2001; 37:1044.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 320 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-ECB61E16A9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9225=[""].join("\n");
var outline_f9_0_9225=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PHARMACOKINETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Types of poisoning and risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Acute and acute-on-chronic poisoning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Clinical findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Long-term neurologic sequelae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Chronic toxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - History and common presentations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Clinical findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      LABORATORY TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      General testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Serum lithium concentration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - When to obtain measurements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Correlation with clinical toxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Renal function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Serum sodium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Thyroid function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      ABCs and supportive care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Hydration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Gastrointestinal decontamination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Extracorporeal removal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Alternative methods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Disposition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/320\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/320|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/63/13309\" title=\"table 1\">",
"      Lithium poisoning - Rapid overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/21/29020\" title=\"table 2\">",
"      Drugs that cause seizures",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13850?source=related_link\">",
"      Advanced cardiac life support (ACLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43319?source=related_link\">",
"      Anticholinergic poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/52/11080?source=related_link\">",
"      Benzodiazepine poisoning and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/3/43065?source=related_link\">",
"      Bipolar disorder in adults and lithium: Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/9/27802?source=related_link\">",
"      Bipolar disorder in adults: Maintenance treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38026?source=related_link\">",
"      Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/17/40216?source=related_link\">",
"      Clinical diagnosis of stroke subtypes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/30/23018?source=related_link\">",
"      Cocaine: Acute intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25753?source=related_link\">",
"      Evaluation of the first seizure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/6/1129?source=related_link\">",
"      General approach to drug poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/29/42453?source=related_link\">",
"      Lithium and the thyroid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/7/34935?source=related_link\">",
"      Maintenance and replacement fluid therapy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=related_link\">",
"      Management of acute severe traumatic brain injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/61/20441?source=related_link\">",
"      Management of moderate and severe alcohol withdrawal syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/4/20553?source=related_link\">",
"      Neuroleptic malignant syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6425?source=related_link\">",
"      Phencyclidine (PCP) intoxication in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/14/32999?source=related_link\">",
"      Renal toxicity of lithium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/63/16376?source=related_link\">",
"      Serotonin syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/11/19642?source=related_link\">",
"      Status epilepticus in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_0_9226="Gottrons sign in DM I";
var content_f9_0_9226=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F70904%7ERHEUM%2F50909%7ERHEUM%2F51110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F70904%7ERHEUM%2F50909%7ERHEUM%2F51110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gottron's sign in dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 229px; height: 323px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFDAOUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD1dbvztRW4MSxQTgQzr93a4GM4PQ/1p10Sl8Y8BGUGI7O+0HBH/fQ/Ws0NLM1wzReYxJlidj80ig4bcvrgn8af9qE91BNIdjPhf944I/DP9K8Sq7PXv/w/9eZ9t7Kz06K3+X9eRu6fLD9mAZsI6RmRepDAt0+p9KdfJzOuPnhYOzE8uztn8cA9axJ7qWGCQcqHhwwyM4DkEe3b860oJJCkqgh5Q8iyY5DIF6/UVkp83u9f+H/4f7zmnRcXz/10/wCG+4WOKRzBcSvlEnaZmHLbHYAN7EMRXP6vaQW801wZMocnlgCDkDkenOeK624WGPTZHKFsRR48vhvMHJ49OK4fxIf9DJ3KY52/eKBlh3X8PlPI9K0qRUY6+v6HRgG6lTR2V7fr/X3D1sb9bWeO2JktDErSZYCT7xI256Dk/L14rZTw7bWulCdbpJl2b5zKWEhmB4CgDPIwMfjWJbyGWz8qeVl3FXG9sKTj5TkduvPv0rbu9OKm0vzdNEJSkcssRz5E20AHn7w7Hgc55rrhyqPNa/6HRXnNSUXK130W/wDX+W5BrFvLLNbzXMySHUE2StkDyp1Xau4DgHJHPtWv4T/eTxXCs0ZkBZlj4Ab7sgx9dhqpOJhcqlxb5jltnt4ZI1GzzyNyj/e475wM81oeGvLzJcAAxO6s5B4UMCrcexH6isHaNe6/r+t/mcWIm3h2vLp+X6fI6xVIRFkVXlZWAI4WQDsfrx+VQxIYRHKWZgEKtAPvHAxirjbYYUbJZYiBlRkgf/qxTJkzIjrIAyyDLYyCD2rsktbr+v61PnFMoLEruoBcRPGYzk88devpWBqkkN/ZuyzeRqO5QWcHa4z/ABdgeBzXQzrNHerIsQkQS7jEDycjkj6dTXOau8osria1IbcCZolAO4hhhvbg4P4VjKVk1bv/AEv6/wCD6OE1mmn2/p/1/wADIv5gBsnZ5LyIiNYs7jnJOQe3XitnTY7uzEMlxue4lUNGjkfu8DcwA6ZPJ655rAiYTXMUqNtulkYtvXBK4GDj2JI61u2EHnxsxL3GWCsSfmxnoPTPr1xXVhvebkeliUowUXt1/rt+ZJqNxJaz+fC0KXcY+Z4wTHKp43sgHGOvGffFJPdpdsrW0bWWuQqNsLJgOf4hjurAjrgjipJLXybTypo40lVWPltnEangkEc5PTbyOawJjPZOovJWZI/3sN6rcqcgHf3IwRke1GI5qavbT+tfL1+8xo04VFpuvx/zXl9x0tmItQha5tGktNQtWwG6lSesbjH3SQcGnQXPnMUQLFIhN4tvcDBQ9XjBxypBJBA79KzvtkiXDXdttaSAL9oSJwy3MJ7j1wc471sys0tsl1a7bx4mLQ7fvOMbtmezBeg9eK456+v5rv6/qvQ5qkeV67Pby8n5fo/USRriC7gt4pi6zHzbZ5AA0TLwyE45znB9ia0heOkUM4QfOT56qo3Kw4JHvz+QrIbf5EP2eTz0wZrKRf4x/FGw65AyB/jWjaTpJHFMhzHM4EiD+GTB7+h/pRSqNNpP+v6/Bo5asFZNr+v6/FPqWYmkbTrotKrtGxZHVANy4BGRViJ2YZWVQk6h4uB8rHk9ufWm2SQozRxqAH+fPuODx+H61SW4kWzlDKES2fAIXgnPb2rZO1pf1p/wGcvLztpL+n/wS0ZXWZw7gCN9jLgcIw+U9PXFLdLIJlAUN5qY4C/MV6ZyO+TTVhH9pTZUHzogXBPXnHJqBXnkhjtbnKyLIVLDg4wcMP0/I1tFtaP+tf8AIair3X9f0/0Oe1KOZYJBGF2xyZQeWpOD1U/L2OfzqK2ltpbu4lUiGOaPDxsi/I+eCOOR7/nita4t3ExZGXfGpWZGb5C3/wBcYrn9Rjt7KWGaMyhHzHnaCCpOGXPt61i4um+b+v66HsUHGouTr/X+VyZLC5NtDcadKsbSgiZTErqWXjcOO9FVNNura2RlSS7jQgMEikwQT1zkH9KKS5Wr6/Jm0o1VJpRT9Ujn7DzvtMouonD5JEi/wOe/41OtxvVkYxtLkhm6EMCDkf59apXcN2L8+Qd9wFO3ZwCi8ngdSAKjHAeUhhNKV3Erj1wwFedWnfT1PbcFP3v6/wCGNWU8XEa5yqh03jqeCVP1z19q0bN3NypgLF2dmgJODyOQfxrMt4oQyNMWeLAYqhwe4YH9Dn3q1axxhIAXO5QxjYthkI7N9D+lZwunc46qVrf1t/wDUt2a4jmCMFSRZAmWIaM9elYF8gktYpmbb+8IbP3V4K7V9jmujsUjezWRkVLmDBODyefmU+/XFY1oYZoodkgAG/ZGRkE5GQfrW8m7L+uxjQlyybXR/wCZm2Vta2KxwzWpkIYtFLK7MEXj5ducHB6cd66SxgijiWFrhkhulaMx3A3RE+gfqG74zkVVS1ZoRayAxu53Ws2c4k/55uegB9/QVp6VN9u0t7KRY0dZxFdW8gzIH3csOw9QR7VpRj9m39dv66BiqznHmv111/Hr/wAP2IbW9n8ptNuIhFfJMLi0fdxI454z1J5H41dhijOpI1qhWC5zMipwrBwcqPRlZRxTIhLBfPpWpxQzwXGZYJn4YN/eJ/hYdKqxOV8sKwMUVyZI5AD+6ZfvIT6HtnrniipsnLW33q3T8d+unQ5GlK/LpdfJ36/ht016nZadOjRRSOT+9XynZuBuXPB9Cefyp0gZwXHl52A4PcA/41jWl1E0k8LBB5v7xGXlWycnI7Yzj8KuvMqQTW9wF2nLRtjaSDyGH0rb2t1b+r/1qeTOi4y/rYcxEt67WzOLjcp5PAbaRg+mCa5ma4Qz6y7blUg4C9BggFWHuTnPtW5dSSxy2b5CJPhX2crtIyG498VzGpRWkw1Hy45EvImOFQ7kfjjcD1780pStqt9fyO/BwV9dtPzKkLRTxIJndViI24PzEtkZB/4COOmMVpWaywqIZndZZB58bqAcIGxwuPvDGDmsZbpCgYOsOFRijKACw7kdD3rTivYPIXbcsLiKQAxFgokQjsf1rTDzjsmelWhK1raf1+poRWtpDJ9qupNSQ7zArzS71J6g7R346etN1K2uoEubeaSO4t8iaR/LAdX9BjjpSpaxSTItm/kzq+8oX8wPtO4YXrjjqKktrpbthDASX3MZomBQl/p6c9a7JJNWehxc0k+Za279O3p95laXbtZXL3OhxpJ5eSLcjAZcAuhB6MMjFbdjeQxwXE2mITZOfNktzxJbSAAbvpwCfTrWIgdLmCQI6S2jnyZQMBlycg+uDu9ufatVbqMj+1I4VCjMV3CowNhHzcevpnr9a8ya5X2/rdfquq13LxEed3et/wCkn+j6O62Ly5XyDaDEdw/n24c/6qXq8RPX5uce9W4o0gkkNqF+y3MRbyx1UqecDuwJzWY3+giaJ43kt3xJHIoO5F/hfPbBxz+FT+btjLSrEt3BKJ5AGBXJxlkPoRyR6j3rJNLV7r8O/wCF/lbscM4N7bfn2/T5+poQyFxDMSQ8BDO399GHDfj/AENNlumhvrmJtpidkO0AnKYCk0y4cNI72zMY5wRG+cAcZx+fPtmqq3hkSM3EJKPGbd8dnHJP0z+Va+0SfL/Xb9UYxp82tv63/wAzQim8q5hjlLCYk2/TAZcEg5+oA/GnyCR7k/aZPKUgRnaMnAzg5P1OfqKxXh8lrZnk8wRSIjq5xjI3BgexJAH41q3UhS/khZS8TsJZCD2xwM9uQK6IOXUJ00mrdiUwo8GQilMgnLD5+2efpXO6haxRvcibKxyOHRG5AcHkjtg1uyzBTGjSkQSt5Zc43juM+nXHHpWVPMUQSEPNcLNhljUnzEDck/hz610OPNp2NcM5Rd0ZZsoyd6XmN3dYT+X4UVal01ry4lxPFCsZ27TJgD6etFJ0v7v4/wDBO/20es/wX+Rz1zEd8kNtvRSd8gYD5ZOg+bPAHT3rIniVCBhm3jA2g4znoO3XFbdy2+WWOJV8xmyzK3GD2Pt/Ws+WJnhZFfCZBbI4zzgge/IrxKslJ3PWoTa3I7C4SSExyBkGPmO7PlsDjP0/xq+0u1xIrb5Q6/KVyM9CG9qxY3WO5BWHcH+Q54b2z2wTnn2q8ZGHlTLkKWXJ4yM8Mp9cHNZp6W7F1aa5rrqaF40slpdeSx80xbAucGReo4/vCsfw/dPJbI8DL5yu26Doyrjn5umB9e9aF/KTp6SlfMeMlvkOGUqM/gR94euMVhWqjTdZmhEg+yy7biB05DKwJGR9Qciuulb2ictv89UOhTUqUo9d/u0f9fcdpaLDdQSy2UivNHgyW8x/dyADqPfGMf7tR3dyDDbakEaOdEGZz83noB8pJHcHucGrUCxQy22o6csKxOP3sEnzc45//Xx9KzY5Es1kt7lpRZ7zIixnO4HnGMevTrXfXpcsbbX6+fRnmRXNJta/n2a/r9DS1OQXybrllhW4Imjl3bjBJjGSeynPK1Qs7+eS/kaeARtOVMilTs81SB8o/iVhVJrFJIpLMzeVeK+VMh+V1zkHcPQdQRz6irVvsurlVlVkeUCOSFpCCXAOGQ9u2B7GuSqpSs7Wf666f138jVU4Qg1uvy/4f816m7ASlyYkilTZLsZCc7Ebk49gc4q2T5pjzJlVZ7cSHqoB+XPt0rOgkkeaNpl8t2TynkDZViOA2e3TH1p898wNy8eGlZFYoq8krxuH5c1g5JannSpuUtCyyzTWsgt3WKeGZ3RJcEYCnABz+lUr668tkaP9/DcxmOUyLtYkFeGHryR9Kliu4pSU+bdM2zJXGVIyOvQ1l3d67SWyzrv8iZUAfjA5HzfnnPritYzvFJP+v+GNKVJuWq/r/hzOv1FncWszspgmZl8p+SpXp9RgjAqextpBPvt4lsieflXcrdieeCcc8H3qlP5dxHqOlvdiV0dntnC4y2cgZPQgH8ael/b2+miDW7bz7ePiKaF2wBjlsDkOBx3xWtLkUve0X69deh6rjJwstX+a6OztfsdHcHXp4ypu4pgoDNvPlkcdQQOhHUUhtNQkLi7WJbhQJS8UgDKB0IPQ/SqgguEtrW40ieC/guEIUtJ95lU9W7ED2rOTV5EugJoJrW6kIjMf3lIH17f4VvUko/He33r7/wDgnDCjKSfs7aeVn81/wDULNdwyHyYkdG8w4lALLgdAfxPFNuJWt9XeJA0cEsMYMYIPnqFAyR03dxzWbrM9jMoMbPLdIQq+V8wY55+YDj6YNMinMqtgs4Vio+YBoSOMHjnBHtXFXk7vr/X/AATaNB8vM1p2+7+v+CdTbzyizEtswl+xkrJEcndEeqj1BHI9xSxqUmj+zzMblU3RtnIkX+JfxB/DZWdb3jtI1zBtW9hQLJEp+WXBG4flk/hTtMcPfAW+VjYlrUt/C2Rx/wChD8ay51ov6+X9aO3c4pUmrv8Ar/hvzV+xqWgSG1MVvOWi8zdHtblMjPHuM4NLEoLSrcqFFzCzRk8bZBwT6dagilSOe4YIkQjfc+0cI5PQ/Xp+FLq7b7gO5KoyiNI8cBsZ/UU042v20MOVuVu/X+v6+8tzxJPbqGC/aWQrkdCwO4H9PyqvbXDtZx42ttkPnN0ySD+nAqjbPNGsJlkHnWpTcp4LwngN74zjPpmmW8kVrezKWOJY9keGyrHJPIxXTGquZN6X/r87otUdGt+v9fI27NEugIldmhO7fJIc7gRx9BkHiqllIbdI5JJJklbCfu+TuHGcdgTVO3+zeQJlkvVKH99wCseevA7A9auMzabax3cqCaF3Cu1v+82KP73Q8+ld1Oaau+hDhZuPfoNVLuSJBHNI0a8AlASfXJ70U+XUrhbO0a3kiWN1LDYm5j7tzwfaitXHzf3/APBKSqPZL+vkczr0MumXSmSNCjplmXghT0yR1+tZ81ykkkZR5BJjDKuDg+oI7dK63xK9tcQSwyK8fmgoD/ATnnDdq8qtL99P16PTrvcrqC6GQZEi9Afrya+bxNqU7R1T/A9vL4vE0uZr3l+J0E0X75BCzbm4O3kAepH1zSWSB12uM7SG45ypPJ+veknYeVIEOMDcCRyB7VJCwmXahBkkhYgD+8vIOe1QnqdLvyljTp1Vf9IbaJDhvQg9CfcelUr232TvHMBFcQYVuM9/lZfUHOD259qluoWt0PllifMDDJGCjDIP1zgZqxFCNUsYJ0T/AEuBdjBm/wBbH2HpuHPPeuulBv3Xuv6f9epCag/aX0f9L+vQNLuLaWTc1rLaOrfMsUhKu3cFWzj6D8K07of2WLee5CmKZxImwkm3H8JY5zyMYxjAqjb2yx7ZEaRrpAF2TAASDJxuLd/TNSi8urieTfYSQzDLKJLdvmzzk4HI9P0r0oO68+n9f13Oaoued47ddf8APX5la98uwvYo5y0blyhaFtwK57E9TVt2luWcqv2h0XIj6AICDuyO/QfjWUSYCReymSGQAxqmGbjgZz/COgPQ962dNMqulvdTebCi/unIG1CccHHGO3FcdWXvPp/X9WKqrlipbtf1p/w4trN8hCgvBKS6ohbA9QATz+NTgz2zZJC+Q4cuCDhSPvfj1xTzp6yKu0mMMSrAEfuiPQ+nWpMmEQHZ8jMY2LYyD6D+fua5ndO7OOU4t6ale+uJhZ3BScSzgA4K8FFP3lPTJHXHbNZVzqQm02RA8O5AAspJZ0yemO4+taEjSDY625kCYRkB+6uOoHYYyKx7mxtrWJrhHVVeUxSocMjAg4KnpwT09cURm91t/X+Z1YeMNnvfT/IbqivDL9qXypZUCmUQfMDHgANj+8Mc/X2rf0S5mDG5tbCO9j8vdJEm0urHqVXqQfbp0rkY8RzwkTs0gjHzBD1BPT1rbtbBXhF1BJcRopCzPE23GTw6gdAeh966qLk5c0f0/r1NsTTj7NRl+T+7p8hIdS0yC48/Ro5LKeOQmaMDdFyCMBT9080up6vHfXAeJ2RUjZHjKbVYkdPm69B7Vfv9NtdRtws8F1d3AX5VlfLBR2BPftx0rmI9Jv4IJgbZpbZpAhLMDLCQDj6nr1reXtaa5LaeSYqKoVPfbtJaatfm9X5fgWLS6ltkhn02OKK62qg2OVIz1+Xpg9+K1Y7CW2YsYnRXYiSRhgu+eWHpz27isS2mi3on2WZEcFGeQ5Zj0J+XIXGB0qaOZkEccM6FVbC+YwO7HHBH9a8+c7Kz1/T5eZtVptvTT+u/l/Wpp2sh+0mObO4cs46j0IP9KvQyiC3J3cRuSrL1z6H9T+FZbm4F8DMDBKV3FV/hPbHbFXknewzJcIrN/q5Ap4IPT3rnelzjqwva3XoWBI8N0dx/eXC7lAGQ6joffuPwq3FIt3IRIHAjQNGM87x29xnj6ViK58wLwfJbcnzYyD7/AOelR/aTb3G+2nAgI+Zu6g9eO/NSqlt9jN4fm23/AK/Q2hdGeQXOFYxqImi/vR4xkfT0qG6thbphv3txHKrxlHyrqQe/5cVVG5JXXCq2AWJOcg9x9ae8gt3WCQhEKlG7nPBHFbqTt739P+vyJULP3f6X9fmbNhcXLSpLbRRpK4MUmXCo2Oec8E84/AU2KG9TfHYmGSMoXbZOrGIf3uOuO3rWFGQNPa5toTKijM2R88LZIAI64OCQ1a+iXAvftMcSoPIj8z5mwzAjOB716mFlz2i/6/Axq0nBOaSst/6v56DbjTbi9K3I1KxhEgyNqL83vwP580VnagLm7nDo6w3AUCYQ4I9s44yB6UVpLlT+F/e/8zeEZqK99Lysv8jT1u5Ll4QyOSTkHgAemK8t8aFIdb0aZWdTHPs8uReUBU9PbgcV3GusGfIWRXzndXnXje/kNzpUDxq7rdo+e/Qj8q8DEzclJM9LKKPK1bzOvilBA3kSNkKWYYzgf/X/AEqxYHN1GHGxHJDOeNuRwf6H6VnWbC5m8t1O1yUVs/jn9K0bHas5kkXfuQSuM5XBPI/D0opPmtIqquVNE91HLeR+RKuJSfKZm42SA5APscY9MkVY0u8kikLELOhJWfIwwAHp1POOlKJYprlo52iUzqMsxIGO4Y/XBz6irdskdw+x1SK9gH7sEYDgds+hGcH867qN09H/AF/X3nDOdocslp/X9eRFePJp4+02csU9pIcrOwyEPox6r+RrOuru9mX91NJHLcHaWhc7WQcDHGcD8DXQOlvOW8m3cCRSrbMbN3+0O3fnBz7Vz8CSRXj29tKBHGBjecrH+PXrXVOfJBWej7f1/wAMLDyi1drVd/1ItMs57i1EcMkhKuHk3DOeON3ccdq32sYljK27sIkbMSP/AAk9Qx7k84rR0mOMxJIuSkBPm3KDYPm7HruPYHtmr90AqgkBJQv3n5Qx5GD9c9+vNc06d1q/6/r8dTkxGNlKpZf1/X36lCORUgEgikP8PkkfdPGCT3+n0ouCkzSLOyyKVUEbscj7vPbHTHtSzSslx/oquDg7mPUpxkY6Zycj1q0LXdGzKhkZARI64yO4bHrjms0nLT+v6/rY5nJRtJmPczECMTuRcY2xsoxh0+6PQg49az7x43lhngiQ2t4DBdRnjDkcMPQZGfwrYurdZFYtLvgDKsm1eYzn5ZMdhnFcvrJeyma3uS/lPIqOwGdmQdh/PH50k7Wv/X/D63/4B6GFSqOy3/r/AIFvl3Mi2klt54szLGsEhjdZFyOM8gjtzxWpo8syXfm2TFl2mICVgquSPukZxt9ziqQW4tPIu7ny2ljnNvcxNj92wAIY+qsrD8jWxp2pwz2UllaxW8lxDIzW5mG1gH52g4IYEHAB5A78V1YZJaN2/r+vmeliG3G8Y3vv2/r9NTRivU1GaS0uYybqBCF3sFkeQ9TuBwdvQVhPd3bXP2WecebNKAVww8s4Iy/HJwaveOF1D7Bp1ymlR2iIXLXqTCQuT2wAMDPI+n1zkz3NxcWVtdIpa4OVLxA7wMdJAfXOQfY11znvHqvyOfC0k4KatZ6WunZrz1Wu9ty/qlwunPZxSSWixwyjiFt2TggnGOvAzzWUsiJp3mKN11O2c8BEjHbHZiwPPpWV9mklMqbUcnAVi3KHPb61oi2+0S5lV4Zh8qxsOo6cgV5datzt6HcqMKUUm/X+vU3FEojw5LMDjB65z09xUwUyL5gYq2MFG4AHpVi2hjt0QXYBlKBlYHjI9D7U2ePbLthCy7ss435x6ken0rmqRa1PLdS7sjOKOkpQhlUDnA7elRhU8yQBEJRNy8feB/h+tWb6RlKSI5MfCliO3v71FdxwLKZomKIuGUr8wPrkdiawt2OiMm9+pXS9jXes4lJQ7Mjsn09agt9RvjcxwXcyPbbswzH70Yzx7ke1WbpHTEiYCuuV75H0rPMVsQWaMwyMDtcN8hHGc989Of0q4OS6nRCMJK7X62NiCa1EskrXd7b3YfdIIUBGM88E9O+DV6003SWupA1zqkybjcGO3KRIAeQwBbJGMcVzTW8YulnuowPPAjdskpwMBs5GVIA9K1dP1RbWS3tbM2tq65SWWUccdMk54HavTw7i/dml/X4GFajLl/dN3+Vvv30NmS5sLFU+z6LaSxyDI+0I7uPqdtFb/hjUdRvLWVZtSmMkTbTm1jwfdTxkHtRXrwotxTVvuPCq4mNKbhON2v70v/kThvEGpR6dM73issZ5LHPyjPevK/iFrGn3upaPLp8qPKJV3GPnj6V6L4wZTeSQyfOmFDn2zzXzVaSrq3xOQ2aCO3+0kqkf3Qq56CvnPZucppvSKbPoqNaGFjSlb3ptR379fkfR+mxholkO4jcOV6eprdtH23cnknCtuSMYzuU9Rz61jadEgtVZhxjp7VrxKJIlbaABgMPUY5xWNC6ihYlptmLfXBj1MSCLdZ3CbolGeGIzg+ldRpM8t7axkRGVIlZwCDuiA4Yj+8vIzjpx71l3ohcws8CNC8QSZF4YEd/r3FWLCyjt4YBb3jJChZxdKQAd3G1wOQ309K9CjG239bfh/WjMsQ4Tpro1/X3/AJ+exbSS0eT/AFk1uyggAOJPm7A98e7dulT3Je4hT9ztuMjaoQAPnjIPYd/eq8toLpE32+HiIV7i3fJZT2bvj2PNdBoVmkSCdI4GiceWkceCQvdvXGPwrWSfw29f+G/r5nn1qkaa5uv9dfMk0/Svs0RxI7xn5WSM/u24+YY6bhz9a0VtCyLhw6ScIuMGM9hn+lTRsY5VCIqQbCUlKq231JAqO7nFtGHjXgjdgc7nPQ8dql8tNabf1/X/AATxpVZ1JebMa80+WK4CbkkdT82F2mX2yOhHOPx9aS1Em51uGCbG25VsNtHIz2yOtXftMj2rfxtnK7VOFb+JSe5Ix1rOjuBJKyGYseNrsOD6fT0+tccpJO66nZBzlFqXQvXMaoxl8sruBRyB8pI5wR26YrmfEVtHPbMXB3QvsYryGRhlGVvVSOnvXSKVVhbhc+a5JWTucHoR/e/KsbUZivEsREaKrK4wcpyMnscGtZWa16/1/X3GuEcozTRxFykk5lwokknwCoBZnZRjoevTOPrWlavNbW9pbSqEO3ziUxzzlXx7enpzUUlmbe7AmUbt37u4QcRv1G09uCDkdc4q7e2txcqL8W+65WPaZIuRJIRy5U9ye3atsO7a63/q59BUqRaUXt/SRu6fqupXaxwNp0IjQnzWJG1fQ4bg46ntWF4s1p5r+aaOwkhuEIRlQ4QkjGc+4qha6xf2s8DzOheNtyCA+W4wf4lPUkZ5/GmasDqCyStc3stwzFljYghs9cAdxXZUxPPTtF6/Iwo4ONKtzSireV+/5fcc+1xJDebjCY42IVNhyG9fyrttFkhMDeer+cSdoZc8etcrZ2MlxexLIp2Qg5VjtBHbPeuotojCURliJ5JYnBPrj0ryG7NyWx2Y9wlFRW5JMCNohLNGWJ8vnANMhmXZIZnUxHhSc5Hrx/WrVpA6xhXMvmncHkIBGP6HH60r2zPckBWRFXlWXLN/TvXPK/T+v6/4Y83nj8L/AK/r/hym8iSrFHJJlUP34x1GPTv9ar/KpU5z/s9C31p94qxkZYAx/MNvGPwqibppJ3WZtvmDPAzj3HtmsW7PU6acLq62HzAPGWcs/BXeTj5vXFZlxczIhMcX2hgAWVR0I6H1HfmtW3jikiDMjSkqPuZz6Z+uPWorywuhHmErDJ0VhwWxz0H8qa5mrr8DopzjGVpfiY73tzcRIiRyC283rKgG3IBKgdKdNCHkD3VtLb27vhH5JDf3R/eH9ajaymmUPPOqS5Kt8uF3ds+nerOmWF1Z3kbsY/IlG4N5n7qTHQf7DZHXgiu2hK7s1c7JShFe60v6/roa1xBoMaxNeXfiAxOgMUkEKKHHf/XAkjP93iitK104Q24abULFrh2PmGSIyDI6BWxyKK9Z0nLWyX9ep5Pt4rTmk/6/wnk/xi8Qvpum3Bjm/wBJucxIQeT2J+leW/CO2afxjEynmKMnPXkkf/Xqv8TtcOueLbpkctbW7GOP0ro/gjbEXV7d9CWEanHTHX+dcEoexwcpPef6/wDAOOFX6zmcKcfhp3+9LX8bL5HvVpGIkCgggjBAPatmzeMyLE+VyjEYPBP+NZul8xtuVdhH4j3xWjaqskqo3IPI/wDrGuaktVbqdeId20wur1kaKJSFmSMYnK549D6/zqzbXcYcw3toksboB8q/u2z3DdAeO/NZtxZukqzlfOhGcsmcEYOMjsQcDNbFmfLSMiWEW8rbwjf6vIHIPXnGe1elQ1V2c9VQUFb+mbVraeSXMcUYsVUF1J+dR2yR96rEFiJ5pHt5Ht5nHHlckJ0wR6Gs0W8Vw+dPL2IcH/R5GOAPXJ/zzWto9o6IstyWE5IAUtj5cYABHXpVSS7af113PGrScU5c2v8AW/RmhanZgPAkUrDc7bsqy9MZ7Gq9xIJLhVgcqjk71Ycxg4yQPTitSaNQoeViruw+UgYJxwCOmB14rHvAFnTDMYguPNA5br0P1IrGurK39fgcNJqcrmJK6RtLE/nSpExUc8SYzg1hw38lvex+W6gH5CoGQ3v9e9dPrEMwghuLUGVo1KxFcBpB/ECPUZ6/WvPL2VZL1lhKowBYE9dwHQjse1eViL02rH0WAhGun/X9f0uh6bYKpsXleMtIyqOuCCDg496ybmFLZJomceSuEzjAkUnnJ9eas+GJFuLCOWRmkmQkEDgDIPP51b1lS0EsEq+arAF9qjHHceh/+vXfD3qal/X9f5HmJunWcH3/AK/D8zz7VElsI7i2bcQGKumM7U4KnjPGCOasWlvdwSqkaTyRucOocMBjlD2x259a0dYtg7WzyZMLnyJJoG+dF+8Dt79RwapQbtNmluLm7maf5gFiizE67j+Iz1H4VpRhGL3se7Grz0lbd/i/l/Wxpzh/LddQsZmRyQF8sY9zkcgelVY4LaK03RMYWxhSFOSfoRWimo210FEeodM7m3FWGeitn+Xao5L4pvgkhDLlZXk3gkRjI/Mkj8q2rRTV1K/4/ijji5rS1vLb8GZctlHbZMdzGyuAQCvzZPbrRBERcRN5igqvTPGfpim3cqzTrF5JTe3BGAQeuM/Qirlp5srgiWIOWyWcdsdf/rV5lR3l/X6nTKUlG8mW4fNuAQQkhOHkaNsY5A2/rU2prJZ20rELJGABnocd+au6TZxsInlljDB9gGzGMda5j4i6vHZ2xjldWLHAAOMn6VM7U6bnLc4qKdfEKlA5PVtURJoyyssDNtUs2QpPT3xUtu+ZEZiykcEAfdGen0rmru0v7i1uLgQwzgx48ncQyjsV9TV7wvfnUdPRw58xRskL/eG09G968tc3xM+qdOKhaPQ6rTjJB5RWVcIS2B1ANaMwDPI89y6wuoYiNMtx3Bz2zWPbiPzFwTk8gkdPbHeuot0c2AKMnB6kDjPrXZQfQ8jEvkkpdzNit2yqRXsQ6PuZM+YecZ/D9aqyaXP5dzAjxbIhuMeSHjJ4L4xyB3x9eas3VqLN2C7mUEfu1HA9Rn+VVJNVhZUg1OSZUUlre8hUebEepUj+IEcc130nHmtLT5/1/W9tx03OXvU9fl/X9bX2NHQvDkl5YqxutOGPS+ZDz6rsNFc88OnJKz3r7vMw0bW37xCv1xkfQ9KK9FVYpWaX3oc6FaUnKM3Z/wB1/wCZ8gbiSSxyScsT3PrXuPwZsBF4eidvvysXx/WvD44zLIka9ZGCfmcV9PeALFLXS7WNVY7IxkAdK580lpCn3f5Hl8PU2nVrvorfe7/p+J19tG0e2TCrj9fatWzzuG3CkZJVu/pVPDSoG8t2QHLDuPeo2BilYrG6xY+8Dk59TXLBWd0elNe00e51MP7pt8QTJGSjnhTjOQ38qaiRwSJDLbyWE0wDfaRJtVv9oj7p69etY+mS3TSReTPuQfKEcYz3x712MMFzHAIPs5uLVvmEYZT5RPBzk5IGeM816dBc6/p/18jycR+5dm9/O39fPcbDHeTKuESe14Lyqx6DjAB/Pj1retojbL5oVooyeUlbcFHt6fhWZaadG0rupnSZCNu04HvkdPwrdYKixwSspUDdydprRRe73/r5ni4mqm1FFa/cJtLJmNG6glgSfb6Zrm9U1BRdi2jYuFXYW9Se/Pp6Vq6i7CbKKCzZJ5xjnNcTqc7NfTlUX5G+YE9+M59a8zFVGtjsy/DqbuzWvZGEalso0ZBLxnA46DHY+/vXAeIbmCXxKJIIwkdxFv2ryVZSQ2e+SQT+NampazdWSeZIGkgUEMqtuCL1O32Ga4lb2K+8YRi2cSQCAyAg9fmIrzMRU5ly+Z9RlmDcOactrM9a8IqBYgb3EQGDtHIG4ck9q6K/YOxKvvD7QQ2fm4I5/MVzvh+SaOyYqygCENu5P8Qzj05rcubtzFdK6Sncu3fnLKeK9TDWjC39dT5zFRbrt+f+Rzlxbxyq9vMQ2VO4oeY2U8dPvf8A16hjDOA8OoBZQ+HV0LAc/KeOpxin6hcTR3E10sSbbi1ZAkf8EnAyffAz6c1QiuTIUNtG5dHAVASGDDjBI656+2a1pqCl/wAOelCEnG/+Xz/ry+/WudPTyDNdLbTxoQSShLR8cDLday7yE2unu8Vxbqtw3AZV+6M5Yd152/WpZYdQDmRPLjiUjbLdJIMknnBA5wM/hVE2z3rZi+xfZomVTIcnzHJ6gY5PWt6qglotS6MWtZS0/r8f68yKzWQSiRxBLkcSFupI547dv0robCNXikXZEXKK21FDbMc546HFVEs0jWK2giUlJTkqmAx/HpW5p53x26qscaHcWLHGPQe/pXmuN5MyxVe6ujUmYQC5YsU3/cEige5JHrjNeHeM7s6p4sMIlRorc+YxPAUngY/8er1nxff/AGOyf5kDMCSN2VQ45AFeB6bqCPqF7MyOZ55iFAH8I9a5cfPmfIuh15Bh7KVd+iNy9gubi1dLN1WbHDFc4/Kud8AXNzDPrVpdAfaEn3OR0OeuBU/ibxlZaJaMskgafHyxK2Tn8OlcR8OvEct14l1Sa4H/AB8R7ytZxw8nQlNLRdfmevPEwjVjQb1fT5N6/doe2adKrAl8grwCfXrXY6CktwmyJEkyThTxx3zmuJ0WRWiYbhh485IyB9a6/R3ELKyJtJ5yOnbP+fpUYZ7OR52Yx0aRrywymYrJYJKxH3QQcqO/HX6Vgy6ZK0MrQ2kLJv2Op27gTxuXvj+tdRa+Q0LsWnjCnBZSPlPY9ary21pcTeXO05ZiX3xMAJF6noeSDk4r2IwU0tfx/wCAeRSxDptr/P8AzKeima1tibRIEilO7E0iK2e+c0VFJ9ssv+PW1jvwxKmVlDHK8cjqP60V2wrKEVF3LnS9rJztF37v/gnxR4PtDe+JLKIDO078V9O6DEscYCP8oHTpnHrXz98LrUzarJIq5bIRf619EaUgjhUOV2Nw3HSvOxsufE26JHo5TS9ll6fWTb/T9DUiu3R0VSp3ED5uB+Jqe4mYpJmP5iCcqec57jsPeqdpHGt5h+EIIB6g+496lktpoQHhYTN0DJ9/A7Ed6IPozWUYKRZ05x9shjjkkgKjfIJkyjjHQj+oNeiWCqGCyREMAAZrViVH1zzXG6C0NzCFWbyJFbaIrld0a+qk/eAP14rrLOzltjtiZ4C2Dnd5kLD/AGW6/gc13Um0tNV/X9dDw8zkpPlejX9f1ubMsj7Ny+XIQeSvysfqKrT3LS3T5OEwF5Xrkc0yZJ5ZWOzbKMAmPB49/aop9wZtxO8AHpgZ9KdSo2vI8eEEVtTkQwGQFd2TkgkYFefarMfMIUks789uvv36V3WrY+y4x8oJ6j8vrXmWrS+XqaAkZxnnpXj4yWqufQ5RT5rlrW3tNO092udvlqu5ypyVXvn1rzX4fNbT+MNTl05/Ms1QMhYdAW6V578SPGVzqurT2dlO6WcLlCVP+sPetv4CSFL7VskkYj4/EVVXDyjQdaWm2nzR6NHHRVZ4Snq3e76XSex9MWEQNhvEKEtEwIDYI/i6dumO9XUufs0JOCZHdG2sCcHB71laVuaKRtpZCmFBHYipbnUvLZi48ojAPPOAD0FVTnypPY8upTc5uO4moTqzXJi2CRJEZR03qc7setWRapqMIw32dioPmKQCRjofXHSqTXYka2WRIyjoXXaQeD/XiuysBACkc1vG5eFJEGB8qhR29a9OhBzvZmWIqOhFWWv9f8OZraTcQ2SCSeO5RlGMy7DGcemCMVmCzhiZJrm1uZgkg3FWC8442gduOvtXX6jLbLbbpYo2Z/4W4AHTFZdtInmELMgAYrs25I4rWtDl0v8Ar+ZyUcTUcW2v0/IxYYLm5vYmnX9wCxTccAJnpx3yTW6i29qvmxxpKFyeBwcDg/jSqIicsXFttxz0P0qnqNw0aqIlYgoUK5xu44OO2K4ZtR956scputJR2Rwvje+aZmACqFGSAeBjufevmPUPGc8VtLa6WPLcyN5lznluew7V7741uGXT9WkxgpBJwTjop718p7TtBx1yw9+a58vowrTnOavt+p7GOxFTCYenSou173/D/MJZHlkMkrtJIxyWY5NXdDvHstSjljbbkFT9KoUAlSCOo5Fe3KKlFxZ89SrSpVVVW6dz6Y+Ht4LrTYHkYZ+6T+HevStIlVFxuKZOTuHX2rxX4P3ImsxFuzyvFewWgJyu4BVP6elfLRi6VSSXRs+xx1qiUu6R0lv5Syu4t45I2bDo2Rn/AD/SpdUXTTA8T2v7pxlZFODGR3/pVKwJMefMwjNnY3Jb3zV+5iukjcNEJV2llaNQ2QexH0r06Mrwtb8D56a5ai1/GxVOm6VfIkv+kQXQUJMFuCMkdOg5+tFZfnIrEPa3HAGGiOMj3or0YSpuN2lf+vI6fZ1Vopu39eZ82/CSyMdktw6sBI27dj+VeuiVTa/K5yTgY5ya4Xwza/Y9PtImBQKnChsDnjJrrTcqY3EUQZhwGjPyn1xXz8q3NWlPuz6elh/ZUoUl9lJfcdHprIINsxL5x8uM/WtpLSxKhGna2nDBy+7kehA9K5bw/d/Z5FxsYEDMcuRyfr/nmttb0xuqm2IRicl1LJ9cjiu6m4yV9GebiqU1NqJ0djayzAwiO31aIqdnz+XMOOoPcD0FbukWwjRrVbu4huNuRFdxfKR6jPX69axtK0zT7vT4LiwY29yjAgCQiIknsw+6a0XvF3LDd3GoWMobEckv71c8/wAddXuwSlL8+nro/vZ89iW6jcI9PL9NU/kjZZtoVGWEKfuyIwPzdxmobiOVZi75ZQPnOBz2zTUTdlbmSGfdgCUDG4+h96gmzGSobIHG7+77VnVm2jz4x1sjJ1q6YyPtyFXPOOOlePfES6eBrmSFgrraO5bOMduvavUNckJZ2TJHI9ia+f8A4y6oYYbmJThpIljP4tnH6V5c4utUUO7PqsttQpyq/wAqbPEwSwJPJYkk/jXqvwIJW51N8jGUHv2rynoAPTivVPgip237c/NIo4+gr2M0dsO/VfmjyskXNikn2f5H0hoTiSBY95UNjPNaN1bbVclUlGR94nkd657RHZFXAYEkcntXQ+YZo3DnC9x0J+ledQd4nXiYuFW62KbaUSBizVk3MwaMn0HGR6Ve08QeZ5Z0/UJpEAOY2bcnuR0IzxUtgq+Q8sku6DdtKFs4wByR+P6VtWVoZ2KQ7Bbs+MKvK9y2a9OjQb1X6HFXxLSal+oqfaLlDNDbZAHzG7gAB9cBRyT61Sa4mW7lCRpHKwwChEisPVcdB+tSfZJH+cXLzLG2VW49FPUYzgfXFVJLcy32ZrmSNgfm+VcMx7ZUkDjvW1W6ic1OMLva3oyQW86rILkRjIA2EE4XJ5471navKpgYIjKh+Vmbklh6Vry2/wB//SidzYB29QOo4/DmsW+dmRvMXBPPoq47gV5VfTQ6MO+aVzzPxuf+JVqgPVoHBx3ypAr5XUEKOD3/AJ19Q/Eyf7FoV7N0xCQPr0zXy8Puj862ypfG/Q687a5KXo/0FpKM0Z4xXrnz9z1r4OT/ALllJweADivb9IuC4Csx6nv09K+ePhRciOaRGOAW6f5+te76M4XYMknjNfL4tcmKkn1Pt6C9rgoS8kddBMUKrGMkZJIq4ZEmjLSyTIwx/qmwV556/wBKzIH3rkZIzx6H61cjwWSU24bsdz/e9uOgrei+h5dSGpckiEbfPfW5BGVM8LM+PfFFVxd2AULLbRTSD7xlGcewNFegpJ7NfiYckuz+5Hic0aw38dtMzx25DPGduec/d69PWujsIJ87IGAZSrg7eMg965y8P/E7sxuQyFZY29AM5DAV11lMU2fvFUMNm8dD7mvOp0U5H10pSVMu3q3EUm82rb3+YhcOuT6H9cY71P4c1/7LdOqSLErZWWOZeMHtg1q6fey6fEqzRrkyBBKBuRgRxtatuEadfRvBqVpB5I++0yfjksOfyNehHDuUlKE7PzPEr4iKg4VIXXdP9P8AghYW+n6pGTAkljNnDNA3yMfXb9e1XydUtYJYJI4b2AL1UHP1IPfiuSh0mTS7iR9Fla5tUYs0EhIlTngqc/N7d/euj8PaxFdFIyzSMW2hQ5Rt3vnv1qoRTlySXLJ9Vs/0f5nm4mk0uem+aPnuv1X327DrTUQ5/dRsVAw0Uv3hR9o3xMVLDaf3gPX0qnrEcsGpzSgxxuX2rnBP0P8A9aor+4aa28wB0cdM+uOn0rjrxdNtPp/XyJjRjK0o9SlrblYZOTuAOQfpXyz8Wb43OvCLGAPmPzZ+n86+i/EN7+4mkLb8IzE/hmvk7xLfNqGt3M5PfaPwqMvh7TEc3SK/M68bL2GBcXvJpfqzNr2H4HKBYTtsBJlJyT7/AP1q8dzXtHwTyulN7sW6e9d2aO1D5o5cgV8RJ9ov80e56cjNsRQcsPTp61qSQtcR4bEYA5IzWXpjSZQKQZGXk9hXRxxHy3LSnHQbRjPvzXnUNehviZuEio8iwQDdMjK6hQHXb+NTwokht9ltPJM5ykltIDsYHPIyBgUyWS3WBzcyibCEMHGePSp9Ni8OTlUjWABUDZjneMqSOflzzivUoyu7XX3/APDnNKVo81n8l/wV/wAE1nmnhVTc2s9vITulTaCG9+CeM9qhmJik2eVDbxn7owWwR1OR9aSz022hVXttSvVMg/dBJgw2+vzg8eopim1hncxXhwV+64IIPOSB2J9K3rOT3/P/AIb9DhSjd8v5P/g/qJcPG4YpMjBMcj7x9SKwdSYO4Ad3xweeq/SrUnkyOWjkCsMsw27QMf56VlTumZJOm87hknoO/wBD1rxK0m2elhqXKzzH4zPnwrec87dpx65r5tHQfSvov4ytjwtdqwOcHH5186dh9K7sq+Cfr+iJzvR0l5fqJRRRXqHgnS+Bbz7NqoUnAYj8j1r6F0S4UK24cqcDPrXzDpMxg1GFwcc9a+hvBjedaxO6sVIDbjzzXz2bU+WrGa6n2eSVPa4Nwf2X/wAE9GtZ3lULCm0ds8Cr1tGspzJKzA9dny4/HmsSC8EXLrvdlwAp4H1q9aPFPGouB5ansrkfnXPCV/MirTau9i/PDpnmndMPYSScj8hRSQanp1nuRIYiCc5IyaK7lOn1cfuOa1VaJS+88PSK4l8R3TW0DyPa2y4aNS21cZDEegOK7nRrmzTTpWvtPlVr1VKsjhRDKc9jxtOOR715h9qltfEfnSuXJVVdGb7zJj5T+XfrXpFjdSXZYRB4ZJjlopV+VuO/tTotJ6bn004uVJJ7fdt/VzahgiS1ZYbtbSYRFpGkiMgyTjaF6444K8jNRTX9zbpGLyJ7aKTaYmZd0Wz1D9MexrU0mz/tJD53nedJ8mQSdqqPvADlunSnxvJbadDC7SC3mLqTMvyM3ZlHY+o/LNdU4WjfZeX6r/hjy3VjzOLV3f8Aqzt5dfwGaJq6NfoRcedJMAyyh+Bj0HXiuhihsdUmEl0saThgWlYbg4HZx0P41ysum2Mim92mKVplQNG23DY+Y49MZqdbS6tPMA3XFs0mWB/dsR13FDg/985qKTnFWmrr+vmc1ejTm+anLlf9fL5fgamuRpHdZiCRJt3SJAd4iGcYH6HHbNUtQu1VnBbJ8pRkc4O0Y/HtTbq9gFrcqj3DyuFD748f8AA69MckVitcLcyySRbvLRwqh+fqT9K4MZUUXp1Lw9BtLm6f8A5jx1qhsvDmpTE/MIXUZ6jPA/nXzXkkZJyTyfxr1j4uawRpwskYgzSncM9QDXk1dmTU2qLm+r/L+meXxDUtWjRX2V+L/wCAkL2Ne2fBz5dMiJ6YwPrXiXODXs/wkl8u0iGOQgwffFXm/wDBXqi+HFetU/w/qj3fTSIIAZGAZ13YA5rViZpCw2Sk8D5mwB+FYGmpiJwpwMcluT+Ht7V01jHYiIfab1gexVsV51FOVka4q0W3uV7O1Fxq6QSRFVkB2gc8/wCFbaQabMVNxZ2a3CAcGPILDuW64x2rISys53DDU/LXPJchq0V0dTB5ketvJnALRoo2gdD1r1MNJpWUU/mjhryi2rya+THuujCNZHtpLCQDcCBlD/tYPB5/GmXOq6XBiNRJIijO1VAUE9zn/PNVV0zUoCG/tTzQGGxG24+hIOR+VUJ7rUYbkR3EAljycRqfmGevXnHFFWU4K7jy/K/5MIUITek+b5/5q/4lG5uree6ItkVQegc9vU1U1ITy24j4APygj/61WZo4pUBQhHVvugjB5PGKRZAUbzSx3DkjnOK8me929z1YWhZxWx5R8ZXYeFZtzHOOQeSTkV89noPpX0R8bSP+EUuiAqsSAeO+4ZAr537D6V6eV/w5ev6I87PHedP/AA/qxKSlpK9Q8EcjbXVvRh/Ovon4dSPNpUY3ZUDcqqePp9a+c2+6fpX0N8NLqCTw/Z+WhbYvzOBjDk8j3wMfnXk5rG8YvzPpOH6lvaw9P1Ouu5pUDLt8sfx565+lWtFiW8Yrvdk4BZ24H0Hes3VYHIaYklVwQh4Le4/wpdMvmijXySpY52nIwe34YrwYRcanv7H0sqfNS9zc6pSumgRlbcbhuBCg7h2OaKy7GCfUlaX7VCmDghztGfb1FFerB1XFOC09UebKnTTtUlqec3VhZTzw6xevK0SM4ufKg81tmwhXC7lzhsZ5GOvPStvw1qSXMifaRF5UieXGwJ25AOARnKnHufrUHhC5dd9tPCryW+RMjD76NxuHrx1FWLTSI7K9a/0u3FxZSnElpkgjPdPpjofWlCo0oo9b4eaMvkdxpupSRMGgVxLGgVoVO08dwfoa27y6gu3aG4SSS3cKQCR8v90r7jrXno1G1eeO6sEnhZAYpradgSrA9uM4wRwc962rq/Ey25WT5V2jZjaq5rqWKtFxvdfmeZXwN5qVrfn/AF2/M0Z9PTzI7YOkFw8hZZEb90V9GU8g++ePerttqModv7Qso7me0AWP7QxKpk8YA+8DzjkVx/8AbcaRtFIWY78mZ8/Lz90e3rUV1cXWoLhbe8YtGQiRMYwR7t029xkVksTCGtP+v+G7lvAzkrVdu/8AT6l/X9VM15c+XH5Sli6qDkR9myf5VAimy0//AEjIIUyhWI4VhkE47n0qnZ+HLqxjS6u7nYkmCiK3mH6luhPvWR491qLStBuJCx3yE4LHlh6/nmvKrOpVqXkvee3zOtRpRioQfurd+n9M8P8AHl/9u8RTgMSkRKj61zvenSyNLI8sn33YsfqabX1lGmqVNQXQ/PsZiHia86z6v8On4Aehr2P4Zgxywp0QqA59sYrxw9K9u8DwJZ6Kb6cMd42KF/vZwOexrz81/hpeZ7/DXx1H5L8bns+mXOUiiWMFl+U5P6ZrQ8yONVLIjsc5VRnGP89awdPuIrWwhjmEbAYkkI7kensa3bS/smkNuGgt45sCZ5eDgZO0kdAcD64riopSlZvU7MRTak2k7FvSb+4fcLLQvtGFLY2DAX15PIqtJNqd5GV/seKGNuyPgpz656fhV3/hJrOwScQXKqXbiONWwvHGe/4VXg8QWk3nPHJHh8KEkUE8cEDtnv0r0mqVlCVS7+X+RxqFS7mqWnRvm/zGWM+poJF/s+4yi740UB/lxzk5GTVp7yZ/LR7O43yYJLAZZfUHPbOPxqK31G3UxLBLti6yFm68dM9cVevWju9OYoD5SMDuLbfL685/pTUVKD5ZP8P8iKjtNc0LX9f8zN1GyUS/6OskRTnbKoB+nGfzqirqqZBYrIQkikYIPWnRXs0M5jlJlRwQZCMkqPT2x3qPUR/o3nQqY2cttJwxx2/GvKrRV219x104yVoy+884+OQx4UvAmCo2/MR23CvnA9Bn0r6H+Kkhm8BX29W3/KdvdV3D5j/KvnknIXGeld+Vu9OT8/0R52dxcakE/wCX9WNpKKK9Q8IWvU/g1rKRO+mzOV3tlD7/AP168rrR0OdobxdjFWzlSDjBFc+Kpe0ptHo5VX9jiVfZ6f18z6wjRboMvyMkiYKycDPTn0NcUYp9MmkkgVp7UsUeMD542HB+o461N4L8Ufb7OGKfGQoVtwByw6Emm6xO9pq4lC+RHMm4oOQTnkjPXPWvnqii9z73CKUZOL2Z1NhPJd2UUto9nHHyv77KscUU3TYb9rNJbG0lurd+FZUDYx2wQcUV1JWWqb+8452UnZr5tXMXQ7E3CqY0aO6TPP8AeX1HqPaugS3yCYysVxnDBeUcn1HY+9ZukQK1sszOhIk24j+V4e4HPauo8l5LYfak85cZFxFxIufWsYwuv6/peoV6ri/6/p/1YxZ0s5iiarY4kU7fMHDKfZhVuPS2iiC6fqKyRFtxSZecfUcGtaG1nYZheK7Rl+dWOGwO3uarPYwQxq8tlPZsc4YZUN+IBHFNwlu/v2/FaHP9Yv7qfy3/AAeqFt7bVECwyQRNjJ3+eAvJ7ZPGallunlnKThlm24+8DhQKxpEEc4aWOe6QcBDKMAdu9Z93He5aUny1TOBI+ePfFEqyjDS/9fJFxw6qO7a/r5sualqYitWLKAVO7Bbk8cZ9B/jXzv8AErX31bUPK3HYp6Z7CvQPFN5O9pKjyYBByegwP514nfzefeSuD8ucL9BWuVU/az9rLpscueVVhML7GG89Pl1K9FFAr6A+JuSQqXmiUdWcCvpV7MWnw/kjmZUMcCMCfmCtnIzj3NfOugxiXW7GNzhTKMn0r6a1gKvg2/kdFMZhaEgd22/K2P6+teVmDvOMfJn1fD8bUpT7yS+7/hzT0Hy5TFOoG9QPKLDAyfukj0zXXTRRx3ay2kKyRztnbL/A/Ta30JyDXm/gjdcaZam5ZNzIzYEmwqoBPJ98cGvSLDVHtllnmsvOh2iOT92rIFPVSu7cOg5x71GCilHXQ9DMYSjO8dfI25LO7eQRhFheNeTJO3OerFVOTj+tYOoeGnWaS5n1GLf5ZfEESnzW6Ac8Y9TXRST26WcbrLJ5BUHe0ikhf+efXJ4/pSWsizJcThFt44QsCKRk7d2dzN+tenXpQqaS1/r5HhUq9Wl70dFtt/nf+vkctD4WgaKQxanPJJu27BCp2DuSD0OOcCpxoN4kscVtqcVxuDADygWXHoevOe3TFT32nyyT+bp4xckfMM7Y7g9Bn0Oe4/GsO91m9iuGFysiOpw7MMgnpwR+VcUlSpL3oW9G7Hp05V6/wTT8mlf8v6+8klsjDcRrNPK9yp2yEnGfcMOmB+NRG+iubaNY0Kg8IW5/dk8MfVj69qdu+0AqbeZokHyxFWQysepJI6L6e9VNVWJrq1F3Ikm9QcAYSLaNqgenygAe9cNeS3jov6/r/I6oR5mlPf8Arp/XbXpwHxAk3+FtTjTfuEZ3EMRgZA6d+Mj8a+el5VcdcV9BeN5Gl0TVSkaiBVZQBwFOOme9fPqfcXiujKP4cl5nmcRRtUp+j/QQ0UHtRXrnzTClRijBl6g5FNooBNrVHqvw9vorlkjSX7NejHlyYBjfnkSD+teia6k7Wf2e9PlSxZkRlAaJT6oewPcCvCfCOonTNSguWiSaNGy0T9GFfQvhe7bUNNDWt0nl48xYJjnDegPfivBxdPknZbM+6wGLdWlGo90c/Y6l4s0aIx21vPJFIdweAttYjv8AL/Wiu0NhCyqzaROuR1hJVT+FFcynJaL/ANu/yOqU6c3zSgm/l/mULFHaJ2YbVbGG749feum0+T7PHGryOjbeGI+X2zXN2GxWjWFgYsnORgCuutHla1Jih89MYdAudv8AwH0rSC1v1+8wxctEnsaNtCb0giJDIBuEkbhGP4Ywf0qGeaWIKDeyop/hngJUD25NRRG2dFVWaFhyQpyCfoelQXd1cxjyobjdHjgkkfpVuWl3v/XozzI025W6ef8ATQ27vZQoxJFtz2iHFc5q8kUhLB2lYnow6H8OtasrStHh1G49wAR/Kud1eQQRSEY3Hng9PxrixE7qx6uFpqL0PLfifqLRW8is3zgBFFeS9Biur+IF79o1IRKcqvzGuUr6DLqXs6Cvuz5fP6/tcU4LaKt+rClpKK7jxDS8POqa7ZM4yofJFfS0oM+jyRQYFtd/u2Lc7T1A+gr5h0xzHqNs47OK+kfDd/BJokLlh9n8wokfBK5UE8fWvGzNWmn5H2HDzvh5JbqX6L/IxPCNynmy2N2hOyHEckYyVwQemeQQDmvXdO03X3MNhFbWWp2ojzHcWVzt+XB++7Drz0xXn8ugNDeQ6lpixyxyBt8KnbtbphfT1x7cVtaBraeQ1jfNNaSRkFoXGxdx67wOSMVhhqsacrVdPP8ArQ93HRlXhzUbO26etul9Gn+h1Mct1pUsUV3pNys6fu2ZXWUFe2F6Z9TmptNv4UY27fvLlzv2K5Pz5wVwRS6dJLBHNG8f2SGU7kkHKyHAwoI6DFR3Omy3JWeG2lUNgCVpAhGejA+mfWvQnKUbOL+Vv8l+NjwnySbVTTzT/wA2/uuW9QeRCTcxRmJWKeX5mCrd8MOOKyTqFpCkmIvtc4kQIpUsACe4H0rTk8KMPMbUdU/dKNscFrGoKsemTjaecdBzV60jTTGittOEqbmw0jopYHud2MgY7UmpvWWi+Tf9fkZqrRjG0XzPyul9/wDkZF1JdtcmW8Z4kjJYo/UA9AAPbHeuN8UXbNNbwI7bBEC54yzbs/5FdPq9zM73DOfIiZiRK3Jx0DY6muYm0/ymjurlj5jkmKDOccfeI9a8vGy504x+bZ62XxjFqcvkkct49lWPwtfl1VVx8qjggnn+VfPaH5Vr274vzNaaJ5cjZMwJ5OSSTgZ9MZrxHsK9HK4ONNt9zw+Ipp1YRXa/3v8A4AGkpccUlemfOMKKKKBGto3IPsa9x+HkMV3YLtJSduhzgCvEPD43zYxnnpXrPhW7urB18j97GT80J6j3U/0rxMya5rM+1yeMpYZcp60r6nAio6zMMfLs+Yfzoqnpuur5RV32MOqsMGiuCLi1fmf3nRKnNP4EZmnxS7YwUjePdlgDya6SwmCti3nMeT8okXJB9OK5W32lx5chhb0PIJ9a3LK4uEDR+Ss4bkgYOauEnf8Ar/hzavHmRvsbsbxJHFMr8blIkBqB4Ttz9nRSDwGGCPzqG0eDZgRSRv1bGSBTmOzBK3Cr0QkcNVyldX/r8jg5XF2/r8yK8bKZcofYDGK4PxheiK3kHQEHkdq66/nCklCSf615X49vGjt5j1G0kmuOX7yah3PSwsVCLk+h45rVwbnVLiRjn5sCqNIXLEsf4iTSZNfYRjyxUV0PzqtW9rUlUfVt/eOopuTRk+1VYy5ie2bbcwt6OK9f8MXphFvGJfkPzFSeAx7j/CvGgxBU8cEGvWfCkSXGFmRip5DrwUPr9K8rNI+6mz63heqk6kX5fqe5ae9nqD2MVhhUubNEu4yojKTqMllzxyRx7VVubPVIWWN7X7TGoO2RRvKKe2OozisnwvE9qgMzO7IeZAf4e2RXZQXF6in+z7iFYpF8uRJBuDAe/XNccHCsv3l0/L+vmevWboTtCzXn/mvL/gmJZa9DA4gKQxBW/wBXcWqkMR1xkdPatiy8R6fHh5Et2Xn5S3Q+v9cVs2MFx5bx31l5luCpxGwb8s4NWJ7XT0BE1pJF83JIyy888jOa1VGcfhn96f8Awx59bE0JOzg/k0Z6eKLCWPDvFFHnIEYAIJ/u+n41BeazbTS7YoWlwPlbDOTx1z+NbumaXbz3AazmdJUIVgYwwAx1NLd21zaRgi6jeONyQwgA5P4/5xWrpV3C8ndeSX+f6HIquHjPlinfzb/yORuVlnt/MSDyVJH7yQcoB6J1JP04rGuzFbxS7JGJjXkuRuwTzz7nnAre1S4aS4lkmlMkg6hBgfXHp7VwPiG4BgnLghQBhQcbvr7V5lZqL0/E9zCRclrojyf4r6mby7hjZsuWLNz09B+FcB3rZ8Z3b3XiG4ZmBKgKeO9YZY57V7+Dp+zoxR8hnGIVXGTa2Wn3afmPFJTdxx260mT7V1WPM5kPopmT7UbjRYXMja8Oc3JHuK9f0FEkjCFSsqYZXBxXjGgysl5kEdq9i8KXZZkBVZI88Fv4a8PNINyR91w9JTwtu1zurTPlDzHVzgHJ/wDr0Unmxox83apPIXrj8aK82zjpdHpON9bC2EjTQFhHByPkSTv64P61a2C3VJDFPbr0OGyCe+O4qlo0EKud8jsMcKr4wMcVuR+TCSm4Sk8hpMk447dK6uTn1/r+vRkVWoysiSwuYpN2y8ljY8FXw64+oxVyR95+TzZGC5O44VPUVTL2Mkkfm2iCQfKfLym73OMZrN1C6giuHEE7mEfgKqcfZxu2jnVL2ktE1/XkGrTIO+F6+wrxL4maiGhlVGzu4x+Nej+ItUL2zIpKlhnOO1eJ+MpmuJlRQWJbAAHYZrPAwVXEKXRDzJvDYGb6tWOW6cUUtJX1B+chRRRQAHp+VeyeCeBDIsituXDA9F9jXjZ6flXsvgvatuBjKvgHPY+teTm7/do+o4ZXv1Pl+p6xoqgeWYCqAqGZXbIHHSuqto4/3cs0MsIPzb4h1Gev+RXKaFDGHVFkyuMZHUj3Fdhpd1Lb7FIO0E4K855Hb09q82glbU9fHXXwm5pqpI2bXVCz5xtkQHA/Sk1NLiAnfJGrqSehwSOnH1qGWaxvHKmCGJ26upKMD6jbjPvTXs4hHm31SaGTO1vNHmr+A6gfWvVht5eT/R/5nhqNpXlp6r9V/kaU1yl1FlS9tLt+YQYG8nv9Pauc1rUFTdbiUkrjr948dT2//XUWoQ3TyB7edZShG541YMzHuOePpWXqkTNIw3MTjB2DAPr15qcTiW1sdmEwsFJO/wDwDPlYtA87n5wRgKOPzri/FcrLaSOE+8c7ickmuxvVUxhceWqqFCL1/GvPvHk4g0md+dioUU574yTXiyvKaifQUmopyPBr6Uz3txKxyWkPNQ0inIBPU80tfWpWVj80nNzk5vrqBpKKOnSmQFFFHFMRd0o4uh9K9M8Lyzbla2BYryQPQda8v084uVNd14cuXgmGx9me+a8rMYcyufZcM1bRcT17TtRiaL7kV2MA7lGNvtzRVKye3u7dTcW8IdRjfA+0N9R60V5Xt2tE/wCvuPopQg3qv6+8TT5o0nC3LuP4eM8j2NbjmOJrgSlvLKkw3DNnj044JrPsp1BRdgkJX5opFBXn3FW4tkSn7Orr6xE5UD0INKElHb+v6+RdR80htvdTTsdkCMVTKO6YK/7Wf61WnuI7ZWlbbLcHJClcqB647mrU8Rn+Uwny8ZLDoB6df0qndOkYZIUxxjnvWVacralx5b6I5XW5J5S/m5MzHLH/AOt/SvI/FD51AR5J2Ak5969c1nEUcrnBL/oK8X1aTztTuG7bsD8K9HKItybPA4nrWw6gur/4JTNFFFe+fCBRRRQAo5IA9R/OvZ/BO0Iu8/KeuOBXjUS7po1HdxXungyFRaxMhO48tnsP8K8fN37kUfV8Mr+JL0/U66081Z4ykjYGd2etdxp8xdjsJDvwPM68DPXtXG2+5wpgDFuVZV7jPUe/auv0qMIkSyEHC4I7fiK83CtLY97H2cU2Sy37xnzHhjfy2BKyr1PoCa3LXWU1GJAYIgUYny3lMhHHIHcD0HQVh3thcTKxtDt2dGKkAH9avWun3UcPnTxNNtUL5qspJyOBjg+1ehGc1okeTWjRlBN7+pauYoFMbFSGXO7LsoJPbH6ZrBuTKY3ihhiCDqO4Hsa2LkoSGeI7gByykDArG1I/I3l5C554xmuOvIrDJ3sZNyURf4QWJJXPXivJPidMU0W5kb5d/wAqj8K9TvWbynBwWwRnHOPavGPi9cj7NDAqBAXUEDr0BrHCx568F5np4mfssJVn/dZ5dQKSl9K+rPzgSil7fhSUAFFFFMRJA22VT711+iyAsoPSuNU4YV0OmTmPaa5MXDmie/kVf2dRpnqGnXDi2AjcAA9+tFQpJHZ6TYS/bLGb7QpfCPlk6cMOxor5mdGopOx93CqmrnY22x4t0KBFX+EHOKtWkz7yWbDEfxVx+nayzDAlKAHp6/Wt2G8WVgxcZPJ/+tWvL1juKdJo2Lhy6FSxGTyB0rNmkCBixyccA9qRrg7jtzsHU1Vu5A6sWI46ZrGer1JUeVanJ+MrsRwvgkD19q8cLFmZieWJNeh+PrvbBIu7k8D8a87r38rp8tK/c+M4lrc1aFNdF+f/AAwtJRRXpnzYUtFFAE9goa+twem8E4r3Twp/qYsMN+wYQHAFeIaQu7Uoc9smvafDMxEamTGOmQM9PSvCzn7KPteF6V6NSXn+h6Fp5jO0ujD+6RxW7bvGExKX8onlHXr+I5rAtCRHFsT5gMnnIwRxW/Y6lIkimVHjKc/MMivOpaKzf4Hp4qLexr208LTqtnetAdpUrI+5M/TAx9Oa0YLW9TDrPbSop2r5T/NuPQ7T2/GsR721vkEUkFrNvJbzI0Ak9cgjv9amjs7Se4YrJfw/IBHFF+9JcdSc54Pt0rvpu/w6/O3+aPIqU7b6fK//AASbVvPVVDbwO+Tn8OvWse+DxYDkAqfuk1Yv0ntpPs8s0pUZwJEAyf6VlagNkbFJCeDknnB9K560Wm9NTqw1PZXM68lBVj1TBwQeRXgnxXuGm1CBHyCrNxjHTj8ele5TlBaSSvkW6r5hOcMfbmvn/wCJN59r1qAg5URZwOgyelaZfB+3i2aZw+TA1F3svxRyNKKKSvoj4EKKKKYAO/vQaBSsMY5HIzSAStrSkacIsYLOxCgDuaxa6z4c2T6rr9vZRyCMtJvLHsAMn+VZV0+XQ78sklXSfUsyaRqcKI32Sba+SCFzRXq86xafbxxoWwXfqfTbRXApq2p9U4Ppc6i40zw/fGOS/wDDrabOMoHsWzF0OCR1z36Vh33hF44XuNDvY9RiRtvkoCJs/wC7XpRt9yR4YFR1461BeaTFKoYL5dwDkSxna4/GqrYRVP6/VfrcujjZ0npJ+j1X46/ieR3X2zTLiO3v4mhmIz5TjDr/ALw7VDNcNL8oxk9K67xTbXRvJBdhr7z1Kq7/AOsWTgBifpj8q4bVoWsPMQSiRkyu9T8pxxxXk1qPI+U9qjiFVhd7nm/jmfdfiEcYYkjFc0rMrZViD6g81oeILg3Gqyk/w8Vm19FhoclKMT83zSt7bFzl52+7QKKKK3OAWiiigDQ0LH9pxZ9DXrnh+RZGijbduc4UjkjJ4FeRaIcaih9jXrGgQhkDM4SLIIYjJUf1NeJmluZXPv8AhNr6vO/f9Du9OedSUjvFkIQlox8rofQ1u2WowxTmWHUpbaUBVaOVeT7g1h+Ebk28yzynzxu5+Xb8xUjGe/410serxx6tDcC3AlRTtyAQxIIJPrxXNShHlUm7ff8A5np4tPncVG+nl92xNJLZ4cXdxJIzd1AUkn37irGl2l1O0L2slzISw8qONgzKvXe2T901BokdhJ4l8q6JZGRjB8mSWwMAc8nqPwrbvtOubK9misndVRgUgyPLO4chGByM5zgjjNddDDKS9pvrbTc8qtUUH7NOzavrsYOpB7KEOLeWKUlgZLgE+dz1/ugj1B61T1WRJLiK2WQwxYBBI3DpknA7E46Vd8Q6pcatcAm0jsoIACyvKGBORnHuT2qsESLS4psObhmkDySfdcZXaijt1/XrWNRRlJqOx1UbxjGU17z87/5/r9xz+uxzzaSzxofJClJDuGFJPIJ7EgDg187+M54LjxBK1rF5MKoqqmc449a+gdWuhZGRhkuFZ5k6g8dAOmBkD14NfOniNnfXLt5TmViC3GOcVtlyTqt+R5/EUnHCRj0cv0Zm0UUV7J8SFFFFIBVwHUsMrnkDuKQ9aKKYBWn4c1OTR9Ztb2HG6Jw2D0PsazKKlq6sy6c3Tkpx3R634t15wljKuFWdWmAToMkcUV51LrU0+nWdpOu8Wu8I2ecMQf6UVwU8I4xsz6OebwbvF9unkdpp/wAWPGxODrsh47wRf/E12/hr4geJ7yCM3OqtIT1zDGO/+7RRV1W1LQrAe/TTlqbeoa7qM+katJLclnS13K2xQQd2MjivPdWkdNLjKnBMWT9aKK8qr701c+iw2kHbz/JHlFwS1zMWOSXNR0UV9Etj82m7yfqFFFFMgKUUUUDNDQ+b78BXruh82s2f4V3D2NFFeLmfxI++4V/3d+p3MMzvbWtqxHkBg+wKBztPPvWqoCWM7KOYsbP9nJAoormpO+/b9D1qytZLv+oKo86BuQyNJtIPI4U8H8TWn4fuZtR1dYbyV5Y0k2gE44PXpRRXVQSul5/5HLXS9lKXVL9SbxNaQW8REMSqEjLLgdDg8/WoNeO6RFONoiVgMcZI5oop4tKLlb+tzmwzcowb8/0OE8VRINXmhA/dFFO3PqMmvnzXmLa1eEnJL5JooqctVqs/66nLxN/ulL1X5MoUUUV7R8QFFFFAB60lFFAC0UUUDFooopDP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous, scaly eruption over the extensor surfaces of the metacarpophalangeal joints and digits in a patient with dermatomyositis. These lesions, called Gottron's sign, can mimic psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John H Stone, MD, MPH",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Gottron's sign in dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 367px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFvAfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6HUBt3anHhcgZ+pqBWXbzUysOeas5Cb6Cjk4wMYpEYHqePSnjluuQe9IaArgimSWyTxtHKpZD2zipl6dTTwcA88VN2Fjz7xn4Zk+zNLAGMaN5kbr1ib0I7rXHWVxd2HiKz1WK3ZY5gqy7PuOOjZ9690DZ68gjBFcnr+mRWJ8+CIfY3P7yIDhD6j2qHFPdHXSxM4R5E/67G1DOJLfdGwZWGVPtXh3imwNp4t1G55An2mvWdGBijMasGgPKg9V/+tXC/ECHbcFwByetc1NWlY1jvcxdNYnHUc10tpIGKmuY04/KAOhrfsZBwuOQeTmiZ6ENjfhYYJ6e1XIZfu8nnt6VmQuCBj9KtwvyO5PvWLNkjZhfhcHmrHmcZI4rNWQZy/I9fSrQkACg9M0ENF2JyQMdO1WQ+FOAWrPhcdP6Vbj+71oIkiXvk9BQr4zuAJPpTNwPfnPNIxOST69u9MmwkzflVR35wSfpUrNvLE5Pt6VWnXaeW59cUmaRK87beRyQcGs+Rsjrj6VdmAIwRjvntVFyQTjr16VLNYlWT/aHbIqnJwc4/GrU3ALdveqch5xSNEVp8BmIPSsq6IKHjA9q0JSDkbunr61mXLADaOV61URtaHP6gvLDvXJ6xGAXrsL05BzXL6t909BWsdzGexxl0qKjFiMBxXYfDue+vtQj0nQ2MBuWxLOTjavrXL3VsbiHYnJaQV6D4D0/+wyl8W2yAfIvqa6ox5mjz6suU97gkk0ASB5jJFFEWLZ+V8Dk/nXBW87TO80hO+Rt5J966PUonh+Hcs8k7TTTTBizcAbyMge3FczaKBtB6jvXPiI8srG+B96LkzSVvmzjj0NTQ/fzjmoUHBGMn1qWIgOAD9cVzncXom4wO9WImPBC84qojZA2qN3cHrVqDGz5iQO1IC9HtC9eeo5qwGOAAMjqapqw2dMj2qWNj5Q+verRm0WN2OMEt1yKXcSue5/Sm7gowM5pN/y8df0qkSI5bbyQRj86z55Dk8ce1WZNwJA4GMnvVG56envQXFEKyq2OQD1zVKa53s+CTk4zUjhh8oBYdTjt9ag8v5M4xz+dN7GlkhpJK4qJ2Prx3qYHjtUEuaaM2V5SdxJzjGaqux2+ntVmQ49z1rPnlwzcc1oZMguJecDmqMzDJ5qeQjcSapStkk5pollWVjlsGs+fkH2q5MccdKoTtgGrRjIptktjNcZ4ymMuqiMfdjG3FdpEAHLN0Ubq8+1BjcX00h5y1WjGRHaZBGa+j/ghpfl6Z9okUAt0Jr590m2NxewxAZLsBX154G05dP0G3QDBKgmuimrJs467u1E6JFAGTz7VOhGOOBUI6YB+X+dSr7fnSZjYZMBktj6VlyJh2Yjr61ruMg1QuEHYZqosTKroXQ4+mKKljXj2oqySYLxxk0q8cimI+O/5VKrdPWshCrJtFTJKBznrURXnGeaTYQeKRRbVwRxn2NPDAnA4ql8wIPORUiSDOT1+lS0BdBzjn8qGRXVldQysMEHoahjcEYzzUyn6mlYDl3gbSr/yclrd/mhY+ndfqKwvGtn9q0+SVOqgtXf31ml7AYpPlOdyP3VvWuYubeSSK4s512zBSrADrkcEVjUjZ8yOilO+h5XYN8owfcCtu0YqVOeeufasC1ypKEDcp289sVs2/DDJBHfjrWdRWZ61F3RuW8hZcdB9a0LYgYJbr0FZFu3TknHetO2lUgr1x2HTFYHSaMZB6cfWrVqpJyTx6VQjdvl2/KtXoW9OD3pEMuxHnjt3qc/MhwcccVWTLLx35xU+AQeCG9f8KCGIjYxk+1TKwOMY57VEOQScZHTPSgkncSMe9MVriuCOeODiq1w2Qck59OtSM3IweeuMVXmYKygcikNIrOACVL9/wqjKeRzz/Orc3JyCRmqMjkEA84NSzaKKs7E59uh9KozHJ2+nfNXZiM8Gqc68k4FBokUbhwDkrkgZrLuGB3k9exFaEwGWxwf5Vlzn04Aqoop7GXdj5T7etczqo64wa6S84U9cYrmtSPzjoK1SMJlLRkjEkjyAYU5/GtSfU2kmRFbjIHFYrv8AZ7MsOrsaTRw1xqlsnJ3SDiuuLsjzKsbyZ9C687L8OdNRs5kuIx+QJrn7TGAc89DXUePYxa+EtDt04PmhsfRTXJ2vLLj17Vz4l3mdeAVqXzNVGA6cYHHvUsPOccGoUHOCeMfnViJiV+XHvXMdiJ4uCD+FWUHAAycVFAh+uauRICcnp60hthETgZ/OrcRyvAGcVAhXJ3cYqYMCuBkZPcVSJkOVwpGSQffmpMAg81AoLHtj3pxztHA9c1SIaGyuojAHX+VZ05LnIHFXpVJPzDIqpIQrHGcnn2oLjoVwHELB/kPdTVKZiST6dqvXAbfk8k/rVWXAQk5pt32ArM45PWopGwM9vansGJ/wqCYnOB17mmiWQzSAgge4rMk+UkKwx15q1L8p6ZHaqUhI3dMHjmrTIasVpic4qnIcnPpVuVuvrVKdjgntWiMmVLnGM96zp24PrVydjiqEwBOM1RkylqEnkabcSHjK7R+NcQqbjnvXUeKJtllDADkuSxrAgXNaRRhJnUfDXSzf+JbZduVUg19Y2kPlwIgGFUAAV4b8C9K3Xr3TLwOhxXvQ6cVvtFI4Ju82xcBQBmhm4/pTWJxwc0gGSM/WlYQ7cSOcCopEYsAMBAO/WpcYGDSt9MetAigI2XJJyc9hRU8nLe5NFWTYorkflUqtgdM0pTkU7Genryagkej5Iz1qeNsjj8Krbe3WnoCBgcc/lSsVct7VcnHWhoc5xxUUbnPPFTo//wCulawEDRsmcZxSpMyEZGcVaBB4OM+lL5SkZA/+vSv3GEM8bn09qbqFnFfRr83lzp/q5R1X2PqPamNajqpIOexqNlmiPDNilZME7bHh+q276frl9azgB4pmBx0554/OrEEmdmeF6YHrV/4lwGPxWZ85FzEknpkj5T/Kse3yQD3Fc9aNmexhZXgmdDaucc8Dj6mr9s646e1Y1q5ONxz3Oa07d1LAEcdetcrO1GhE3I5JHqa0YHIVcZ+p71lxEmUdh71pQHpvBIxjcD3qRsuxu23P8Poe9WeqjA5qshxhjyvTHrTzvx1wRxx2oJtcsIxyR1XHJoYHPJyOopqSYPo3TPapMgkbgc0E7EUi9GzkH07VVlHy8e/Tqaty7fmG7j0xVCTcoJxgDFBUVchfcGB247571TkA/iPNXGPVSCDnnNU58AEgHBqTRalGfALYbIz6VTnOQcEn0qzMSTgk5HTFVJfUHnGMD0pmljOuCQ3Q/SqM2DjJXHbFaE+3OMHd2zWdc8pnAyKuImZF8Dgj9O9c5fx7mPPIrpbzJyf6Vz2oLgP15rVGMzA1P5LW2Ud2Y1ufDnTJ9S8VWFvbRGSQvuIHQAdSfasXVxgWY/2WP1Oa93/Z10ZINMv9UkQGeUiJT3VRzgV0xPMrO1zpfiZbeVommoWDP9pALY/2DxXFW6bWGM/WvQPimB/Ylk2ORdD/ANBauDi7cnHSuau7yOzA/wAMuKN2CRj0qxCOgH145qCPJ7nFW4OOe2ccVznYXIhwMDqOfrVpOmaqQqC31OAKtI3G0/T8aQh2c54BOenrT0IJJxkHqPSoHOSMYAB5qdCqrkjmmhsnXaAeeT7dqbkeYPbk+1MDBuOc0qnBIB+lWjNoSUhtwOfy61UnjA6c47VcwN2QeMce9V7g8Hjk88UMa0KDB2buT71WnXrnGAO1XpBhSRy3vVKUs3GOOpoKuUGbknsP1qvK/H6VZlGGHaqc4Gec4znFNMGQyMOOce3rVCcDnBzn9KsyMd2Mc1RuWIbHY9xWiMpFe4AVs9apTEMvpViQkkkniqs545JrRGMijcNk4HQVTkyXx61ZuCBmqYcBmc8BAWP4VaMZHK+JZRLqpjXpGNtRafGWZVAySapvIZ7qSU87mNdL4Qsje6xbQgZywrWKu0jnnKybPoP4U6ULDQo3ZfmfBrvM+vJ9KpaRbi1sYIlz8qgVfUHPNbzd2cK2GgHcBjg+lPwFyT+dOX6UHGOlQAnDLkfhTXwe1KTuFMIABzTQiJv69qKD68kUVQiPoMdaco546U1V9TxUmQozUCBk4Bpduef6VIhDDgDFKBk9ARRcZGF9uKeAR9O1Ox045pcAUXAVTge1SL3wc00cY4p3PTPAqQHgnpxTyRUOCBntTh8vHakBwHxhtM2ul3qIPkd4GP1GQPzBrz+GTcCCdpr134j232vwbf4Ul4Cs6gf7J5/QmvHoB684FZ1VomejgpaWNa0fgEZ+o6VrWpGAe/pWFAxU47+wrYtZCyglsZ744rikepE0omG7qSO/9K04JNpHPHpWXFhuGGRxzWlB0HynI/WoLZoRS5UDK4HWrUSAKT1U847VQjILDaPl7Z4q4S6AMRjFIlomUqehxxg0ZwcAYI4ApI8Dbnv0zTnIAGBnHpxTII5u2Ac9eO9QEA4zzu6VJKSDnIx0wah3gnBH8NK5SRVnGCWDZUHnNU5TknOQScZNXJx27EZ/GqcoOeQOefwpM0iUbgbufyFU5yBwQeOCO1W7gjJ25PGOOlU5v3keVGOM0GhQlIZflGCOcGqNz1O7GD29DV2YhfmA6iqcpypGQGJxitEQ2Yt0frzWHqJ4I79q6C8Azjn8BXP34wzcZHT/AOvWqMp6mdcW4kuLUtg7I+B7k19F/BWIR+DlAHLSEmvBYYgzw8cBen419A/CAAeGMDs5610Q6s8vEbFj4pL/AMU9bHGcXafyauAix93OR0xXonxSGPDCf9fMf9a86t+AM/nXNX3O3A/wzRgHfOcnBGO9W41KtnsO1UojjuM9atRyZ5JHr9awZ2otqdo6jJ6+1PR8nqc59KrKcgEngnINSZA3bc+9K4WLKkM3HFPB3Ekc47VBGQVHXBOc4qymDxjn1NMHoKD6Zz0NKg+RsZ68igsF6DBNKpwAentTTJEdznjH4iq8jqy9e/PHSpnYHdkjpVOdgQQMAUwIZ5NucHI9T3qqX+Q+/vT2K5H55NVZR34wf0oRWhHKwZs+1UpSpB2qTz61NK+Ccjj1qhNId21RxiqRLIZDkkjgCqM5wxz1qzO/QDjFUJ2HJ75rVGT1IXbk5PFVpjweaklbnI9Kpu3H0q0YyKtwQCfpWRrc/wBm0e5k6M/yCtGc5J5rl/G0+2O1tVODje1aROebMWw5xXr/AMFNK+16157LlY+eleR6aOBX0r8D9N8jR2uCPmeuiktb9jkrPSx6ki4UU/pzQB2zxR/Og5wzwOKDz14NGaG460ANJA6Y9zUbE59acfm/Dmkx3x0poQ3GOPWipNvPPWincTSK4PB6H6UoY/UmmIwzTge5P5VIkSDIxk04Z4Iz+dRh+On4VIpbBxgfSkMlHsKcF57Z61GCxwCakBHc/jSEO5/+vSrjPNKOeKUfjSuADoeKULz0/GlXNPXg8UrjILy1+12d1bN0miaP8xivnWNGiYxOMOhKn6g4P8q+lV4IPvXgvjSzNj4u1WFcAGUyqB6MA39TUy1idWFdp2K0DnfnqCK04CS6Acdqx7djxz+AHata3PzYBB+tccz2YM2rXOwD8q0ITuAAYDPT/Csm3fGFGSSa0oDvUDpg56cVjc1aNKEN8oBG7tV5FLKNxyetUIMk8gYA4x61oQuCoHtn3+lBEh0bENyT9TTpOVPFNJG0nnbnkUx5A2ece4oZO5G7nB6fU/0qqSylj/DnJHcipXbI4PT1qsxOT27YFTc0SEZ8HPA+tVJtxI24qSR9uRkep9qryYJyHznvQVYpz8PhfzzVC4lAbcuWAGeBxV+Vh83OfwxWfOMd8A9h0FNFFKYZG5gfU1SlYbiT68VcmfBc5ByBmqEo+Q5P0J9K1RmUrtuvXdWDfDO70PBPtW7e8dSPzrFvR1HP/wBetERJaC242qjY/gFe8/BvLeEhIeS0jfzrwK4fbHEoP8Ar374RMLf4f28hGfmYgZ6nPArpieXXLHxQJfw5JtJ2QTxFuOpyf8RXnlu3yjB/+vXpXj6Bv+EKujJ/rA0bvz33ivNLfnA79K5q+52YD4H6lyIkHngnoaux5xwO3SqkYGOecDFXY85JJ7YrmO65Mo+XnH0qVE53HOB6npUfIwQcD0pRLxjHGePrSDUnyChIOMelPjYjPPaq6kkkjBX+tTxZ6HgH9fai4Eit8vGM560DcAMkc9aGCqAc801+v3j9RVXAYxwQOfxqpMzEE8ACrErgZIIArOnfe3yjii40rkBmJcr6VBNLuOF49KgmmO7PGM44qB5ecZGOwpopodMeMMfyrNuHcMec/TtVuSXdzwT7dqozHnBwK0iZNleR88D/APXVWQnkDPSp2I7ciq0px3z3rQxZWlJ3EnNVLh8cHr61akxknNUbhhg4/wD1VaMZMrHLSBe5NcH4ouDca1Ng/Kh2j8K7d3EayTHpGhavN5GMk7ueSzE1rE5ps1tFjMs8aDqWAr688A2X2Lw7aoBg7ASO9fLHgS2+0a5ZxnnLivsPTI9lpEg+6FFdEdIXOOq7ysWxnPse1HTp3p2M0HHbipMhBkUjDP8AWnHHuaRvWmBGRj39KAMN0yTTm5pQOevSmAh7Y/Oin5FFFyTLVuakD84zUSgjHSnjPTGKZBKGU8cZxmpV2nkdarDI5NSK3o2DSHcsA+uDUgJ/KoA2cdKlXB78VLQ7kytgHJpytgDioxS4J4H51NgJlcZIqQOOe1VdrAnDfhS4K4AYmlYZaDcda8l+MFr5PiG0ugPluLfDY7lG/wAGFeobTn7xzXC/F+2LaRpt1yfKuDGSfRl/xFFtGa0pWmjzuB+E6cd60bWXaQeDk8nHSsmPG1c4P16Vdtz8uCcHrmuOaPbps3rV9z/KOnete3YHGcZ64rn7UkNtHB9c8VsWo5Dbj+PaudnTbQ2InxjAzng//qqzGzIw5GBVK3f7p3AkdQauxkZxwx6g4oTJZPK25cjAY4/CqxkIIycDvUzglRjqMHGMZqvcfdKg9M59hSbJj2GyED5enHeq7Sc4Y8k85psrnrkAHoPSqjuAAdwyO2Oam5qkTzjqT9MdqrSjjkjt+FK0qkY5wOo7Go53BGRj0GD0oAqTv2JOPpnNZ1zLtQnJ9Mj1q1dMAgAbjPQVm3JHDfePXB7fhVxGys7Z3cDGPujvUDnaoxyM+tPY7j1y3oKr7iRncDk1qiGQ3QBUA9B7Vi3a8nGa2rjHrWTcD5uDirRnLYzdRfbOqAniNT+Yr6G+EytJ4P01D/q0Bkb3JPA/rXzhqwd9cSGPJd44wB6k9K+tfCelLovh2wsBgtFEoc+rY5/WuiJ5mIKvj9d3g/Ux6ID+TA15NAcjnua9f8ZJ5nhXVVz/AMu7H8ua8ct2wo9T+tYV90dWAfutGpFjI7mrcTZHsaoREhfQ/WrMbFSADg4wRXMd9i2zcgKenQ03d8y55UfpUJfHBHJH1xSRnduHBPXrUlrYvxsGIAGDT9+D34HOOcVXR1iwTnngVKoMgGeD/WgkkY5GSaHlwpz2ppGGGTx3FQTtuTHLY6c00MjuZxgj16AVnTyHB+9u6fSnXGQc7iPUVRmkbORyB3plbEN2+Acnr6VTLllBzyOKLmQ4+bp2qmJSrevf6VokS2XHJ2jPUVWkPy9dy85pPOJY5+tIzfLg445qkZSZA547Z6mq0xy2ec4qSViM5PNVp2zg+3erRnIrTsQCcnFUpW65/KrMxOST1/lVKcnPWrRhMytem8nRZsHBkIQVxCDkYrqfFkhFvawj3c1zaL81bLY5Jbnofwds/tXieI4yEwa+rLYbYwBXzt8ArLdfTXJ6D2r6JgPye+K6XpBI4pO8myfjFA6c0g6UvXrzWYhM0mMnPenkAcU3p0zTEIcZpFzmlx707jPBoAUYAoocHbx+dFFiTMHQfzpwH50gHvxT8DA/WmQA456Cnrz2B9eKTbwRk/SpFXjHcUDBO3GalXtxzTUUY+tPXA6dzUsZJyVz0PrQODzSA8804EDHekA4Lkj1+tOwBxTB6GhSOOSMUgJl6cfnXL/E6HzfBd6x6wyRS/kw/wAa6RGG4+lYvjtRJ4M1dewty35EGhblRdmjxCMYJUkDI7mrMTfvOc5xxVVcbuQcZ/MVagl2SI2O3Oa5JHu02bNoxODzkD8q1rdgOejemKwreYAHJ47D1rWs5fkDEAf59a5pI61sbMBGR8uF6YBzzV+JhwCQAeOvFZtvh+g28dMfpV1cEjoB9alCZfLDaQG7Z9qpTyAhsduxqTzMggZP+NVbk8ZHJwTjFDFGJSnkyWXPPUH+tVpGJ4Oc9h6VYlwyHAx0wapyqVGAcNj06VBsiEnqCefSmyMSmQQQPbpUbMqvghQTxj1/GopH2Ngcj2pgxLhsr3A/WqEjFhjOMdfepndZGx14zx1NVZOB0IyTgYzWkUQyFyccgHAx7VFjaCf4qnK87gOpHU0xkABA9M5P9a0RJSlLANnp2Pr+FZ8g3EYxzWjJk5HTPrVKZQMdcjvVozkP8Kaet/8AEvS0lGY0eEMCOuBmvqU9favnn4exB/iRp3HI+c/glfQxrojseViPiM7xEgfQNTVhkG2k/wDQTXh1uxCqcn7ox69K931cbtHvge8Dj/x014NZkMiH/YGeaxrdDqwD0ZqQNkIMAe1WN22T5uQvrVK3IPUdB09Knk9MjJ5zjrXKz0kPLGRiV9evpU4wnC459B0FVIRtAwOD3qznC7vfGe5qSl2LMY4GX6dPU1ZXpjd05HrVCGQKc9c1aiyxzzn0NJA0PHzMctxjrTLj92jZ6n2qwqKik46/pVG9YYO05btVIFqyhNKuRk81nXTjbhSAv0qec7uAdo6kms26yGIOcHqeuKtIckQXJwMJ25HNZ79cg5NSXTc8jj27VU3nkAZPatNjImRyOvJ9akV8jPTmqokxgHrQDnqeOopkMfK2cjr/AFqCUHGOtPkbKEnjHU1Xc5U56iqRlIqTfexVN8kk1auDjOOneqwGSM9+K0iYTZzHitt2oInGEQCsVV5rV8QfNq0+T0OKoxpucAdzit1scstz3/4G2Zg0cSnguc9Otey2+QuK89+Gtp9m0S2XbtO0GvQouFzg9K6KnY4lrqTik9qT3JzTiRz7VkMOuKQ+n86KDzwaYg47CndOaBj0ppPykGgQFucUU0kDk9KKdhFUY4/WlyMZx+dIF7YpQCBk9KCBwI6Z4zT16dOlJGDkcDHUknmpFxxjoe9AwXHH86eME00e3SnYzjBxUgO7+1KRjH6Yo69RzSjpjPFIBAef88U5etKF6fWnhcUhjQCc5zms3xYufCur5yf9Ffp9K1gOASKyvGbBPCOrt0/0Zh+fFOO6GkeERH5Pl6dqU5Dr0+hpsA+U9OuMikmwkigg++K5Wj3I6Glpql2LE7R27iugso1zgDPtWFpmGX5gAO/H866K0jVkDKR6Zz+lc09zrhsacCD5flwAAcdcVbhA3fMdwGcgdQKrogO0HqAMg96sIGCkA8HnHrUDsTKoLHJXnoD9KhlQHIGPqak29AF+b9aUhiMuD06VLBaGdIqqDgnnufWqFxuDcjPGDWpPld/fjFUZ1IJLZA9PSkaIwrnjrkkdM1Sabcu053A9u/8A9er+ocEkgYPQjjmsOWTD4Jx7jtWkVcJF0NggNnbn060xyTIOCevQc5qIShtpBA/z1qePGz5hk/XJ61VrGZGB5jAEYz0JFI6hlIxhh0xVhVDdQV9CTSTx4XdjAP6+lO4rGZMgwCODVOVQckD8q0pQd/PQc4qjN97nmtImcjo/hnHu+JFpntCx/wDHK98xzXhPw1AT4i2pHe3bIP8AuV7sBXTDY8nEfGV9SAOm3YOcGJ+n0NeA2n+qjGB90c+2K+gb3/jzn/65t/Kvn62YrGuM/cFZV+h1YD7RciY8beMnp3p7OWJwc5OPp7VE3CBQAB9aSJvkGefqK5Gj0kX1G0gr1I+lPUghSD34HY1XVyTnOe30qaHLNuVTt/nUtFouQxhRz1qZGYKcD5vem2w3OMjBHrVk5LHGPQ0JDb1Im3Mvde+apXZCjGOPYdKuy8H5iemRWfK5LjPAHbHSqSGtSlccIS/XOcVlXbHyyD+AHetW+3bSEOf5Vk3xcHbgAAYFWhtaGZc5HXoRyKzpPlYn6d6uXZKgnP4E1nySd849KsxkrDi3P04qXOV5btVRW3YPNTq3AFOxix5bKnODioJPXOf6U5+Tmmbge30BqkZsqTHJxmoYl+Zd3TdViboc9aZEMOvGOa0juYT2OL1g7tUuT/tml0eETanbJzy4qPVj/wATS6yf4zWp4Jh87xDaAjo2ea3hq0jkqaJs+oPC8AjsLbPGFFdSvCcen51j6LFttIs+grYH3fWtp6s5UtCQHgfnSggUg4HHWg8DkVABnA9/ejoTnrSZPbFJ060WEOJ9PxpmcHrSFvTOKZIeQO9UkIHcZJNFMY+g/GiqES7MH8KVkznB/SgH8eaduxg4rMQgXvzmnqMD2pB06/hmncZ560CDHOeuadjHtQW6UbucUhj+QcUoA5Iyec4NM3A0bvXoD1pAS9sdqXOO/FQ7x0oD+9KwyYEKuD2rA+IMqp4K1QkkblVOO+WFbG7k5Ncr8T5gvhQoSMyXMS/lk/0ppFQV5I8mgILngYplzky7Tk06P7xPf3pWXLgsM8dK5We5FGlpcZMOBu5+bOPauj0xAkK5IBPA96yNNUbOmew/rWzaKVJK4GOw757Yrnk7nbFaGvAoIIO4g9z2q1k5OMDPOT61XtpF2YYdOmecVOzgqRkAg44H+c1JFh5YEHBz/tE1E5YnOOoyQOlKSOQQMnrnIBpkmQQAML3IPWkxpEEpBbBABGMj0qC44Ugg59x61ZdcYJGM/jUMnCsMgY5yaixaMHUUKjOcgdjyK5bURsJZegPPHSuzu1AUh+V9a5jWFVWJAxzWkNxy2KFs5wCv3vzz9a2rdAqehI6Z6Vj2i/3RlenB7+9bduMEHBJqpELUc0QIUnjB4HXFJKoZfXB5zUzYIGep9O5ppYBSpHPrSQ2jIu1I/ujGeD2/GqUn3uCRzmtG5ILEDoR37VSIAY5/StomMkdJ8Ozt+IVicZ3QH/0E17rXhfgABfHunnr+6wD/AMANe6E4BJ6CumGx5GJ+MiuRmGUDuhz+VfPcOBEgxwOa+hXB8l89SD/KvntT8gHHLfhWNbodOA+18i2PmAGMjrSOxRGwc8fQU+MYTJIPHSqF7KdwTA+Y4C5rmSuz02X7UGUjsOmO1bUSHYM9PQ9qzNNULgEZK1q7+AD16mk0UWY0+Xn+XapRtycD5gOuahUgdTg/WlLKvLAZ7e1JIVitcktIMgFR2zUDIFjAYDIOM4zmnTtliGzntmq7l9mGHAHY46fzraK0NUmVbhMRhgflB2gZ/Wsi6JV2RnDHoD0rX3qqtnBHddvT8ax7xA42gbWOcseT7U7FqN9zDv2w7H7o6EdRWUXJLDsKv3+DIRg59ulZqtvJLDp0zQZVY2RJGSOKlBPQioYgd5Pt0qwcBeOnvTORoCxIPoKjJIGeCaecYAHAqJz7dKaJaI2Gc88jtRGP3ink8ilI4HJ55oX749K0juY1FocFrZxq90B/fNdV8K7f7R4mhBGcVyviIFdbugBj569A+Btv53iMnHCiuih8SOGsrRZ9K2ShY1A6Yq4OoyM1DEm1RgVIWXg9K0Zz2JQcnjrTQT07UisPWl/lSEGcdetMySaVgxJKnB7bhTcnJ7Y7+tNCFZgD14qJyMHNK2PqabnbjuaaEJwepopOtFUKw7PI5PrT1J6cVWWTPepVfng/WosRcl3EAZ60bz2NMzkZyeaXqRjvSsMeZDjr0pd5wKj7ZFL3+tFhjyx9qC59efemngdeaOo7/T0pAKXJPTNCyZGQeDSbRuPP/wCqpAuV7nNA7jRvbjtXE/FmQx6TpsWR89wzH14X/wCvXd7RxjHvXnHxjmAm0iDnhJJCfTJAob0ZdLWaOFjzjB4br9KlQhpR9c88VViYlQCeD+tWoUDsuBgAZPvXFJnuUzatTsVcHGRzgc//AK61YGAC9k6jB6VlKAFycZ9R3q9auPly2DjkGuVnZHY1YZiCAM5PY1ZFx8u0j5vyxVMlgoIGM85zTid6FmOD3yOD7mqQrl+ORc5YBc98dT6e1J5yYwpO7+6OxrMknAXJzzx905H4ihJwDkKSfu7h3Hahodi48gwQpA4zn0NVJJfnK5wp5I96rSTEFl42+o/x9KyvtEzSbcfKT0J5qUi4xLt5IzrgdOmO2a5bUJWIIk5IJ5HtW5K7OTuPzkZ59f8A9VY97Bxk4JPJx3q4ik7FeyLZXpkjsc1sxy4xgHnpx3rHjXaRjJYnpWhC4ZVGc5pyIRoBsoc9O4AyTUMrEnOeRxyKRWCgEcH+Lnmo5HzkAkHGCPWkkDkUpmKu3QHPr0quzZA574BNSzkbyoxu/n71CSS4z3/KtoowlI6HwM+fHmmIvYDIx0whr3dzlwo+prwH4dSrJ8R7fP8AAZOewASvfIlLDe24MTnHt6V0R2PJxDvMkbkHFfPMagzsnIwzZyOvNfQufmr55YiPUblSfuyuOf8AeNZVdUdGAesi1yE5P3eBj0rImLPejkY64PetV87SMqdwrGndknznAJxyKwjuem2dHZyYXpuyMgVcFwdgJK84OB1FZGnzZQK55H8J61fC/ugUJOf4T696HZGsWupejlyOoJOcZFPlnyhLfQCs/wAw4VUXPOee1P8Alc5JB7YJqC0kI2FIJbPXg9/wpmVAYEAnr8wFLIhZWx8o+nNMZFIwW7fTr9KpMvQjdyVGCfoOAayppPn+btk5NarWzyZICgY5G2su7tm3rnqDzntTuF0YWoAvyepz2rPCYDZz/jWxdqGypZhn9aoujbfQD2pmNSV1YpsPLGRjmgyEcYFSsn5Y9ahmOSB3pnOwJ4zTDyQT37U9QD14NNP3ifzpkNgW4Ax+NMYkOD708cU1sZ459R2rSJlPY4bxSCuv3Ge5Br074AIDrUp54AFeceMVA1skdGQV6H8BrgQ61KueSBXTQ+I4K/wn0gSB1/Kmn5hxUZl3EMOnalUk9DgVZzgrkHbyalBz9KrsOc96kViRyMUATduajY4o3dyelNbPbimhAxwM0w5znoKU4A9TQDlcmqEN2sQOcCil3Ac9PrRTFZGXHLuGMgGrAkYDk1UlgKZK9qfDIPut/wDroaOYtrN71J5nXPNVWTAyvHtSK3HvU2GXhL0H61KHFZ+4A55AqaN+nX8KTQ7l0EemTnpTgenNV0fpUitnjPNKxRP94e3rUgGKqK+cjgGrK5I7cYqWgJMgYP515N8Y5Q3iO0iU/wCrtBkehZif6V63/kZNeL/Fhw/jKdeGKQRD6cE/1pPZm2H/AIiOWSXgcduK1dPOWXB5IyB3FYqkjHTI9+1a+ngZQ46VxzPaps29rLgAqRjANWbONTw2COcevSorQl8HdkgZI9PSrcLMCDgDv+P9K5mjqT0Le5FUAHgjv61FJKXlKrwQMkDp9afD82VPy4PHPWnmPB4GfU4/pTWgJq5GY0mjJy7SE4JPTH9PwqB0CxNuJbjjHPfp9KuhsZBQdOvaq8nzM+MgHkqOtO5SZUdAW2oTtJ9OtNNqC5MZG0D1qZwokHXGOnp71X88eap2nuAO/wCApWNCK4QKSVG0Z6/pWNcyqpGOoPf1rfuthjBJDZ6elcxfsGZsDawyB2qoondEURYyYwSemBVwNsi7hjycCs+MFX68Z5HTNPnlATO75j/OrtczbNKOXcQFzgDHX+VRvNg8AdeMdaowXIVQC2W9acjbmJ9T2oUTNsc/VsZ5ogHmTqpPy7h+FRu3yj070jTC2srmc4HlxMw574wP51pEzmzqPgdpbah4i1HV5f8Aj3tiyL/tOx/oB+te5k4HNcd8I9J/sjwDpquu2e4U3MueuX5H6Yrr2OeK2Wmh49SXNK4q/erwDWY/J1y/jzgpdSgD/gRNe/x9sV4X42iEHi3VVIxmbf8AUMoNRNaHTgpWkyj5m6PIb+H8qyZhvVT1I9TV5GJAA5zx9arMoV2GAADjHpWC0PUbLFhJumTI2kfLz3rdjkJQheWPOO1YVuOODz69f8mtCKRCgwxGKmRcWXAu4rtU46CpdhwCuBx061HHcKxCRsCfU9KkQjuAfp3+tQzRSGMCxwCDkc5FPtrZIwQyr6kVIXVAT8pHXpwKeOQNueOw4/nTKc9CRtkQK4OO3asfUHHOAMD9atzuRG3JPPQ9qx7uVirAA4HTHGKNzNaamTcrgk4GOwFVGVgWOcr2H860FLSFjgHHeopI/m4PPqatClLoZ0o+U4HB7+tUZRt4zgA1rzR4BAHFZlyQvQYAHWmjJsrBvWnrnP4VAuAezduKmB646d6ozbBuMY49/WmE+1OZv5d6jJywq4mU2cv4xTGpQP2MYrZ+Fl79l8Rpk4DD1rN8aIc2jnupFVvC8pt9WtnXPDDJrqo6TTOCu7xaPryxm86CNhyCPyq2nPTJrC8LzCbTYm6jbW8vToK2mrM5kxSORmlQgfSmk+/FKD7cdM1I7j+KQn0pvI47etB7E0xXG55yOlIGwTzlqHOCeaYPbvVIVx2FZlLLll6E9qKcBRQK4joMYwM1WeAHJ4xVw4zzwKiOOeKhMwKygocHkfWnNEMl1yc9qfgf40seAcc07gV8bakTGcHip5oQAGQdetQY5I4zRcZYXiph2B/+tUCDH0/lTugIpDQ9SPMAzj61cjJ2qQfzqgn+syBV1Pu/d4zUsaLC84968Q+JZz431HgfKIxx/uCvbFz0x0/WvDfiKS3jjVs8kOg/8cFS/hZvh/4hz6nB3ZHHtWnYMAVPGT0GazdoIGePc1ahkAKBuoHXsK5ZI9eDOlgfhW6LnBPsB29604XVgOMtwMVzEM2TlH2HkcnjP+elacNyBHuOVAHp3rBxOpbGwhA4HU9Qee9ToRxuIDDnOc4rEW73ksVG4DGTVhJBMG++CR0B5Of89qFC5aVzQaYNkLIWycfL3zVG4ZoMqc7ur+w9/p6UrMCil42IRSY3zjHPf8agDLwH5HBAA+96/WrUDSKQSBpFVs/MTyGHzZ/wqtdfLyDsYjAxkk89qnmctODknBJy3zEY+ntWdfMj5YeYoIyrdDj1Ge3vRylxepHcagscRDcueMYBz9QKwpZTK771A24B+bgnPH0pZwyhlLyOVyQWx65/EVSmkUKdoAPPzdzn+eKpRsOdlsWvNdT8uCOAc9aZN+8hU45xwSOKpxTAxlSRgjPuPx9amik+Ug/dHQDmg5Jy10Fts7ssR6CtANj5cAbu2Oaz4sCLbyM8+1WN+5SF5H1/SgyuOlmI3gN3AAx0qZ7V9QFjpsXMmoXSRf8AAQQTmqcZ8yXOBkcYrtPhdp39oePxKwDQaTAWz28xuP6n8q0ijGtO0We4QxJbwRwxjEcShFHsBgUZyaVj2NInOa0PJJVrxz4q2/keLDKw+W4t0YY9Rlf6CvYxXnHxlsybbTL5RkI7QsfZhkf+gmk1dHRh5ctRHmqEqwI24/rSSEBwRtJI5zUW7oSR/jQGznIAzWDR6qZItwY+QKsw3KAsmYz0P0/z6Vkzvtb5T9c+tRJcNtChsdwMcUrG0NTciu8SbFbnPf1q9aX6vEysSW74GMCucZo2Q7R83XGePzp1vcsHITgMP4u9Tym3KmdO02IwDhfQsetW4512bt2R68VzEF3H5e0M4IHI6ip47/EoG5BxnaO9LlE4s17p92MMAOvH86y7gKAzMT6+pzTTc5zgqc84HX/9VVLi72r8xBAGcnvQoMmz2IJmVVYg479aiEoc9c8VmXN35z5UAr6c/nRDcBSFK4/2fWqsKcbItXEwxgH61k3Mmc84Pf2qxcyIWyX+XHGKzZZgXOBnkj6U0jnbJ4hxhiBjtShsE4xRH90k/lTuFwT06cUzMM8Z7+tQydjmpnPGfxqN+VP51UTORj+Ll3WNq3cORWJZNsljbONrA1veJctpEbY+7Jiuajc8dq6Ys45q59S/DmfztJjPJyoNdmDwc/oK8x+EN2ZdKhG7jGOtelBiQMV01N7nHDYf/F0py9Ouaap7nqacKgoU8009qcSBk9Kj3AAihCYjdeo+lNyOgPNDnPemhsEBFz6mqJZMvGMjr09TRRGDnnOaKAJW+YHp0qDOTz6VLuxkYJ4qNuSD7VmZkTHB9DRu+ankZGSeaicZ6NTFYs28u5drYNNliCMfQ/pVTcQQRwfSriSho+e3FAxFHtSnjj8qbx95c4pN2eMGgCRB8/GavRcAZ4z2JqnEDu981aBxggAc/WpZSRMOf4uR2rwrx583jbWOvEwGc/7Ir2wzFCcDAzxXhvjJvN8Zaq4G0mfv16ClJWizfDL94ZRJC5x7YHao+NpycE96tOuIycFvTNU+VLdyPUYrlPWSJkkKgqTnpgnp9avQTGONGLDJ6jGfoP61khzvwWyMYX/9dWrOT94A4+YHeQB7fypWOqDujoY+TvSRSrDJwcHHpV1ldtrQxSlgctsOAvsR3rHt5ovI+chSCFIVQQADnjNTNLGFco6BQO6bSM9c564pqxqmaYYRQ4SUNkbyTkZPcHP6YqqbhQGjGcMvGW/Gs55nkjjO87F4jYsULD1OMiopizsMEthcc5x70mO9i2lyqmdg4YgqFQd8/wAWazrq6CybhgDJ+Ut0OePy9KikOGIHysePl4wPUVRnwZQCBxkge/f6ZxRoJVEmOu58nJOSDlmbjJ65xWXc3AdCAMrnjipZJJHLMQOu/aB3zSSRIZWK5O85wDyO9JsiVQhtgXjKsM4OCPTnirsYEYIBHv7UxYguOw7/ANKeV3bjgjnv+hpGLdyQHew9OtWDgR5UfX2qCBSQODnj8KcX3D5Qe/b0pohkkbi1R7hwNsa7iPU/wj8TXsXwQ0o2PhE30wPn6hIZST1KjIH9T+NeNR2Umq6zpeiWvElzIrSH0B6Z+gyfyr6et7eKxs4LW2XbDAgjQY6ADArWKODEz6Erct/SpFGRUUY3HnPTvU61RyIUe9YPjnT/AO0/C1/CF3SInnRj/aXn+mK3ifwppI6Hp0IoKTs7nzGJP7vPegv8+A3PetHxRph0fxBf2eDsjkJTP9w8r+hrHbA5Xr1rKSPWhO6uF03BA5B5IqrG6ggkMQTg5qaTJHPXvn0qlKWXiM//AFxUG0ZWLTzhThSAx4zjpT7chhGCwaTocDr71nCRN44bcenOB+Iq1BcRbirDLZx93OKZ1wmrGoCFJCspJ47ikk+cEExlF7BSMmqwlO35SwDdcnqPcVNFI4zjBzjPpj2qki+Yf5dwYS6r8oAyc/4dTVa4ba/DGQYBHTHvV+VonQoqBnC4AVyMH3//AFis2QhkCoQSpJ24PH9KbRKZnSEggM7MoJIzx+gqEkoCN56ZwRV2YbFbAYd+cAisufJJ2ZI5BPvUMmbuiO4kwHUr8wO761BHgDdgYY9aWR/lO8AtjOR3ptt93pgE4/Cg5Jl6EsMHPGMe1SrkEr0qNMMyhQMDp61ZQbgMj6VJCRCzfeHSoWbJ98VZlXJOQBiqz+oHSrRnIo6+A2iS88hwa44Pzyea7DVsnQ7ojGBjP51wyv8ANW6ZyS3Pof4IT79PQE8j1r13dnJ/WvD/AIDT/wCjlW5AJFe2qecd66pa2OJLcmQ8dPpUg6e1RqPw/Gn5H1FQULzzkZHvTHGeTwKdu9ufWo25J5z7U0IaxBPH6U5fpn6UwHOelSqD3qiSRSTgDp1+tFKuBxRU3HYaeme3emE/SpMce1RsB78VJkIO49ahI29KkPXjr60Fcr/WmIpynGOSKmtJAPTaeuaSZMjH5VUQmOTI6d6rdAaIJjuCM/IwzTtuJMDPXimD/SIeD+8XpT7ZhJlXyrjr7VJRPECR1qbOV7fSmplF7ZxQx3DkgGkNCMo24LEe1eGeLwy+LtWB6/aD17cCvcQcEY59sZrwvxYf+Kq1clix+0MASeSeKU/gOjDfxCK3QMqjJJPHWormDDA8A+9WbHGACfm9PT2qzcRbiASMr6dq4Wz2EjFEGTljjHPH+etWAFXoeTgkKKsbOcH7uSfWpmhXbhyPn4+XrT5iloZ0hdFBByuMBR2H+FSSqUg+Zsbjx6n3qR49u0bSM8Z/wqvPuUuWBDgdDTNk7hFPPOXhhiK/xgdAfXip1kyjYzkLzg9D6VXtBN5rGOXYQD1Yr19PeqO/ypTH5pIHQ45zQ9hydy+HzCSTlvrVYsFO7aGJHf1psbb+FBz2+vrTzHuZjnnOB2xU3MWyF23Bh3YgE47UxVAm3MBg/rV4QgDkkEcCo/K2rxjOaLk2G+XyueT6Y6VMsXy89cnig7VwRye+KiuJMgqvDUkDFBCocE7iOaYhBY7idpBLn0UDJqIMdpHb1FVdUm8rTioJDXDeWMdSo5b+grRGUnZHonwH046lruoeILhPlhUJFkdHb0+igfnXtkjZPQnPGK5j4a6R/YngjT7dl2zSr9om/wB5uf5Yro4wXbH41ulY8qpLmkWYgcVKOKZGABmnGoJQGmMecd6VuDzwPr3qKU844poGeY/GLTSs9hqiL/rAbeQgfxDJX9Nw/CvMpDzwpBr6D8X6WNY8LX9mqgy+X5kXs68j+WK+fByctnJ6ZqJnoYWV427EH3HySSv1qC4j4LIcAjv/ACq/5GVJY4wegpkiA8bT069M1nc67GNKjqGZe3X6+tIJGjXII6Y5rSkh8tyRxnsKozxDcxGMnoKDSErOzJYZy7p1IIxk9QatRyABgxHbHA5/OsWECIbQWB3ep61c+cfOr8E5HH86aZ0p3NRR5kTJI0mxeQ2SV/EL1p0dqYMGRgQSNu4YB/DqRUEDOh37Aw7huRj6VZGFwpkB2jcCcfMPQf8A16vzBvoV7tI1OYyWJOM45H0Has5lRUkXGAT3PXHer97iQkjhd2QSfvenSqUgHTnjrxWbepMnoZUqjzNwBK/1oTIIzjtzVmbaFZThdvT2Jqa0gDMS3QjpSuc8tQhQsvuPbtVxCe44FPWLYfvc49adINgHAANSKxUucFQOnNUZTwc9fWrkzckHOR0qjO3Uds9K0iYzKt4C2i3iYydhNefKelejqC8FxEerxtgY9q86IxIwxg5rY5JHs3wIlw7qeAGr39emTzmvnb4FSEX0i5ONwPFfRKDoQK638KOLqyZCAM+nYU7jHT8qjXdkjipcZI9vSoGMbH4HrUZ5JA4xUrDkjNRN19/amhAvykd6nUepOfeoV6g+1WEGME9adxDselFPUE5GOaKVwK8MwdAe/pTnAwMc1iafd5C8/nW3G4YA9qTVjIjOR2/CkHJzjipSOOO3rUajBpARyjPvVKVeTxz6Zq+4GQTyOlVWHPPf9KpCIrWRo3yvBXqPWtLYGKyp361kspSYMPu9fpWnYuAuM5Q05DRZSQ7cEDjmlZsjjb9aQxjgggCmsCpwSCfT0qCh6sQysehPbrXz5qcv2rWb+cEHfcOQfUbjXumq3X2TS7q4wD5UTsM+oFfP0RYlScZPzH8eamo/dOrCq87mtYnjHQ9zjtWiq4UqflH+NZVqp69VH5VqwYZT/P1rhkevEb5fzDAwOlPRRuADcgZORxj0pzoQ/JyopxGfu8g8H2FQWOaMMNw9enp7Vnzwh0XcuCOcZ4q/v2nBxkeg6VTnO5jnj17VSYWMyQAp8wz6kcVV8lS2do74z6VoyxAIRxk802OBT90AmncZDFAucKDkgY9qtRwqpywBXP51IiBd2exwSKlZQGJyCuOOf1pXFYrbBsLHknt6VWl4z3bpirDucZBIPb3qnI2Xyc470AV5JgpIx05qJ3DHAOc0XByzEDHNV1boO/eqRmyxGCzYXOWIWpNDsx4g8baVp0XzRK6o2fQHc/8AKmQbQwZidi5ZvoBnFdb8A7AXmuanq0y/6mPapI6M5/oBWsFdnJXlaJ7pKVXCoMKBgD0xT7Y88nmq7cnru/DrVuIAY4561szzixnHApu76D3ppbng00H1qLDHlsDPbvVUtmUj3qSVwFNQRc85PBz9faqQFtHIK8e9eA+NdOGk+Jr+1QERF/Oi9Nj8j+o/Cvet3yglvxrzr4x6b5lnYasinMLfZ5T/ALJ5U/gcj8amSujbDT5Z27nmaj5QGB4/Wh1PBPPYe1EZBHP5+lSggKfrXOz14sryxhl2tn1/CqM8eTgjnOPcVrMgKY6c5+tU5osZYn8aVx2MiSPkgAHPTnFNhl8qLPJOeVNX5Yt69iB3PFVQqbguAQM9sU7mkJEsTqpB3Yz90+n4VJchXIkXcRxuz/PFLHbqwUnBCkVpmAKN20bMflRctzM5EyzMQQg49MVXntjndgBO/Na42jK/w9Qf61UlYMCMDrzSJ1ZnrahyCRk/SrEcYMZOAMelOiA3FecdjU6pwcDgjmkQyEqeMdPWo5iAvXnHX0qyU4OMkD9Koyt82TnFCQmVpuHXPAxyapyDaxJHHOD71bn6/TiqM5IAycjPPtWkTCauLbk+crN1ziuC1WH7PqU8eOjmu8j7bhgD0PeuZ8aQeVqolA+WZQ4rU5pI7P4GyBdZkUnuDX0qnTg9f1r5b+DUoTxFtPQgGvqOHHlr9K6/sROFq0mDZ3AipYzgYHXvSEfnT1wMVIDJMnnqKauG5/Pmg9wTkUsY7jr7UySRQeOnH61KnHX/APXSehAFKB1z1pCH56YGM0Umcj0xRQBwdrOUb5eo610dhdblA7H3rm7m3MTnGR6VNY3JjcAnitpRuYJnYhhkc/h60jjPI4PtVK0ulbapJyRnmtAYI9ax2GQdCf51DKDxkAZq1KmR8tQH5lyck9zTQFI8NjtVm2GOhqLjIz0qeEhQM8ZpsEXUbjjOPen4zjiooz1BHFO3cdCRmoLRy3xLuWtfCV4EIBuGWHOccMeR+hrxyMZfJyBXonxgvQU02xUg8vcOoPXHyrn8zXn0YDsMnr1rKs9kd2Ejpcv25O35SCRWlE2SCOuKzoAd4GMKOo9K0IRzgDg9ciuRnpRLEalgVH3RwR3NTLGxGCMEf5/KkQ4Gep6DPH41YxhflOenQfnUGiKhRnYkYzjofX2qCSI8BhtJ5PrWgQASeTgcVXmUB2LZz0Ge1BVjNeHoSMZ5zTVUqCMfXmrREYZ225L43NnrjpUbZwxP3SOaAsQliW47+1NkAIPJJHIzT2YDhRzUTYUDccjqcVSQmRMMHnAGPyqlOx+YdAe9TySZyTwD6VRmkwrkt8vrTIZXuX+Xap5A7VEDls9KXO5hnq3QetKoy+T34zVIzbDUGEWl3LE/M4EQPoSf8Aa9l+CVgLPwWsxGHu5Wk/AcCvFdZUm1togPmkcn8sAfzr6U8M2g07w9p9qoC+XbqDx3xXRTRwYmXQ1owWfBFW84UA4qpB+JBqyeeucelUzjFJ7cUmWBz26U3IBHr601m4/rSsMjmYlguP1qRB8oyMCoUAZjnOOlSZ4zjtxkVQDweOMHv7VS1nT01fR73TpMj7RGUVj/AAv1U/nirBPHLEnrwKAM9Gbn3osK9tT5xUPFK8cyFZY2KOPQjgirCkMc5/E10nxV0r+zvEgvI1xBfjzeOgkHDD+R/GuTSUKFYfqK5pxsz2KVTmSZdJCp7jr9KrykZA+638qlRsn2xzVabIk3NyOhFZM6EweMMFAxt7e1ReUUGAOPU1ZCkAEccUpG7OeP8aQ0RIqh8jj39Ktq6h8E4XoTntVJ9wYYI2jr7VJHCzfM2WP86C7Fm7j+Vdh4PQ1nmFwSEAz3J71qwuNuyQkLnOcZ/CmyxID8hBA6e9MLmckYXrk1KRhc9MdqkOADxg+lQyMSenJ/LFAmV5n5ODzVSXjhiDzyatuoxzkZ6VSlx0H3aERIgI+bdiqc4DFuMEVd25OQD+FRTryMckirRkysq4YdB3zWZ4xt/O0qKfq8LbSR6GtgqD8wzxwRSzW63djcWzc704+vatUc8zB+GU5g8UW2WwG4r61tG3W8Z7EV8ceHC1nrduTwUkwa+vPD0wuNKt2PAKCuqGsDhqK0zSHTAA+maJeRnoPelShRlqCGMCEmpVXB609VGD6UvGKLisIB1xSg8ev1oyMkU0nHOc4oEKx4z3oqB5O360UWEZV/ablIGfasCaLy2KkYIPWuwlUMMEGsjUbQOCRjPatYy6M59inp1ztYBjyPeugs7gYAJ49a5BgY3+la1hd5GCckUSiUmdL196rXMZXMiD6j1FFtPuAUn6VZyCo46VlsMzcg4IOQalQEYIGfxpLmBky8fQ9RUcMgfgHBqgLyE7euPp3qTDFenX36VXQkAYGPWpTOsUbO+CI1LkH0AzU2KueL/ES7+2+LrwK2Ut1WBPw5P6msWIfd2jPv2qNpzd3M9w/LSyNIT1zk5qzbgnaeMd+1ctV3kevh48sUi5AMyhV/M1fwNpVTgE5yzc5qrCuSo5x+VX4VG8ZAyT1rBnWizbRktnIyvc1ZUDcBjj+v1qFAM7WGP61ZTJAUjIA71JaGZzyBg9fbPtVaZCTkkDB5Gc1a3jaT1z0x61XlbYpyeKGikzNmXY3y989arM7AEYzwc89KtXLjcdowc4qm7ZHB+UU0O4xSQwGTuHWoZ5ASMDgU+RkA+Ukk8/hVd2yhZjxmmS9Suz5yCO3TNU5TuyW6H9att3xx7VWlwT7gdTTRlJkLDOfbt2FPVQM47nj3pQCGAHfmpI1HHTGeDVGYtrbG+8W6HbEblZ13KPdv/rV9L7QoCcEAba+fvBcAl+JekBhlY4t/HsDXv4J4x1Pc10U9jz8R8RPG2RwD+fAp+ePmP4VEoIHTP8vyp5GCe4x3qmc49iAuQcdvqagZskjoM8880krnbg8+lRIMnt6UIZZUY579qdkYyScdeKhYkdME9KhZj0GfXg0WEWyVAwTz6UmAe+f6VRJkzjaVHoDkmmFZfoPQU7AUPH+kLrHha6SJQ91an7TCPUqOR+K5rwmJssfmDA19Cqk/GOF7g9x3zXh3iXTDpGv3lpjCxvuT3U8j+dZ1I9Trw07e6VIWJ+Un8alJB/3vftVWMng1OjZ2jvnIrmZ6MSdFIXGef5U1lwWPehGx157U88nOMZ4z6VDNUQKuecZA7Vct0wmRgY6e1NiQEY2j61YRd3HJPXHQmpuUBUevHr61JtUodiFnPXnpUgwYzlQCeDk9DTAuGBHrz70JiKMyMHKkdOeKgddyjA5HStPA3OXygJ4BHJqrIm3JC8Z/KmJszmA4xg5PJqtKhyenPBAq86Acdveq0gJc4GQaaJZTkQgfKOOx9KrzqcKR0I4PrV2QD5gN1VpgduM5welWjJlXP3vcdKfA/wA6sBjb1prgkYxjng0iZ+8MD69q0izCaOZ1eA2etuQMIzCRfpX0x8Ob0Xnh23OclVAr588Vw77S3uB1U7TXqXwN1MT6e9sx5TjFdVHZxOKt0Z64CM4FSjA7VADgZXGfSkL8ZPWqMizuGaaWxnJqv5ueO9QtMQeQaLCLZde1QTTIh+du9VZpzn5eB61Vkmx0AJ9zVKIrlx5jk4zg+9FZzzgHAwc0VSiSbuR7c1HLGCCMcelCHoamHIrMxOb1K0x8wAH071lxuYXyp5HUV111FvUjAzXO31sUPAz+FbRdxLQv2N2JEHtWvDPuUZxxXIWkpiYf3fSt+0mDDgg4qZRKNcHIqpPAR80fBqWFwepqbGRxWadhlOGXnbICG96o+M7v7F4Q1SZThjD5an3Y4rUmjVuoBPauK+Kk7xeGYLcHia4UN7hQTT8yoq7SPL7cAduB6VqWpwRuyR2rKgGCD1rVtAHJBPHU+9cMj3Ka0NGFAW3ZwTwSen4Vct9yOQowaghxjABPoBVyKLcMAc9STWTNokwweSAewA71KAMDBIb0FLGhO1QMAfkaEG18Ae4pFodKCqdscc9MYqjMAwJY5yOK0HyxwOmOtZ07bWY4OT6ckUMpFC5yOFBwemTx+NUpF6cgDpVqbk/e6+9U5GBJ6cU0xNFeQ/MfXHWq7NkHI4xyDT5Qc5zz2FRSYIAPFNEtjJJADkDOKhA3ZLY/Knr82Bx7Z7UAZZR/DVIzkNUEE9BmpVA4PAPf3oGMg0KBn9aCTe+Hw/4uZZ5yB9mPP4Gvc0yTyPxNeF/D44+Jmnk87rVgv1wa9yVW4yTjPP0rphsebiPiLJYDAHzH19KHbjJOMUi88j/9VNlO1CG9MY9qZhYikYlhjGKfHkADAz1+lVkAbBPbpVgdBnIFMbJCwJ9vUUu5Rkgf/XqNuOh/SkOcHGBQKxKWUdRS7h6Ae9QZwMdT60o5AJOAO1AWJt/90fia8u+L1oF1GwvgD++hMbHHXaeP0NembyPuD3ya4r4rxiXw9byDJaK5HPT7ykY/Splsa0NJo8oQfLkD6j3qWM4JI5FREsqH07U4f7J5Fcsj14ExJOOf/rVJG5PysvI4PH61GiqdvUkc1LEOcgkE9Kg1Ret2zJ0HTjjpVlAF52jLd+9VEOxdwB/D0q7EpY5HPHTNQxgyKzDPGOx70OFyAucj9KmkQdVx7806VElQOG2kHG0ChAZlw7BiGyMngnmqshwWBwfxzV+VMn5OGHOT6VXlhPmfd4PtVIRTwf4hwKgkGRnjGMcnpVp4v4s9qglH7spjHemSyi5wBxndwKrSlQSDVmdcDnpVWROc8k9apGbRUkPQ9DTEGGIPQ80+T7wx06GonPznnj0q4mMkOv4/O0+5hOCduQD7VJ8INV+w+IfKYkB+2ajgbEgV+Q3B+lctZzNo/ihCCQI5evtmuinK0kzjqq8Wj7BWQNGGAHIzUTTL2rG0K/F5pkEgYEMo6djV5mzwB+tdLjZnKSvMCe/p0prPjv8ArUDM3bAqMnt/KnYQ6Vt2QBVcqTjgCn7ckDBqVYiecU9hFfbg8DmitBYhgFhmii4EsMmQMEfjVxHx1xmsK3lIxmtKCUHB6gnrUNGJfIyOoqleW529MirKNnPWpCAw5/I1KdhnI6jb4/eIOnWixnZTxhvQdM1t31tgEgfKeoxXPzxNDLuGMZ4xWyfMgR0cMm4ZHPrVmOXBA7ViWE4YYJwa1kZHHv6Vm0MtgA5HGK80+MUxVtJts4H7yUj8gK7/AHNHwFyK8s+Ldx5viC0QEkR2/P4tUvSLNaSvNHLW5yM4yelalupABxj171k2wzweMVrWr/KNo+YdCa4We1A14CGVVOM+npV+CMbSGJUgdQayoCd2ckEfrWmj5RcjnI4rNmyLMWUXBOO+alQJuHU49P8AGm8EcE5z1zTQWBAUEZPQcHFKwxJ++GHbIBrOuSOdvJznir0rbFJwG6/hWXOSzyM/Tp9aCrlOdwcjsD196pS8ZGTxyc1YlycjjPt2qnMSWJGMdOtOwXGPy2RVV85PB5/nUwzuH+c1DICGJPWgkaxG3oKTB3EE9DxSYyTnvSqpyMnOPyqjMl2/KQelGSO3Pp7UjcAep7UIc8Z70CNXwi/k/EbQGycOrJx3PNfQMa4GWHt+NfOWkT/Z/GXhyQY/15XPrz/9evoncS3vXTD4TzsQveJ+vcZ9KqXT8Dr7mpdwAPXAqq5LSd6tGA+IdzkDsBUwOeCcevFMTgcd6U+nSgTH9uMD3zTDyQaTgYA5pDy3J5oEB6kAcjuOlOLdCSOeKjJ7Ac00cEk/Mf60Bcf97ndgCua+JCB/CM7AEgTRHP410qqXOW59BWJ8SEx4Ku8nBEsXT/epS2NKb99HicmASBmnITgEck0Hl845xzmhMZ4FcjPXiSxtwe+e1TRH5sdz1qqThjxzmpocnBHXvWZtE0YQQRg5Hp3q0Zdijb1/lWdGSGBWrAbjkEn1pWKL6vujABIOeKeocAMcenB7VURixVV4xwRUwXAUE5X2/rRYVyTZ8vAAUdz1qCb58fLtAHHtVkEFD/DxgYqrdA4GT155pk3Ks4AU8jnmqWMZLc5q2zK3Utg9c9c1WlOAeDn3qrCKUyksdvftVOZeeMircmBzzn+VVZzwc4+tNEMoSZU9eTVV8bgc9asynIOR+NU5m4H14qkYzAEBxk+2a5zxhGU1GKZekig5963c8Yxkis3xXHv0qKXHMb4z7Gtkc0kev/CHWReaKsLYJQY59a9GXecHt6V87/BXUzDrDWzNwxBFfSMEZKLwBx1Fdt7xUjg2biQmEnr396abbJGCa0VjHHH50uwfSp5hlGG3IPXn1qcR47VOF4zikale4hoUYwBxRSMSFz270UxGFGoU8HmrsEnPJ4/Kqm3I7U5CMj2q2YGxFIGAweanVxwT+tZUMhGOn41dRiy5zmspIpFxwGXmsbULPKkrWshO0enSkmTeuCBzRGVgaOQV2gmwenvW7YziQKTnNU9StPlLDg+1ULWZoZSCOBwa1autATOqUqy85/rXjXxQJ/4TCROm2GP34Ir121nVxkEDHWvGPiVJv8a3xGfl2LyPRRWM/hZtQ/iIybUjdzWrbH1x/Kse3OdpGea07ZtxGMZzXCz2obGxbkYJGefU81diY7cgn1x6is2IjPy4xnvV6BtygbyMelSa3NS3fdI3BzjIx2qSUEPzuU44JqvbvlwBwcdff0qbOU5PX5st3osFyvKdozkKPfrWbcuQOD8ufxNXLltvG7APJyM5rMuG5OM89fWkUilLkA89Kqbgz49OakmYjIAzzxVQttYeh9utIY/AB46E/jULNj15pzMeSCDmq7MeM0yWOXtxgZqRRgdT71EgyN3HtVgYbaAMd/amQg24IyaB96mynaQKXJz7igRXv5Db3+i3A6x3Q5/KvplNuAwOcjI96+XPErkWNvIp+5cK3P0NfSWmXXmaVZzE/fhQ5PXoK6Kex5+JXvFueTaO2TxTIhgZPXNQKTJJubpVlcjjnH0rU5iQYxQeMdFH86Tk55wDSbgo7k0CBSc/KoA9fWmyHnAPPdjSSMdpLtsA61Efm+6DgdWP9KBDgwzhByT17VMiDGWPXqKji5J2fnip1bA68DvQBMuFHUYFcz8TXA8G3AHUzxDP4k10IcZ5Oe3Ncl8VJSnhRRu+/dIMD2BNTLY0pfGjyOXhiCeTyaavAPrilYg85yfQ01ySPl71yM9hDuSxxwD3NTRNwEPGP1NQqxZOnzLx+FPUAHJGOeCe9J7GsS4jHIwOfXNW0bgnIIUVRjcBTycE9MVKc4BBxnoDU2Hcu2rAnp8wq0SXJYkg+3Aqhbkqp65/rVxSCCCDz1zTsJljadwwSpHXFVbp1yy54HX2qQyMI8DoOQe9U5WJj2twByMmqSJKjNz+PWoJjwe565p8vcA557VWd+MHGelAXI5SN3OeeeO9UJT1wePerT8FjwMd6oy5JOTx1p2M2yrMwxjORVJ+HyeasXGc5qjNJke4qomUhHfDg55puqqLjRLgY5ADY+lQs5//AF1NCwkt7iPrujPBrVbGEtzI+H1ybbxPZsDjcdpr7A09t9pE/qoNfF/h2TyNctG6ASivsTQJlk0m3Ib+EV1Q1p/M4KmkzWJGADTd3X1qJn4Izg1G0gzyaVgJGfA5z+HNRtLjoKieQDPINV3lBOD2qkiSZ5u2cg0VRmlbouM+9FXYQ0Nlc9qQKN2cdTVW3lOfmI9uatblI4OTQYEik/w9u1WoZMkDOM1SDZHX/Cnq+3mk0UjVRuAMmp13DGMCs+KYEAH8Kto4NZNFBPFuWsDUrMqS6gge1dJkYxxxVa4iDocd/WqhKwmc/Y3RjYKxHFeT+O5jN4s1CQnq4/kK9Wv7UxMWQfL16V454tf/AIqC9LEk7/6U63wXNsP8Yy0bIGcVq274281iWpBXgjFa9s3BPJNecz2Ys1EbIxnJ68Vfg3KBtAz2APSsyAjIBx+FaEZI2kLUo1NS0IXaZN2R1xzk1Ydx5ZGD2Ix0JqrbMQhYL+PepmZvKydq460wM+5kAyRySD1NZc7nAI6d6tXT7iRj5lJ6+lZ1w5U7enAyaVikQTtlvl6VWbPIOOfSpZGBPGBjrkVCW56ZqRsjbjIP86hzubI6etPlYFs9O/41GnG7HFMhkwbHC8kdvWp0bC4zmoEGADxntmplORjAyaYDXwfcD1ppZScetErfjUXmYPNMkq+IstpTj0kQ17/oTN/YOlIDyLZCfyFfP+tndpUvoCp/WvoDw2m3RrDjn7PH+Pyit6Jw4nobMS7VIAGQc1L0Gd3J9ahBzjk81IACBnFanGPz2J5prNjBC8dqYzhfugk9OBUZkcsckBfQdRTEPPJLDB7Zb/ClXhu7/oBUSt83zc+lPTnJbhR2WgCcHnHBNOznp+LNTE/2VG3tmpMZ+8Mn2pDEX0AzjvXE/FyTGj6bED9+dmx7Bf8A69dzk4PyjjtXnXxfkIfSY8Y+SRsfiKifwmtBe+jzh/RqAQOhwMfnTX+91/8Ar0ucZ7NXKz1oiK3lsM9DxUytufAGAO3pUUnIBxnvQG+bOAaktF3OU+XgDsKcu5QjZ5XpVdH4PXHGamjYZIPUjgetAzQiZHA3AD19M1YUqNpxnjkKcis2HGOeB6VYjOGGMZzVJXE3YvOMgcgDvntVOUFkkOOnerEjlRuB6jHHNUppCSM5PGKdhXK03yg4IyR271Rc8H+dWZWxuIIGOnFVJWHA744oEyKZiAOQfaqcjjBA47YqS6cDK9SO5qk8nynOM0EMhuGyDgc46VmyNnOKuTtl+oOeOe1Z0xO48Djj61UTORDIdp44/Gp7VyJgPUVSlPP8jS2cn79BnoetaoxkYMT+TqYPTbKD+tfW3gu587QbcqeAvUV8iXx26hN/v19P/DGfzvDUHso/lXTQ1i0cNfSaO3aTaOCPpULyD1xmoy3HNVpHHrmtEiCZ5OOtQSygEc1XduPvEmoJGTI5JNWkImeck8c0VUeT32iinYV7FbT71JlVgRg962EcHBrz6VpNLn3IS1ux7fw10+lags8YO76c1LRitTokYE5yKAyuSeevU8VSR+MKeB2zVhJAevHFIZOsmM5HFXYJcgc4FZrEEd/anwylScnjpUtDNmOQE4qXqDkVnRyn/Jq1DNuBBOD/ADqGhjbmAOPr6V8/ePFEPirUI8cCXp+Ar6H3A9enTivnz4nKYvGmojGMsrfgQKU9YGtDSojNs3yBmtW2fJ5zjpWDbSAY5J+ta1vLyp7gVws9eBswycgA1djk3Lhuc9cmsi3ZiRz3q/BwMDp15pG2hsWzyZKqTz/FU07/ACYz82OveqNrLhuefWieVhkMAfQ+lUhNkUuArE8kdBWZdNuG4jjOcVcuWwg2n7w/KsudhnkYI/WpZSIZOT8vU1GXwegx3p0uFQP69arhsDIHFTYpsdIxYjavTkmo1BYc/nSl8j7x59aYjEKARyetBKLIztGOnpUi9jn86gY9g3btTlbj0780CYsmOfXpVfPze1Pdj6k1Ac5NMi5Fqrj+zLjsAB/MV9BeGJS2h6dtHBgjOT9K+d9XbbpNzjP3QP1Fe/8AhIMPDWk+n2ZP5V00epxYp7HRKwK8nFPLZXC46cfWoYzgEnqe9RvNglVGD1rWxxsldmI+9gHuBUQK5JUAnuT0qNj08xmYnkL05qSNSfv/ACj+7VWsIlUGRcgkL/Op0AGNxyey1EQMZJxjlRmplIBwFGfXNSwRIpJAO38KduPGRjPvTD0ycn8aXjHQ0hj856HOO1eX/GGUf2tp0ZOAtuTx7tXpoc7civJvi3IX8QWq9lthx+JqKnwm+H+M40N6YprtgHk47Zpm7aD15okc7c46frXKz1EO3sBxyT1ppft+tIxyQDUFwjPHiFtjdd2M9O1SXc0VkG30x0FSxjA3NnHSsyJiSCT055rQifKjceFGcDvQh3L8b7enQCp42BAOBkfyrJilYuSMg/zq1BIxOcHjjHrVolmi53kDGTjg1QnJDHPbsKtIxCnJwvTmqcx3E84P86ZN7FaYktyRVOaTOemB3qzJjB3fnVC4zknOO9JhcrXDZwexqlI3yk8VPM557Vnzy43dCB3oJZFJIDkA8VSlbAOeSe9SSOOpGDVGaQADrWiM2MmfI6Ej+VNt3xMD6GoZH9TxSQPlxzWkTORl6mf+JjN/vV9EfCC53+HIVGeFAJr501Js6hKR617z8GZE/sKME5OMYNb4fqcWI+JHp0kig8nJqNpcggelNVvVSM0j8k4z/hW5kQEnOD0qJiB2H41I5Cjk5NV3kUZB9KpCZFM4xg8CioJpQF45op3sKxkB1mjaN+/asRZJNLu9yZMRPT0rau4dp3rWbdEFORn1zSaujCO9zq9M1BLmIEHOa1IpARXnFldNY3OFP7tjwPSutsbsygYPJ71K7Glup0PmE4OeacHwTVKOXKAjvUokHJOSfaiwi7HNj2HXFWYpypyM8Vk+aAQKnWQj5c49qTQ0bgk3AMDXgnxa+XxjcEdGRDz9K9lt7oDajk7SeMeteOfGVNnilZM/6yIH9cVEl7rNKWlRHLwy4x16dK1LRywFYVs+7Pr3rUtmC464rgkj2IbHQW8nyjPWrsMm7g/rWNbyDaOTz3q3BJnqDjvUo0NyCRcgbj16VLcsdpBZT3IHSsyBjySSc8j29qmeVmUbT29KoXUieXAk5PTABrOlOD/jVq4crgE5zzwKoXLcgFsc9allIbI2AMniq8rDIAOM/rTXkyMfr61AXJ5xUg2WXIPA7DFNU4OMnmmoeD+lG/A5GD/OgETKfm9zwRTucAc1GGBHpign9aAFZsZOaidhxt/nUUjHJxUZcn2oRDIdZfOmy9izqp/OvozQYxHpFghONtvGP/HRXzZqhzHawgn97Oq19LWR8u0gQjcFjXB/DFddBaM4MS9i/vGMDPrxUZdpGO0ZIOM9sVE0pfbnCr3oRyxCoPl+tb2OQsRLg5xuY9yelTgA43kHPaokixjeevYVbSMADgdOlSwEALAb8dOmOlSoMYAxSDA/xpR161Ix69MAYz60HI+6M9uTTGcDGc4xzVe4mAwMEknpmnYB0sgzycV5P8UXD+IYegAt1B/M16ZjefmJJPavL/ir8niKH5QP9HXj161FVe6dGG+M5BmIyKTdlMN07VC7/MNxz6U3ed2MkCuNnpomY4wRyab5hG4j04qMt6Uwscj2pFkiyEuF52+561Z81pH5AGDms9WBPtnNWYpOBnPvQhGlEeeDjjODVqKQDPPI9KzVdckZODU0chYEZxnk1SAv+YTuOeD71Xll6D+91qJpm9cenFV5pCDnPPaqJHSvjoenas+eXnrU0zkKT3rMuJOevHepYhs8gVu4I71mzyZOcY/rTriX5hyaqPIM4ppCY2Vs9s1QnYn6VLNJ1wapyvwTVolkTtgdaIGPmLg1A544JxS25w4781aM5FK8bN7IT617p8GZVGjpkA9q8EuGzcyH3Ne5fB1gNGXPOa6MNuzhxG69T1QSHHB69KZI7YALY9T0qs02MknA+lNeUkfNzXSZDnfOcnJPaq8zjA3Ypk1xtBA64qnNcYXknmncVhLqdVJA/Gisa9utrk96KhsaR//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     Erythematous to violaceous patches with overlying scale are present on the extensor surfaces of both knees in this child with dermatomyositis.",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; 2012 American College of Rheumatology. Used with permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Gottron's sign in a patient with amyopathic dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; 2012 American College of Rheumatology. Used with permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9226=[""].join("\n");
var outline_f9_0_9226=null;
var title_f9_0_9227="RTOG late morbidity crit";
var content_f9_0_9227=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F73580&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F73580&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    The RTOG late radiation morbidity scoring criteria",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Grade I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mild headache, slight lethargy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Grade II",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Moderate headache, great lethargy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Grade III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe headaches, severe CNS dysfunction (partial loss of power or dyskinesia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Grade IV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Seizures or paralysis, coma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Grade V",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any toxicity that causes death",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: www.rtog.org/members/toxicity/late.html.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9227=[""].join("\n");
var outline_f9_0_9227=null;
var title_f9_0_9228="Compare melanoma subtypes";
var content_f9_0_9228=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F57168&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F57168&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Comparison of histologic patterns of four major subtypes of melanoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Superficial spreading melanoma",
"       </td>",
"       <td class=\"subtitle1\">",
"        Lentigo maligna melanoma",
"       </td>",
"       <td class=\"subtitle1\">",
"        Acral lentiginous melanoma",
"       </td>",
"       <td class=\"subtitle1\">",
"        Nodular melanoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pattern of RGP",
"       </td>",
"       <td>",
"        Diffuse pagetoid",
"       </td>",
"       <td>",
"        Lentiginous",
"       </td>",
"       <td>",
"        Lentiginous",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dominant cell type in RGP",
"       </td>",
"       <td>",
"        Epithelioid",
"       </td>",
"       <td>",
"        Epithelioid, spindle, and uncommonly dendritic",
"       </td>",
"       <td>",
"        Spindle, epithelioid, or dendritic",
"       </td>",
"       <td>",
"        Not applicable",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epidermis of RGP",
"       </td>",
"       <td>",
"        Normal to hyperplastic",
"       </td>",
"       <td>",
"        Atrophic",
"       </td>",
"       <td>",
"        Hyperplastic",
"       </td>",
"       <td>",
"        Not applicable",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dominant cell type of VGP",
"       </td>",
"       <td>",
"        Epithelioid",
"       </td>",
"       <td>",
"        Spindle and epithelioid",
"       </td>",
"       <td>",
"        Spindle and epithelioid",
"       </td>",
"       <td>",
"        Epithelioid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Desmoplasia",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Uncommon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurotropism",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Uncommon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frequency of regression",
"       </td>",
"       <td>",
"        Often partial regression",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"       <td>",
"        Uncommon",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     RGP: radial growth phase; VGP: vertical growth phase.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9228=[""].join("\n");
var outline_f9_0_9228=null;
var title_f9_0_9229="Clinical categories TTP frequency severe ADAMTS13 deficiency";
var content_f9_0_9229=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F85772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F85772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical categories TTP and frequency of severe ADAMTS13 deficiency: data from all patients who had ADAMTS13 measurements, 1995-2009",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Category",
"       </td>",
"       <td class=\"subtitle1\">",
"        All patients",
"        <br/>",
"        (N = 283)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Patients with ADAMTS13 &lt;10 percent",
"        <br/>",
"        (N = 65)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allogeneic HSCT",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        1 (10 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregnant/postpartum",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        3 (21 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Drug-associated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Quinine",
"       </td>",
"       <td class=\"sublist_other\">",
"        20",
"       </td>",
"       <td class=\"sublist_other\">",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Chemotherapeutic agents, calcineurin inhibitor",
"       </td>",
"       <td class=\"sublist_other\">",
"        12",
"       </td>",
"       <td class=\"sublist_other\">",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Other drugs",
"       </td>",
"       <td class=\"sublist_other\">",
"        6",
"       </td>",
"       <td class=\"sublist_other\">",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bloody diarrhea",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        2 (8 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Additional/alternative disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        SLE",
"       </td>",
"       <td class=\"sublist_other\">",
"        21",
"       </td>",
"       <td class=\"sublist_other\">",
"        2 (10 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Other autoimmune disorders",
"       </td>",
"       <td class=\"sublist_other\">",
"        16",
"       </td>",
"       <td class=\"sublist_other\">",
"        1 (7 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Infections",
"       </td>",
"       <td class=\"sublist_other\">",
"        23",
"       </td>",
"       <td class=\"sublist_other\">",
"        4 (17 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Malignancies",
"       </td>",
"       <td class=\"sublist_other\">",
"        10",
"       </td>",
"       <td class=\"sublist_other\">",
"        1 (10 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Malignant hypertension",
"       </td>",
"       <td class=\"sublist_other\">",
"        6",
"       </td>",
"       <td class=\"sublist_other\">",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Other disorders",
"       </td>",
"       <td class=\"sublist_other\">",
"        12",
"       </td>",
"       <td class=\"sublist_other\">",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic",
"       </td>",
"       <td>",
"        107",
"       </td>",
"       <td>",
"        51 (48 percent)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Data are presented for 283 consecutive patients in whom ADAMTS13 was measured immediately before their first plasma exchange treatment, November 13, 1995 through December 31, 2009. Patients were assigned to clinical categories based on their clinical features during their initial episode and without knowledge of the results of the ADAMTS13 measurement. Chemotherapeutic agents were mitomycin C (four), gemcitabine (four), carmustine (one), and pentostatin (one). The calcineurin inhibitor was cyclosporine (two). Other drugs were alendronate, clopidogrel, cocaine, ticlopidine, trimethoprim-sulfamethoxazole, and vancomycin (one each). Other autoimmune disorders included immune thrombocytopenia (ITP)/Evan's syndrome (five), antiphospholipid antibody syndrome (two), scleroderma (two), Wegener's granulomatosis (two), and once each for bronchiolitis obliterans with organizing pneumonia, Hamman-Rich syndrome, periarteritis nodosa, Sj&ouml;gren's syndrome, and unspecified vasculitis. Other disorders included multi-organ failure (11) and congenital hemolytic anemia (one).",
"    <div class=\"footnotes\">",
"     TTP: thrombotic thrombocytopenic purpura; HSCT: hematopoietic stem cell transplantation; SLE: systemic lupus erythematosus.",
"    </div>",
"    <div class=\"reference\">",
"     This research was originally published in Blood. George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 2010; 116:4060. Copyright &copy; 2010 the American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_0_9229=[""].join("\n");
var outline_f9_0_9229=null;
var title_f9_0_9230="Contents: Demyelinating diseases";
var content_f9_0_9230=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?0/63/1022\">",
"       Neurology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Demyelinating diseases",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Demyelinating diseases",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Immune mediated and infectious disorders other than MS",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/3/26681\">",
"           Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/59/17336\">",
"           Progressive multifocal leukoencephalopathy: Prognosis and treatment",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Leukodystrophies and leukoencephalopathies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/58/40872\">",
"           Alexander disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/36/12873\">",
"           Aspartoacylase deficiency (Canavan disease)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/4/34888\">",
"           Cerebrotendinous xanthomatosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/40/9862\">",
"           Leukoencephalopathy due to heroin inhalation (chasing the dragon)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/9/13465\">",
"           Pelizaeus-Merzbacher disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/3/26681\">",
"           Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/59/17336\">",
"           Progressive multifocal leukoencephalopathy: Prognosis and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/53/35671\">",
"           Sj������gren-Larsson syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/31/38392\">",
"           Vanishing white matter disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Multiple sclerosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/15/37112\">",
"           Clinically isolated syndromes suggestive of multiple sclerosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/7/36985\">",
"           Comorbid problems associated with multiple sclerosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/19/35130\">",
"           Diagnosis of multiple sclerosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/44/32458\">",
"           Epidemiology and clinical features of multiple sclerosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/31/23032\">",
"           Natalizumab for relapsing-remitting multiple sclerosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/15/9464\">",
"           Optic neuritis: Pathophysiology, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/15/29944\">",
"           Optic neuritis: Prognosis and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/63/3061\">",
"           Treatment of acute exacerbations of multiple sclerosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/41/26265\">",
"           Treatment of progressive multiple sclerosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/7/41082\">",
"           Treatment of relapsing-remitting multiple sclerosis in adults",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-3842810A1C-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f9_0_9230=[""].join("\n");
var outline_f9_0_9230=null;
var title_f9_0_9231="Contents: Endocrine tumors";
var content_f9_0_9231=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?3/12/3278\">",
"       Gastroenterology and Hepatology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Endocrine tumors",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Endocrine tumors",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Adrenal tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/13/5338\">",
"           Approach to the patient with hypertension and hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/1/37911\">",
"           Clinical features of primary aldosteronism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/5/22618\">",
"           Clinical features, diagnosis, and management of von Hippel-Lindau disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/48/22282\">",
"           Epidemiology and clinical manifestations of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/31/31225\">",
"           Establishing the cause of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/25/21913\">",
"           Establishing the diagnosis of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/0/3081\">",
"           Medical therapy of hypercortisolism (Cushing���������s syndrome)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/63/1016\">",
"           Overview of the treatment of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/26/17834\">",
"           Primary therapy of Cushing's disease: Transsphenoidal surgery and pituitary irradiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/8/18569\">",
"           The adrenal incidentaloma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/51/40762\">",
"           Treatment of adrenocortical carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/16/40199\">",
"           Treatment of primary aldosteronism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Carcinoid tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/11/12472\">",
"           Carcinoid heart disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/60/969\">",
"           Clinical characteristics of carcinoid tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/63/9206\">",
"           Clinical features of the carcinoid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/8/11400\">",
"           Diagnosis of the carcinoid syndrome and tumor localization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/61/39897\">",
"           Treatment and surveillance of non-metastatic carcinoid tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/31/16888\">",
"           Treatment of the carcinoid syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Metastatic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/30/43496\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/32/6665\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/46/39658\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Multiple endocrine neoplasia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/42/8872\">",
"           Approach to therapy in multiple endocrine neoplasia type 2",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/16/22794\">",
"           Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/14/43240\">",
"           Multiple endocrine neoplasia type 1: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/49/17174\">",
"           Multiple endocrine neoplasia type 1: Definition and genetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/61/38871\">",
"           Multiple endocrine neoplasia type 1: Treatment",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pancreatic endocrine tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/57/18330\">",
"           Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/5/22618\">",
"           Clinical features, diagnosis, and management of von Hippel-Lindau disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/10/14504\">",
"           Clinical manifestations and diagnosis of Zollinger-Ellison syndrome (gastrinoma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/35/22071\">",
"           Diagnostic dilemmas in hypoglycemia: Illustrative cases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/57/31640\">",
"           Glucagonoma and the glucagonoma syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/30/12777\">",
"           Insulinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/51/6968\">",
"           Management and prognosis of the Zollinger-Ellison syndrome (gastrinoma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/34/3623\">",
"           Somatostatinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/59/16311\">",
"           The VIPoma syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Parathyroid tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/19/1338\">",
"           Clinical manifestations of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/26/5545\">",
"           Diagnosis and differential diagnosis of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/47/8954\">",
"           Management of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/23/13688\">",
"           Parathyroid carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/28/40387\">",
"           Parathyroid cysts",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/41/30361\">",
"           Pathogenesis and etiology of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/60/18377\">",
"           Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pituitary tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/3/30776\">",
"           Causes and clinical manifestations of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/18/29992\">",
"           Causes, presentation, and evaluation of sellar masses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/61/22489\">",
"           Clinical manifestations and diagnosis of gonadotroph and other clinically nonfunctioning pituitary adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/4/43076\">",
"           Diagnosis of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/28/41413\">",
"           Diagnosis of hypopituitarism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/34/41510\">",
"           Management of lactotroph adenoma (prolactinoma) during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/20/327\">",
"           Thyrotropin (TSH)-secreting pituitary adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/9/7322\">",
"           Treatment of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/41/8857\">",
"           Treatment of gonadotroph and other clinically nonfunctioning adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/52/31561\">",
"           Treatment of hyperprolactinemia due to lactotroph adenoma and other causes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Thyroid tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/10/23721\">",
"           Anaplastic thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/47/23288\">",
"           Chemotherapy and immunotherapy for medullary thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/43/28345\">",
"           Chemotherapy for differentiated thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/16/14599\">",
"           Clinicopathologic staging of differentiated thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/4/4165\">",
"           Exogenous hyperthyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/17/39191\">",
"           External beam radiotherapy in the treatment of thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/21/9560\">",
"           Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/23/38263\">",
"           Medullary thyroid cancer: Treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/15/8440\">",
"           Overview of papillary thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/17/44313\">",
"           Overview of the management of differentiated thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/49/1818\">",
"           Radiation-induced thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/13/34010\">",
"           Radioiodine treatment of differentiated thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/39/37496\">",
"           Serum thyroglobulin in the management of differentiated thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/30/13799\">",
"           Struma ovarii",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/6/41064\">",
"           Surgical treatment of differentiated thyroid cancer",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-3BACBE69BA-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f9_0_9231=[""].join("\n");
var outline_f9_0_9231=null;
